id	sid	tid	token	lemma	pos
easat-8115	1	1	edelweiss	edelweiss	PROPN
easat-8115	1	2	applied	apply	VERB
easat-8115	1	3	science	science	NOUN
easat-8115	1	4	and	and	CCONJ
easat-8115	1	5	technology	technology	NOUN
easat-8115	1	6	issn	issn	PROPN
easat-8115	1	7	:	:	PUNCT
easat-8115	1	8	2576	2576	NUM
easat-8115	1	9	-	-	SYM
easat-8115	1	10	8484	8484	NUM
easat-8115	1	11	vol	vol	NOUN
easat-8115	1	12	.	.	PROPN
easat-8115	2	1	9	9	NUM
easat-8115	2	2	,	,	PUNCT
easat-8115	2	3	no	no	INTJ
easat-8115	2	4	.	.	NOUN
easat-8115	2	5	6	6	NUM
easat-8115	2	6	,	,	PUNCT
easat-8115	2	7	1331	1331	NUM
easat-8115	2	8	-	-	SYM
easat-8115	2	9	1341	1341	NUM
easat-8115	2	10	2025	2025	NUM
easat-8115	2	11	publisher	publisher	NOUN
easat-8115	2	12	:	:	PUNCT
easat-8115	2	13	learning	learn	VERB
easat-8115	2	14	gate	gate	NOUN
easat-8115	2	15	doi	doi	PROPN
easat-8115	2	16	:	:	PUNCT
easat-8115	2	17	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	2	18	©	©	PROPN
easat-8115	2	19	2025	2025	NUM
easat-8115	2	20	by	by	ADP
easat-8115	2	21	the	the	DET
easat-8115	2	22	authors	author	NOUN
easat-8115	2	23	;	;	PUNCT
easat-8115	2	24	licensee	licensee	PROPN
easat-8115	2	25	learning	learning	NOUN
easat-8115	2	26	gate	gate	NOUN
easat-8115	3	1	©	©	PROPN
easat-8115	3	2	2025	2025	NUM
easat-8115	3	3	by	by	ADP
easat-8115	3	4	the	the	DET
easat-8115	3	5	authors	author	NOUN
easat-8115	3	6	;	;	PUNCT
easat-8115	3	7	licensee	licensee	PROPN
easat-8115	3	8	learning	learning	NOUN
easat-8115	3	9	gate	gate	NOUN
easat-8115	3	10	history	history	NOUN
easat-8115	3	11	:	:	PUNCT
easat-8115	3	12	received	receive	VERB
easat-8115	3	13	:	:	PUNCT
easat-8115	3	14	24	24	NUM
easat-8115	3	15	march	march	NOUN
easat-8115	3	16	2025	2025	NUM
easat-8115	3	17	;	;	PUNCT
easat-8115	3	18	revised	revise	VERB
easat-8115	3	19	:	:	PUNCT
easat-8115	3	20	27	27	NUM
easat-8115	3	21	may	may	PROPN
easat-8115	3	22	2025	2025	NUM
easat-8115	3	23	;	;	PUNCT
easat-8115	3	24	accepted	accept	VERB
easat-8115	3	25	:	:	PUNCT
easat-8115	3	26	30	30	NUM
easat-8115	3	27	may	may	PROPN
easat-8115	3	28	2025	2025	NUM
easat-8115	3	29	;	;	PUNCT
easat-8115	3	30	published	publish	VERB
easat-8115	3	31	:	:	PUNCT
easat-8115	3	32	17	17	NUM
easat-8115	3	33	june	june	PROPN
easat-8115	3	34	2025	2025	NUM
easat-8115	3	35	*	*	PUNCT
easat-8115	3	36	correspondence	correspondence	NOUN
easat-8115	3	37	:	:	PUNCT
easat-8115	3	38	agus_somia@yahoo.co.id	agus_somia@yahoo.co.id	NUM
easat-8115	3	39	relationship	relationship	NOUN
easat-8115	3	40	between	between	ADP
easat-8115	3	41	clinical	clinical	ADJ
easat-8115	3	42	,	,	PUNCT
easat-8115	3	43	laboratory	laboratory	NOUN
easat-8115	3	44	,	,	PUNCT
easat-8115	3	45	and	and	CCONJ
easat-8115	3	46	radiological	radiological	ADJ
easat-8115	3	47	parameters	parameter	NOUN
easat-8115	3	48	with	with	ADP
easat-8115	3	49	polymerase	polymerase	NOUN
easat-8115	3	50	chain	chain	NOUN
easat-8115	3	51	reaction	reaction	NOUN
easat-8115	3	52	positivity	positivity	NOUN
easat-8115	3	53	sputum	sputum	NOUN
easat-8115	3	54	in	in	ADP
easat-8115	3	55	adult	adult	NOUN
easat-8115	3	56	hiv	hiv	PROPN
easat-8115	3	57	patients	patient	NOUN
easat-8115	3	58	with	with	ADP
easat-8115	3	59	suspicion	suspicion	NOUN
easat-8115	3	60	of	of	ADP
easat-8115	3	61	pneumocystis	pneumocystis	ADJ
easat-8115	3	62	jirovecii	jirovecii	ADJ
easat-8115	3	63	pneumonia	pneumonia	NOUN
easat-8115	3	64	kadek	kadek	PROPN
easat-8115	4	1	surya	surya	PROPN
easat-8115	4	2	atmaja1	atmaja1	PROPN
easat-8115	4	3	*	*	PROPN
easat-8115	4	4	,	,	PUNCT
easat-8115	4	5	i	i	PRON
easat-8115	4	6	ketut	ketut	VERB
easat-8115	4	7	agus	agus	PROPN
easat-8115	4	8	somia2	somia2	PROPN
easat-8115	4	9	,	,	PUNCT
easat-8115	4	10	i	i	PRON
easat-8115	4	11	desak	desak	VERB
easat-8115	4	12	putu	putu	PROPN
easat-8115	4	13	agung	agung	PROPN
easat-8115	4	14	krisdanti3	krisdanti3	PROPN
easat-8115	4	15	,	,	PUNCT
easat-8115	4	16	ni	ni	PROPN
easat-8115	4	17	wayan	wayan	PROPN
easat-8115	4	18	candrawati4	candrawati4	PROPN
easat-8115	4	19	,	,	PUNCT
easat-8115	4	20	ida	ida	PROPN
easat-8115	4	21	ayu	ayu	PROPN
easat-8115	4	22	jasminarti	jasminarti	PROPN
easat-8115	4	23	dwi	dwi	PROPN
easat-8115	4	24	kusumawardani5	kusumawardani5	PROPN
easat-8115	4	25	,	,	PUNCT
easat-8115	4	26	ni	ni	PROPN
easat-8115	4	27	luh	luh	PROPN
easat-8115	4	28	putu	putu	PROPN
easat-8115	4	29	eka	eka	PROPN
easat-8115	4	30	arisanti6	arisanti6	PROPN
easat-8115	4	31	1,4,5,6department	1,4,5,6department	NUM
easat-8115	4	32	of	of	ADP
easat-8115	4	33	pulmonology	pulmonology	NOUN
easat-8115	4	34	and	and	CCONJ
easat-8115	4	35	respiratory	respiratory	ADJ
easat-8115	4	36	medicine	medicine	NOUN
easat-8115	4	37	,	,	PUNCT
easat-8115	4	38	faculty	faculty	NOUN
easat-8115	4	39	of	of	ADP
easat-8115	4	40	medicine	medicine	NOUN
easat-8115	4	41	,	,	PUNCT
easat-8115	4	42	udayana	udayana	ADJ
easat-8115	4	43	university	university	NOUN
easat-8115	4	44	,	,	PUNCT
easat-8115	4	45	ngoerah	ngoerah	PROPN
easat-8115	4	46	hospital	hospital	PROPN
easat-8115	4	47	,	,	PUNCT
easat-8115	4	48	bali	bali	PROPN
easat-8115	4	49	,	,	PUNCT
easat-8115	4	50	indonesia	indonesia	PROPN
easat-8115	4	51	;	;	PUNCT
easat-8115	5	1	suratmaja89@gmail.com	suratmaja89@gmail.com	PROPN
easat-8115	5	2	(	(	PUNCT
easat-8115	5	3	k.s.a	k.s.a	NOUN
easat-8115	5	4	.	.	PUNCT
easat-8115	5	5	)	)	PUNCT
easat-8115	6	1	candrawati@unud.ac.id	candrawati@unud.ac.id	NOUN
easat-8115	6	2	(	(	PUNCT
easat-8115	6	3	n.w.c	n.w.c	NOUN
easat-8115	6	4	.	.	PUNCT
easat-8115	6	5	)	)	PUNCT
easat-8115	6	6	jasminarti@unud.ac.id	jasminarti@unud.ac.id	PROPN
easat-8115	6	7	(	(	PUNCT
easat-8115	6	8	i.a.j.d.k	i.a.j.d.k	ADV
easat-8115	6	9	.	.	PUNCT
easat-8115	6	10	)	)	PUNCT
easat-8115	7	1	dr.eka.arisanti@gmail.com	dr.eka.arisanti@gmail.com	PROPN
easat-8115	7	2	(	(	PUNCT
easat-8115	7	3	n.l.p.e.a	n.l.p.e.a	PROPN
easat-8115	7	4	.	.	PUNCT
easat-8115	7	5	)	)	PUNCT
easat-8115	7	6	.	.	PUNCT
easat-8115	8	1	2department	2department	NUM
easat-8115	8	2	of	of	ADP
easat-8115	8	3	internal	internal	ADJ
easat-8115	8	4	medicine	medicine	NOUN
easat-8115	8	5	,	,	PUNCT
easat-8115	8	6	faculty	faculty	NOUN
easat-8115	8	7	of	of	ADP
easat-8115	8	8	medicine	medicine	NOUN
easat-8115	8	9	,	,	PUNCT
easat-8115	8	10	udayana	udayana	ADJ
easat-8115	8	11	university	university	NOUN
easat-8115	8	12	,	,	PUNCT
easat-8115	8	13	ngoerah	ngoerah	PROPN
easat-8115	8	14	hospital	hospital	PROPN
easat-8115	8	15	,	,	PUNCT
easat-8115	8	16	bali	bali	PROPN
easat-8115	8	17	,	,	PUNCT
easat-8115	8	18	indonesia	indonesia	PROPN
easat-8115	8	19	;	;	PUNCT
easat-8115	8	20	agus_somia@yahoo.co.id	agus_somia@yahoo.co.id	NUM
easat-8115	8	21	(	(	PUNCT
easat-8115	8	22	i.k.a.s	i.k.a.s	PROPN
easat-8115	8	23	.	.	PROPN
easat-8115	8	24	)	)	PUNCT
easat-8115	8	25	.	.	PUNCT
easat-8115	9	1	3department	3department	NUM
easat-8115	9	2	pulmonology	pulmonology	NOUN
easat-8115	9	3	and	and	CCONJ
easat-8115	9	4	respiratory	respiratory	ADJ
easat-8115	9	5	medicine	medicine	NOUN
easat-8115	9	6	,	,	PUNCT
easat-8115	9	7	faculty	faculty	NOUN
easat-8115	9	8	of	of	ADP
easat-8115	9	9	medicine	medicine	NOUN
easat-8115	9	10	,	,	PUNCT
easat-8115	9	11	udayana	udayana	ADJ
easat-8115	9	12	university	university	NOUN
easat-8115	9	13	,	,	PUNCT
easat-8115	9	14	udayana	udayana	ADJ
easat-8115	9	15	university	university	NOUN
easat-8115	9	16	hospital	hospital	NOUN
easat-8115	9	17	,	,	PUNCT
easat-8115	9	18	bali	bali	PROPN
easat-8115	9	19	,	,	PUNCT
easat-8115	9	20	indonesia	indonesia	PROPN
easat-8115	9	21	;	;	PUNCT
easat-8115	9	22	desak.krisdanti21@gmail.com	desak.krisdanti21@gmail.com	X
easat-8115	9	23	(	(	PUNCT
easat-8115	9	24	i.d.p.a.k	i.d.p.a.k	NOUN
easat-8115	9	25	.	.	PUNCT
easat-8115	9	26	)	)	PUNCT
easat-8115	9	27	.	.	PUNCT
easat-8115	10	1	abstract	abstract	ADJ
easat-8115	10	2	:	:	PUNCT
easat-8115	10	3	pneumocystis	pneumocystis	ADJ
easat-8115	10	4	jirovecii	jirovecii	ADJ
easat-8115	10	5	pneumonia	pneumonia	NOUN
easat-8115	10	6	(	(	PUNCT
easat-8115	10	7	pcp	pcp	PROPN
easat-8115	10	8	)	)	PUNCT
easat-8115	10	9	is	be	AUX
easat-8115	10	10	a	a	DET
easat-8115	10	11	fungal	fungal	ADJ
easat-8115	10	12	infection	infection	NOUN
easat-8115	10	13	of	of	ADP
easat-8115	10	14	the	the	DET
easat-8115	10	15	lungs	lung	NOUN
easat-8115	10	16	caused	cause	VERB
easat-8115	10	17	by	by	ADP
easat-8115	10	18	p.	p.	PROPN
easat-8115	10	19	jirovecii	jirovecii	PROPN
easat-8115	10	20	,	,	PUNCT
easat-8115	10	21	usually	usually	ADV
easat-8115	10	22	affecting	affect	VERB
easat-8115	10	23	patients	patient	NOUN
easat-8115	10	24	with	with	ADP
easat-8115	10	25	human	human	ADJ
easat-8115	10	26	immunodeficiency	immunodeficiency	NOUN
easat-8115	10	27	virus	virus	NOUN
easat-8115	10	28	(	(	PUNCT
easat-8115	10	29	hiv	hiv	PROPN
easat-8115	10	30	)	)	PUNCT
easat-8115	10	31	.	.	PUNCT
easat-8115	11	1	the	the	DET
easat-8115	11	2	polymerase	polymerase	NOUN
easat-8115	11	3	chain	chain	NOUN
easat-8115	11	4	reaction	reaction	NOUN
easat-8115	11	5	(	(	PUNCT
easat-8115	11	6	pcr	pcr	NOUN
easat-8115	11	7	)	)	PUNCT
easat-8115	11	8	test	test	NOUN
easat-8115	11	9	is	be	AUX
easat-8115	11	10	used	use	VERB
easat-8115	11	11	in	in	ADP
easat-8115	11	12	the	the	DET
easat-8115	11	13	diagnosis	diagnosis	NOUN
easat-8115	11	14	of	of	ADP
easat-8115	11	15	pcp	pcp	NOUN
easat-8115	11	16	and	and	CCONJ
easat-8115	11	17	has	have	VERB
easat-8115	11	18	good	good	ADJ
easat-8115	11	19	sensitivity	sensitivity	NOUN
easat-8115	11	20	,	,	PUNCT
easat-8115	11	21	but	but	CCONJ
easat-8115	11	22	it	it	PRON
easat-8115	11	23	is	be	AUX
easat-8115	11	24	not	not	PART
easat-8115	11	25	available	available	ADJ
easat-8115	11	26	in	in	ADP
easat-8115	11	27	all	all	DET
easat-8115	11	28	healthcare	healthcare	NOUN
easat-8115	11	29	facilities	facility	NOUN
easat-8115	11	30	.	.	PUNCT
easat-8115	12	1	clinical	clinical	ADJ
easat-8115	12	2	,	,	PUNCT
easat-8115	12	3	laboratory	laboratory	NOUN
easat-8115	12	4	,	,	PUNCT
easat-8115	12	5	and	and	CCONJ
easat-8115	12	6	radiological	radiological	ADJ
easat-8115	12	7	parameters	parameter	NOUN
easat-8115	12	8	can	can	AUX
easat-8115	12	9	serve	serve	VERB
easat-8115	12	10	as	as	ADP
easat-8115	12	11	alternatives	alternative	NOUN
easat-8115	12	12	to	to	PART
easat-8115	12	13	support	support	VERB
easat-8115	12	14	the	the	DET
easat-8115	12	15	diagnosis	diagnosis	NOUN
easat-8115	12	16	of	of	ADP
easat-8115	12	17	pcp	pcp	PROPN
easat-8115	12	18	in	in	ADP
easat-8115	12	19	hiv	hiv	PROPN
easat-8115	12	20	patients	patient	NOUN
easat-8115	12	21	.	.	PUNCT
easat-8115	13	1	this	this	DET
easat-8115	13	2	study	study	NOUN
easat-8115	13	3	is	be	AUX
easat-8115	13	4	an	an	DET
easat-8115	13	5	analytical	analytical	ADJ
easat-8115	13	6	observational	observational	ADJ
easat-8115	13	7	study	study	NOUN
easat-8115	13	8	with	with	ADP
easat-8115	13	9	a	a	DET
easat-8115	13	10	cross	cross	ADJ
easat-8115	13	11	-	-	ADJ
easat-8115	13	12	sectional	sectional	ADJ
easat-8115	13	13	design	design	NOUN
easat-8115	13	14	.	.	PUNCT
easat-8115	14	1	the	the	DET
easat-8115	14	2	assessment	assessment	NOUN
easat-8115	14	3	of	of	ADP
easat-8115	14	4	clinical	clinical	ADJ
easat-8115	14	5	,	,	PUNCT
easat-8115	14	6	laboratory	laboratory	NOUN
easat-8115	14	7	,	,	PUNCT
easat-8115	14	8	and	and	CCONJ
easat-8115	14	9	radiological	radiological	ADJ
easat-8115	14	10	parameters	parameter	NOUN
easat-8115	14	11	of	of	ADP
easat-8115	14	12	pcp	pcp	PROPN
easat-8115	14	13	patients	patient	NOUN
easat-8115	14	14	was	be	AUX
easat-8115	14	15	conducted	conduct	VERB
easat-8115	14	16	from	from	ADP
easat-8115	14	17	june	june	PROPN
easat-8115	14	18	to	to	ADP
easat-8115	14	19	december	december	PROPN
easat-8115	14	20	2024	2024	NUM
easat-8115	14	21	.	.	PUNCT
easat-8115	15	1	variables	variable	NOUN
easat-8115	15	2	were	be	AUX
easat-8115	15	3	compared	compare	VERB
easat-8115	15	4	using	use	VERB
easat-8115	15	5	an	an	DET
easat-8115	15	6	independent	independent	ADJ
easat-8115	15	7	ttest	ttest	NOUN
easat-8115	15	8	if	if	SCONJ
easat-8115	15	9	normally	normally	ADV
easat-8115	15	10	distributed	distribute	VERB
easat-8115	15	11	or	or	CCONJ
easat-8115	15	12	the	the	DET
easat-8115	15	13	mann	mann	PROPN
easat-8115	15	14	-	-	PUNCT
easat-8115	15	15	whitney	whitney	PROPN
easat-8115	15	16	test	test	NOUN
easat-8115	15	17	if	if	SCONJ
easat-8115	15	18	not	not	PART
easat-8115	15	19	normally	normally	ADV
easat-8115	15	20	distributed	distribute	VERB
easat-8115	15	21	.	.	PUNCT
easat-8115	16	1	nominal	nominal	ADJ
easat-8115	16	2	variables	variable	NOUN
easat-8115	16	3	were	be	AUX
easat-8115	16	4	compared	compare	VERB
easat-8115	16	5	using	use	VERB
easat-8115	16	6	the	the	DET
easat-8115	16	7	chi	chi	ADJ
easat-8115	16	8	-	-	PUNCT
easat-8115	16	9	square	square	ADJ
easat-8115	16	10	test	test	NOUN
easat-8115	16	11	.	.	PUNCT
easat-8115	17	1	multivariate	multivariate	NOUN
easat-8115	17	2	analysis	analysis	NOUN
easat-8115	17	3	employed	employ	VERB
easat-8115	17	4	logistic	logistic	ADJ
easat-8115	17	5	regression	regression	NOUN
easat-8115	17	6	analysis	analysis	NOUN
easat-8115	17	7	.	.	PUNCT
easat-8115	18	1	a	a	DET
easat-8115	18	2	total	total	NOUN
easat-8115	18	3	of	of	ADP
easat-8115	18	4	80	80	NUM
easat-8115	18	5	patients	patient	NOUN
easat-8115	18	6	participated	participate	VERB
easat-8115	18	7	in	in	ADP
easat-8115	18	8	the	the	DET
easat-8115	18	9	study	study	NOUN
easat-8115	18	10	.	.	PUNCT
easat-8115	19	1	from	from	ADP
easat-8115	19	2	the	the	DET
easat-8115	19	3	multivariate	multivariate	NOUN
easat-8115	19	4	analysis	analysis	NOUN
easat-8115	19	5	,	,	PUNCT
easat-8115	19	6	clinical	clinical	ADJ
easat-8115	19	7	parameters	parameter	NOUN
easat-8115	19	8	such	such	ADJ
easat-8115	19	9	as	as	ADP
easat-8115	19	10	low	low	ADJ
easat-8115	19	11	-	-	PUNCT
easat-8115	19	12	grade	grade	NOUN
easat-8115	19	13	fever	fever	NOUN
easat-8115	19	14	(	(	PUNCT
easat-8115	19	15	pr	pr	NOUN
easat-8115	19	16	23.9	23.9	NUM
easat-8115	19	17	;	;	PUNCT
easat-8115	19	18	95	95	NUM
easat-8115	19	19	%	%	NOUN
easat-8115	19	20	ci	ci	NOUN
easat-8115	19	21	4.086	4.086	NUM
easat-8115	19	22	-	-	SYM
easat-8115	19	23	141.01	141.01	NUM
easat-8115	19	24	;	;	PUNCT
easat-8115	19	25	p	p	X
easat-8115	19	26	<	<	X
easat-8115	19	27	0.001	0.001	NUM
easat-8115	19	28	)	)	PUNCT
easat-8115	19	29	,	,	PUNCT
easat-8115	19	30	non	non	ADJ
easat-8115	19	31	-	-	ADJ
easat-8115	19	32	productive	productive	ADJ
easat-8115	19	33	cough	cough	NOUN
easat-8115	19	34	(	(	PUNCT
easat-8115	19	35	pr	pr	NOUN
easat-8115	19	36	7.108	7.108	NUM
easat-8115	19	37	;	;	PUNCT
easat-8115	19	38	95	95	NUM
easat-8115	19	39	%	%	NOUN
easat-8115	19	40	ci	ci	NOUN
easat-8115	19	41	1.25–40.1	1.25–40.1	PROPN
easat-8115	19	42	;	;	PUNCT
easat-8115	19	43	p	p	PROPN
easat-8115	19	44	=	=	PROPN
easat-8115	19	45	0.027	0.027	NUM
easat-8115	19	46	)	)	PUNCT
easat-8115	19	47	,	,	PUNCT
easat-8115	19	48	and	and	CCONJ
easat-8115	19	49	oral	oral	ADJ
easat-8115	19	50	candidiasis	candidiasis	NOUN
easat-8115	19	51	(	(	PUNCT
easat-8115	19	52	pr	pr	NOUN
easat-8115	19	53	8.81	8.81	NUM
easat-8115	19	54	;	;	PUNCT
easat-8115	19	55	95	95	NUM
easat-8115	19	56	%	%	NOUN
easat-8115	19	57	ci	ci	NOUN
easat-8115	19	58	1.62–47.8	1.62–47.8	NUM
easat-8115	19	59	;	;	PUNCT
easat-8115	19	60	p	p	X
easat-8115	19	61	=	=	PROPN
easat-8115	19	62	0.012	0.012	NUM
easat-8115	19	63	)	)	PUNCT
easat-8115	19	64	were	be	AUX
easat-8115	19	65	significant	significant	ADJ
easat-8115	19	66	.	.	PUNCT
easat-8115	20	1	laboratory	laboratory	NOUN
easat-8115	20	2	parameters	parameter	NOUN
easat-8115	20	3	such	such	ADJ
easat-8115	20	4	as	as	ADP
easat-8115	20	5	lymphocyte	lymphocyte	ADJ
easat-8115	20	6	count	count	NOUN
easat-8115	20	7	≤1.2×10³/µl	≤1.2×10³/µl	PROPN
easat-8115	20	8	(	(	PUNCT
easat-8115	20	9	pr	pr	PROPN
easat-8115	20	10	19.4	19.4	NUM
easat-8115	20	11	;	;	PUNCT
easat-8115	20	12	95	95	NUM
easat-8115	20	13	%	%	NOUN
easat-8115	20	14	ci	ci	PROPN
easat-8115	20	15	2.5–149.3	2.5–149.3	PROPN
easat-8115	20	16	;	;	PUNCT
easat-8115	20	17	p	p	NOUN
easat-8115	20	18	=	=	NOUN
easat-8115	20	19	0.004	0.004	NUM
easat-8115	20	20	)	)	PUNCT
easat-8115	20	21	,	,	PUNCT
easat-8115	20	22	albumin	albumin	NOUN
easat-8115	20	23	≤3.1	≤3.1	PROPN
easat-8115	20	24	g	g	PROPN
easat-8115	20	25	/	/	SYM
easat-8115	20	26	dl	dl	PROPN
easat-8115	20	27	(	(	PUNCT
easat-8115	20	28	pr	pr	NOUN
easat-8115	20	29	5.59	5.59	NUM
easat-8115	20	30	;	;	PUNCT
easat-8115	20	31	95	95	NUM
easat-8115	20	32	%	%	NOUN
easat-8115	20	33	ci	ci	NOUN
easat-8115	20	34	1.062–29.4	1.062–29.4	NUM
easat-8115	20	35	;	;	PUNCT
easat-8115	20	36	p	p	X
easat-8115	20	37	=	=	NOUN
easat-8115	20	38	0.042	0.042	NUM
easat-8115	20	39	)	)	PUNCT
easat-8115	20	40	,	,	PUNCT
easat-8115	20	41	and	and	CCONJ
easat-8115	20	42	cd4	cd4	PROPN
easat-8115	20	43	count	count	VERB
easat-8115	20	44	≤200	≤200	PUNCT
easat-8115	21	1	cells/µl	cells/µl	NOUN
easat-8115	21	2	(	(	PUNCT
easat-8115	21	3	pr	pr	NOUN
easat-8115	21	4	14.3	14.3	NUM
easat-8115	21	5	;	;	PUNCT
easat-8115	21	6	95	95	NUM
easat-8115	21	7	%	%	NOUN
easat-8115	21	8	ci	ci	NOUN
easat-8115	21	9	2.06–99.69	2.06–99.69	NOUN
easat-8115	21	10	;	;	PUNCT
easat-8115	21	11	p	p	X
easat-8115	21	12	=	=	NOUN
easat-8115	21	13	0.007	0.007	NUM
easat-8115	21	14	)	)	PUNCT
easat-8115	21	15	were	be	AUX
easat-8115	21	16	also	also	ADV
easat-8115	21	17	significant	significant	ADJ
easat-8115	21	18	.	.	PUNCT
easat-8115	22	1	typical	typical	ADJ
easat-8115	22	2	radiological	radiological	ADJ
easat-8115	22	3	parameters	parameter	NOUN
easat-8115	22	4	(	(	PUNCT
easat-8115	22	5	pr	pr	NOUN
easat-8115	22	6	20.6	20.6	NUM
easat-8115	22	7	;	;	PUNCT
easat-8115	22	8	95	95	NUM
easat-8115	22	9	%	%	NOUN
easat-8115	22	10	ci	ci	PROPN
easat-8115	22	11	2.9–144.2	2.9–144.2	NUM
easat-8115	22	12	;	;	PUNCT
easat-8115	22	13	p	p	X
easat-8115	22	14	=	=	NOUN
easat-8115	22	15	0.02	0.02	NUM
easat-8115	22	16	)	)	PUNCT
easat-8115	22	17	and	and	CCONJ
easat-8115	22	18	atypical	atypical	ADJ
easat-8115	22	19	radiological	radiological	ADJ
easat-8115	22	20	parameters	parameter	NOUN
easat-8115	22	21	(	(	PUNCT
easat-8115	22	22	pr	pr	NOUN
easat-8115	22	23	5.43	5.43	NUM
easat-8115	22	24	;	;	PUNCT
easat-8115	22	25	95	95	NUM
easat-8115	22	26	%	%	NOUN
easat-8115	22	27	ci	ci	NOUN
easat-8115	22	28	1.47–20.05	1.47–20.05	NUM
easat-8115	23	1	;	;	PUNCT
easat-8115	23	2	p	p	NOUN
easat-8115	23	3	=	=	NOUN
easat-8115	23	4	0.02	0.02	NUM
easat-8115	23	5	)	)	PUNCT
easat-8115	23	6	showed	show	VERB
easat-8115	23	7	a	a	DET
easat-8115	23	8	significant	significant	ADJ
easat-8115	23	9	relationship	relationship	NOUN
easat-8115	23	10	with	with	ADP
easat-8115	23	11	sputum	sputum	PROPN
easat-8115	23	12	pcr	pcr	PROPN
easat-8115	23	13	positivity	positivity	NOUN
easat-8115	23	14	for	for	ADP
easat-8115	23	15	pcp	pcp	PROPN
easat-8115	23	16	in	in	ADP
easat-8115	23	17	hiv	hiv	PROPN
easat-8115	23	18	patients	patient	NOUN
easat-8115	23	19	.	.	PUNCT
easat-8115	24	1	low	low	ADJ
easat-8115	24	2	-	-	PUNCT
easat-8115	24	3	grade	grade	NOUN
easat-8115	24	4	fever	fever	NOUN
easat-8115	24	5	,	,	PUNCT
easat-8115	24	6	nonproductive	nonproductive	ADJ
easat-8115	24	7	cough	cough	NOUN
easat-8115	24	8	,	,	PUNCT
easat-8115	24	9	oral	oral	ADJ
easat-8115	24	10	candidiasis	candidiasis	NOUN
easat-8115	24	11	,	,	PUNCT
easat-8115	24	12	lymphocyte	lymphocyte	ADJ
easat-8115	24	13	count	count	NOUN
easat-8115	24	14	≤1.2×10³/µl	≤1.2×10³/µl	PROPN
easat-8115	24	15	,	,	PUNCT
easat-8115	24	16	albumin	albumin	NOUN
easat-8115	24	17	≤3.1	≤3.1	PROPN
easat-8115	24	18	g	g	PROPN
easat-8115	24	19	/	/	SYM
easat-8115	24	20	dl	dl	PROPN
easat-8115	24	21	,	,	PUNCT
easat-8115	24	22	cd4	cd4	PROPN
easat-8115	24	23	count	count	VERB
easat-8115	24	24	≤200	≤200	PROPN
easat-8115	24	25	cells/µl	cells/µl	NOUN
easat-8115	24	26	,	,	PUNCT
easat-8115	24	27	and	and	CCONJ
easat-8115	24	28	typical	typical	ADJ
easat-8115	24	29	and	and	CCONJ
easat-8115	24	30	atypical	atypical	ADJ
easat-8115	24	31	chest	chest	NOUN
easat-8115	24	32	x	x	NOUN
easat-8115	24	33	-	-	NOUN
easat-8115	24	34	ray	ray	NOUN
easat-8115	24	35	images	image	NOUN
easat-8115	24	36	are	be	AUX
easat-8115	24	37	associated	associate	VERB
easat-8115	24	38	with	with	ADP
easat-8115	24	39	sputum	sputum	PROPN
easat-8115	24	40	pcr	pcr	PROPN
easat-8115	24	41	positivity	positivity	NOUN
easat-8115	24	42	in	in	ADP
easat-8115	24	43	hiv	hiv	PROPN
easat-8115	24	44	patients	patient	NOUN
easat-8115	24	45	suspected	suspect	VERB
easat-8115	24	46	of	of	ADP
easat-8115	24	47	having	have	VERB
easat-8115	24	48	pcp	pcp	NOUN
easat-8115	24	49	.	.	PUNCT
easat-8115	25	1	keywords	keyword	NOUN
easat-8115	25	2	:	:	PUNCT
easat-8115	25	3	human	human	ADJ
easat-8115	25	4	immunodeficiency	immunodeficiency	NOUN
easat-8115	25	5	virus	virus	NOUN
easat-8115	25	6	(	(	PUNCT
easat-8115	25	7	hiv	hiv	PROPN
easat-8115	25	8	)	)	PUNCT
easat-8115	25	9	,	,	PUNCT
easat-8115	25	10	pcr	pcr	PROPN
easat-8115	25	11	sputum	sputum	PROPN
easat-8115	25	12	pcp	pcp	PROPN
easat-8115	25	13	,	,	PUNCT
easat-8115	25	14	pneumocystis	pneumocystis	NOUN
easat-8115	25	15	jirovecii	jirovecii	ADJ
easat-8115	25	16	pneumonia	pneumonia	NOUN
easat-8115	25	17	(	(	PUNCT
easat-8115	25	18	pcp	pcp	PROPN
easat-8115	25	19	)	)	PUNCT
easat-8115	25	20	.	.	PUNCT
easat-8115	26	1	1	1	X
easat-8115	26	2	.	.	X
easat-8115	26	3	introduction	introduction	NOUN
easat-8115	26	4	pneumocystis	pneumocystis	PROPN
easat-8115	26	5	jirovecii	jirovecii	ADJ
easat-8115	26	6	pneumonia	pneumonia	NOUN
easat-8115	26	7	(	(	PUNCT
easat-8115	26	8	pcp	pcp	PROPN
easat-8115	26	9	)	)	PUNCT
easat-8115	26	10	is	be	AUX
easat-8115	26	11	a	a	DET
easat-8115	26	12	fungal	fungal	ADJ
easat-8115	26	13	infection	infection	NOUN
easat-8115	26	14	of	of	ADP
easat-8115	26	15	the	the	DET
easat-8115	26	16	lungs	lung	NOUN
easat-8115	26	17	caused	cause	VERB
easat-8115	26	18	by	by	ADP
easat-8115	26	19	pnemocystis	pnemocystis	PROPN
easat-8115	26	20	jirovecii	jirovecii	NOUN
easat-8115	26	21	,	,	PUNCT
easat-8115	26	22	usually	usually	ADV
easat-8115	26	23	affecting	affect	VERB
easat-8115	26	24	immunocompromised	immunocompromise	VERB
easat-8115	26	25	individual	individual	NOUN
easat-8115	26	26	,	,	PUNCT
easat-8115	26	27	such	such	ADJ
easat-8115	26	28	as	as	ADP
easat-8115	26	29	human	human	ADJ
easat-8115	26	30	immunodeficiency	immunodeficiency	NOUN
easat-8115	26	31	virus	virus	NOUN
easat-8115	26	32	(	(	PUNCT
easat-8115	26	33	hiv	hiv	NOUN
easat-8115	26	34	)	)	PUNCT
easat-8115	26	35	patients	patient	NOUN
easat-8115	26	36	.	.	PUNCT
easat-8115	27	1	however	however	ADV
easat-8115	27	2	,	,	PUNCT
easat-8115	27	3	reports	report	NOUN
easat-8115	27	4	on	on	ADP
easat-8115	27	5	the	the	DET
easat-8115	27	6	incidence	incidence	NOUN
easat-8115	27	7	of	of	ADP
easat-8115	27	8	pcp	pcp	NOUN
easat-8115	27	9	are	be	AUX
easat-8115	27	10	still	still	ADV
easat-8115	27	11	very	very	ADV
easat-8115	27	12	few	few	ADJ
easat-8115	27	13	due	due	ADJ
easat-8115	27	14	to	to	ADP
easat-8115	27	15	difficulties	difficulty	NOUN
easat-8115	27	16	in	in	ADP
easat-8115	27	17	diagnosis	diagnosis	NOUN
easat-8115	27	18	,	,	PUNCT
easat-8115	27	19	although	although	SCONJ
easat-8115	27	20	this	this	DET
easat-8115	27	21	condition	condition	NOUN
easat-8115	27	22	can	can	AUX
easat-8115	27	23	be	be	AUX
easat-8115	27	24	life	life	NOUN
easat-8115	27	25	-	-	PUNCT
easat-8115	27	26	threatening	threatening	ADJ
easat-8115	27	27	.	.	PUNCT
easat-8115	28	1	the	the	DET
easat-8115	28	2	prevalence	prevalence	NOUN
easat-8115	28	3	of	of	ADP
easat-8115	28	4	pcp	pcp	PROPN
easat-8115	28	5	was	be	AUX
easat-8115	28	6	estimated	estimate	VERB
easat-8115	28	7	5	5	NUM
easat-8115	28	8	%	%	NOUN
easat-8115	28	9	in	in	ADP
easat-8115	28	10	hiv	hiv	PROPN
easat-8115	28	11	patients	patient	NOUN
easat-8115	28	12	with	with	ADP
easat-8115	28	13	overall	overall	ADJ
easat-8115	28	14	mortality	mortality	NOUN
easat-8115	28	15	3.3	3.3	NUM
easat-8115	28	16	%	%	NOUN
easat-8115	29	1	[	[	X
easat-8115	29	2	1	1	NUM
easat-8115	29	3	]	]	PUNCT
easat-8115	29	4	.	.	PUNCT
easat-8115	30	1	microscopic	microscopic	ADJ
easat-8115	30	2	examination	examination	NOUN
easat-8115	30	3	and	and	CCONJ
easat-8115	30	4	smear	smear	NOUN
easat-8115	30	5	staining	stain	VERB
easat-8115	30	6	to	to	PART
easat-8115	30	7	detect	detect	VERB
easat-8115	30	8	cysts	cyst	NOUN
easat-8115	30	9	or	or	CCONJ
easat-8115	30	10	immunofluorescence	immunofluorescence	NOUN
easat-8115	30	11	techniques	technique	NOUN
easat-8115	30	12	is	be	AUX
easat-8115	30	13	the	the	DET
easat-8115	30	14	gold	gold	ADJ
easat-8115	30	15	standard	standard	NOUN
easat-8115	30	16	in	in	ADP
easat-8115	30	17	pcp	pcp	NOUN
easat-8115	30	18	diagnosis	diagnosis	NOUN
easat-8115	30	19	,	,	PUNCT
easat-8115	30	20	but	but	CCONJ
easat-8115	30	21	have	have	VERB
easat-8115	30	22	very	very	ADV
easat-8115	30	23	low	low	ADJ
easat-8115	30	24	https://orcid.org/0000-0002-0034-9048	https://orcid.org/0000-0002-0034-9048	PROPN
easat-8115	30	25	https://orcid.org/0000-0001-6339-3401	https://orcid.org/0000-0001-6339-3401	PROPN
easat-8115	30	26	https://orcid.org/0009-0007-4923-1693	https://orcid.org/0009-0007-4923-1693	VERB
easat-8115	31	1	https://orcid.org/0000-0002-6634-0994	https://orcid.org/0000-0002-6634-0994	PROPN
easat-8115	31	2	https://orcid.org/0000-0002-2716-5222	https://orcid.org/0000-0002-2716-5222	NOUN
easat-8115	31	3	https://orcid.org/0000-0003-1702-3906	https://orcid.org/0000-0003-1702-3906	PROPN
easat-8115	31	4	1332	1332	NUM
easat-8115	31	5	edelweiss	edelweiss	PROPN
easat-8115	31	6	applied	apply	VERB
easat-8115	31	7	science	science	NOUN
easat-8115	31	8	and	and	CCONJ
easat-8115	31	9	technology	technology	NOUN
easat-8115	31	10	issn	issn	PROPN
easat-8115	31	11	:	:	PUNCT
easat-8115	31	12	2576	2576	NUM
easat-8115	31	13	-	-	SYM
easat-8115	31	14	8484	8484	NUM
easat-8115	31	15	vol	vol	NOUN
easat-8115	31	16	.	.	PROPN
easat-8115	32	1	9	9	NUM
easat-8115	32	2	,	,	PUNCT
easat-8115	32	3	no	no	INTJ
easat-8115	32	4	.	.	NOUN
easat-8115	33	1	6	6	NUM
easat-8115	33	2	:	:	SYM
easat-8115	33	3	1331	1331	NUM
easat-8115	33	4	-	-	SYM
easat-8115	33	5	1341	1341	NUM
easat-8115	33	6	,	,	PUNCT
easat-8115	33	7	2025	2025	NUM
easat-8115	33	8	doi	doi	NOUN
easat-8115	33	9	:	:	PUNCT
easat-8115	33	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	33	11	©	©	PROPN
easat-8115	33	12	2025	2025	NUM
easat-8115	33	13	by	by	ADP
easat-8115	33	14	the	the	DET
easat-8115	33	15	authors	author	NOUN
easat-8115	33	16	;	;	PUNCT
easat-8115	33	17	licensee	licensee	NOUN
easat-8115	33	18	learning	learn	VERB
easat-8115	33	19	gate	gate	NOUN
easat-8115	33	20	sensitivity	sensitivity	NOUN
easat-8115	33	21	and	and	CCONJ
easat-8115	33	22	require	require	VERB
easat-8115	33	23	bronchoalveolar	bronchoalveolar	ADJ
easat-8115	33	24	lavage	lavage	NOUN
easat-8115	33	25	(	(	PUNCT
easat-8115	33	26	bal	bal	ADJ
easat-8115	33	27	)	)	PUNCT
easat-8115	33	28	samples	sample	NOUN
easat-8115	33	29	to	to	PART
easat-8115	33	30	increase	increase	VERB
easat-8115	33	31	sensitivity	sensitivity	NOUN
easat-8115	33	32	.	.	PUNCT
easat-8115	34	1	several	several	ADJ
easat-8115	34	2	studies	study	NOUN
easat-8115	34	3	have	have	AUX
easat-8115	34	4	reported	report	VERB
easat-8115	34	5	that	that	SCONJ
easat-8115	34	6	the	the	DET
easat-8115	34	7	polymerase	polymerase	NOUN
easat-8115	34	8	chain	chain	NOUN
easat-8115	34	9	reaction	reaction	NOUN
easat-8115	34	10	(	(	PUNCT
easat-8115	34	11	pcr	pcr	NOUN
easat-8115	34	12	)	)	PUNCT
easat-8115	34	13	test	test	NOUN
easat-8115	34	14	in	in	ADP
easat-8115	34	15	pcp	pcp	NOUN
easat-8115	34	16	diagnosis	diagnosis	NOUN
easat-8115	34	17	has	have	VERB
easat-8115	34	18	good	good	ADJ
easat-8115	34	19	overall	overall	ADJ
easat-8115	34	20	sensitivity	sensitivity	NOUN
easat-8115	34	21	with	with	ADP
easat-8115	34	22	samples	sample	NOUN
easat-8115	34	23	not	not	PART
easat-8115	34	24	only	only	ADV
easat-8115	34	25	from	from	ADP
easat-8115	34	26	bal	bal	PROPN
easat-8115	34	27	,	,	PUNCT
easat-8115	34	28	but	but	CCONJ
easat-8115	34	29	also	also	ADV
easat-8115	34	30	sputum	sputum	NOUN
easat-8115	34	31	and	and	CCONJ
easat-8115	34	32	oral	oral	ADJ
easat-8115	34	33	mucosa	mucosa	NOUN
easat-8115	34	34	.	.	PUNCT
easat-8115	35	1	pcr	pcr	ADJ
easat-8115	35	2	test	test	NOUN
easat-8115	35	3	can	can	AUX
easat-8115	35	4	also	also	ADV
easat-8115	35	5	detect	detect	VERB
easat-8115	35	6	smaller	small	ADJ
easat-8115	35	7	number	number	NOUN
easat-8115	35	8	of	of	ADP
easat-8115	35	9	pathogens	pathogen	NOUN
easat-8115	35	10	than	than	ADP
easat-8115	35	11	standard	standard	ADJ
easat-8115	35	12	conventional	conventional	ADJ
easat-8115	35	13	smears	smear	NOUN
easat-8115	35	14	with	with	ADP
easat-8115	35	15	high	high	ADJ
easat-8115	35	16	sensitivity	sensitivity	NOUN
easat-8115	35	17	(	(	PUNCT
easat-8115	35	18	94%-100	94%-100	NUM
easat-8115	35	19	%	%	NOUN
easat-8115	35	20	)	)	PUNCT
easat-8115	35	21	and	and	CCONJ
easat-8115	35	22	specificity	specificity	NOUN
easat-8115	35	23	(	(	PUNCT
easat-8115	35	24	70%-96	70%-96	NUM
easat-8115	35	25	%	%	NOUN
easat-8115	35	26	)	)	PUNCT
easat-8115	35	27	.	.	PUNCT
easat-8115	36	1	delays	delay	NOUN
easat-8115	36	2	in	in	ADP
easat-8115	36	3	the	the	DET
easat-8115	36	4	management	management	NOUN
easat-8115	36	5	of	of	ADP
easat-8115	36	6	pcp	pcp	PROPN
easat-8115	36	7	due	due	ADP
easat-8115	36	8	to	to	ADP
easat-8115	36	9	late	late	ADJ
easat-8115	36	10	diagnosis	diagnosis	NOUN
easat-8115	36	11	increase	increase	VERB
easat-8115	36	12	the	the	DET
easat-8115	36	13	morbidity	morbidity	NOUN
easat-8115	36	14	and	and	CCONJ
easat-8115	36	15	mortality	mortality	NOUN
easat-8115	36	16	.	.	PUNCT
easat-8115	37	1	several	several	ADJ
easat-8115	37	2	alternatives	alternative	NOUN
easat-8115	37	3	such	such	ADJ
easat-8115	37	4	as	as	ADP
easat-8115	37	5	clinical	clinical	ADJ
easat-8115	37	6	,	,	PUNCT
easat-8115	37	7	laboratory	laboratory	NOUN
easat-8115	37	8	,	,	PUNCT
easat-8115	37	9	and	and	CCONJ
easat-8115	37	10	radiological	radiological	ADJ
easat-8115	37	11	parameters	parameter	NOUN
easat-8115	37	12	might	might	AUX
easat-8115	37	13	aid	aid	VERB
easat-8115	37	14	diagnosis	diagnosis	NOUN
easat-8115	37	15	of	of	ADP
easat-8115	37	16	pcp	pcp	PROPN
easat-8115	37	17	in	in	ADP
easat-8115	37	18	hiv	hiv	PROPN
easat-8115	37	19	patients	patient	NOUN
easat-8115	37	20	.	.	PUNCT
easat-8115	38	1	tang	tang	PROPN
easat-8115	39	1	[	[	X
easat-8115	39	2	2	2	X
easat-8115	39	3	]	]	PUNCT
easat-8115	39	4	found	find	VERB
easat-8115	39	5	that	that	SCONJ
easat-8115	39	6	routine	routine	ADJ
easat-8115	39	7	indicator	indicator	NOUN
easat-8115	39	8	examinations	examination	NOUN
easat-8115	39	9	such	such	ADJ
easat-8115	39	10	as	as	ADP
easat-8115	39	11	lymphocytes	lymphocyte	NOUN
easat-8115	39	12	,	,	PUNCT
easat-8115	39	13	monocytes	monocyte	NOUN
easat-8115	39	14	,	,	PUNCT
easat-8115	39	15	red	red	ADJ
easat-8115	39	16	blood	blood	NOUN
easat-8115	39	17	cells	cell	NOUN
easat-8115	39	18	,	,	PUNCT
easat-8115	39	19	total	total	ADJ
easat-8115	39	20	protein	protein	NOUN
easat-8115	39	21	,	,	PUNCT
easat-8115	39	22	albumin	albumin	PROPN
easat-8115	39	23	were	be	AUX
easat-8115	39	24	significantly	significantly	ADV
easat-8115	39	25	lower	low	ADJ
easat-8115	39	26	in	in	ADP
easat-8115	39	27	pcp	pcp	NOUN
easat-8115	39	28	patients	patient	NOUN
easat-8115	39	29	compared	compare	VERB
easat-8115	39	30	to	to	ADP
easat-8115	39	31	non	non	ADJ
easat-8115	39	32	-	-	NOUN
easat-8115	39	33	pcp	pcp	ADJ
easat-8115	39	34	,	,	PUNCT
easat-8115	39	35	while	while	SCONJ
easat-8115	39	36	ldh	ldh	PROPN
easat-8115	39	37	was	be	AUX
easat-8115	39	38	significantly	significantly	ADV
easat-8115	39	39	higher	high	ADJ
easat-8115	39	40	in	in	ADP
easat-8115	39	41	pcp	pcp	NOUN
easat-8115	39	42	patients	patient	NOUN
easat-8115	39	43	compared	compare	VERB
easat-8115	39	44	to	to	ADP
easat-8115	39	45	patients	patient	NOUN
easat-8115	39	46	without	without	ADP
easat-8115	39	47	pcp	pcp	PROPN
easat-8115	39	48	.	.	PUNCT
easat-8115	40	1	the	the	DET
easat-8115	40	2	combination	combination	NOUN
easat-8115	40	3	of	of	ADP
easat-8115	40	4	decreased	decrease	VERB
easat-8115	40	5	lymphocyte	lymphocyte	ADJ
easat-8115	40	6	cells	cell	NOUN
easat-8115	40	7	and	and	CCONJ
easat-8115	40	8	increased	increase	VERB
easat-8115	40	9	ldh	ldh	NOUN
easat-8115	40	10	was	be	AUX
easat-8115	40	11	able	able	ADJ
easat-8115	40	12	to	to	PART
easat-8115	40	13	distinguish	distinguish	VERB
easat-8115	40	14	pcp	pcp	NOUN
easat-8115	40	15	patients	patient	NOUN
easat-8115	40	16	compared	compare	VERB
easat-8115	40	17	to	to	ADP
easat-8115	40	18	those	those	PRON
easat-8115	40	19	without	without	ADP
easat-8115	40	20	pcp	pcp	PROPN
easat-8115	40	21	with	with	ADP
easat-8115	40	22	an	an	DET
easat-8115	40	23	auc	auc	NOUN
easat-8115	40	24	of	of	ADP
easat-8115	40	25	0.941	0.941	NUM
easat-8115	40	26	(	(	PUNCT
easat-8115	40	27	95	95	NUM
easat-8115	40	28	%	%	NOUN
easat-8115	40	29	ci	ci	NOUN
easat-8115	40	30	0.892	0.892	NUM
easat-8115	40	31	-	-	PUNCT
easat-8115	40	32	0.990).2	0.990).2	PRON
easat-8115	40	33	this	this	DET
easat-8115	40	34	study	study	NOUN
easat-8115	40	35	aims	aim	VERB
easat-8115	40	36	to	to	PART
easat-8115	40	37	assess	assess	VERB
easat-8115	40	38	the	the	DET
easat-8115	40	39	relationship	relationship	NOUN
easat-8115	40	40	between	between	ADP
easat-8115	40	41	clinical	clinical	ADJ
easat-8115	40	42	,	,	PUNCT
easat-8115	40	43	laboratory	laboratory	NOUN
easat-8115	40	44	,	,	PUNCT
easat-8115	40	45	and	and	CCONJ
easat-8115	40	46	radiological	radiological	ADJ
easat-8115	40	47	parameters	parameter	NOUN
easat-8115	40	48	with	with	ADP
easat-8115	40	49	pcr	pcr	ADJ
easat-8115	40	50	positivity	positivity	NOUN
easat-8115	40	51	in	in	ADP
easat-8115	40	52	sputum	sputum	NOUN
easat-8115	40	53	in	in	ADP
easat-8115	40	54	hiv	hiv	PROPN
easat-8115	40	55	patients	patient	NOUN
easat-8115	40	56	with	with	ADP
easat-8115	40	57	suspicion	suspicion	NOUN
easat-8115	40	58	of	of	ADP
easat-8115	40	59	pcp	pcp	PROPN
easat-8115	40	60	.	.	PUNCT
easat-8115	41	1	2	2	X
easat-8115	41	2	.	.	X
easat-8115	41	3	methods	method	NOUN
easat-8115	41	4	this	this	DET
easat-8115	41	5	study	study	NOUN
easat-8115	41	6	is	be	AUX
easat-8115	41	7	an	an	DET
easat-8115	41	8	observational	observational	ADJ
easat-8115	41	9	analytic	analytic	ADJ
easat-8115	41	10	study	study	NOUN
easat-8115	41	11	with	with	ADP
easat-8115	41	12	cross	cross	ADJ
easat-8115	41	13	-	-	ADJ
easat-8115	41	14	sectional	sectional	ADJ
easat-8115	41	15	design	design	NOUN
easat-8115	41	16	conducted	conduct	VERB
easat-8115	41	17	at	at	ADP
easat-8115	41	18	ngoerah	ngoerah	PROPN
easat-8115	41	19	hospital	hospital	NOUN
easat-8115	41	20	,	,	PUNCT
easat-8115	41	21	denpasar	denpasar	PROPN
easat-8115	41	22	,	,	PUNCT
easat-8115	41	23	from	from	ADP
easat-8115	41	24	june	june	PROPN
easat-8115	41	25	2024	2024	NUM
easat-8115	41	26	to	to	ADP
easat-8115	41	27	december	december	PROPN
easat-8115	41	28	2024	2024	NUM
easat-8115	41	29	.	.	PUNCT
easat-8115	42	1	this	this	DET
easat-8115	42	2	study	study	NOUN
easat-8115	42	3	evaluate	evaluate	VERB
easat-8115	42	4	the	the	DET
easat-8115	42	5	clinical	clinical	ADJ
easat-8115	42	6	(	(	PUNCT
easat-8115	42	7	fever	fever	NOUN
easat-8115	42	8	,	,	PUNCT
easat-8115	42	9	cough	cough	NOUN
easat-8115	42	10	,	,	PUNCT
easat-8115	42	11	shortness	shortness	NOUN
easat-8115	42	12	of	of	ADP
easat-8115	42	13	breath	breath	NOUN
easat-8115	42	14	,	,	PUNCT
easat-8115	42	15	oral	oral	ADJ
easat-8115	42	16	candidiasis	candidiasis	NOUN
easat-8115	42	17	,	,	PUNCT
easat-8115	42	18	spo2	spo2	PROPN
easat-8115	42	19	/	/	SYM
easat-8115	42	20	fio2	fio2	PROPN
easat-8115	42	21	ratio	ratio	NOUN
easat-8115	42	22	)	)	PUNCT
easat-8115	42	23	,	,	PUNCT
easat-8115	42	24	laboratory	laboratory	NOUN
easat-8115	42	25	(	(	PUNCT
easat-8115	42	26	hemoglobin	hemoglobin	NOUN
easat-8115	42	27	,	,	PUNCT
easat-8115	42	28	platelet	platelet	NOUN
easat-8115	42	29	,	,	PUNCT
easat-8115	42	30	lymphocytes	lymphocyte	NOUN
easat-8115	42	31	,	,	PUNCT
easat-8115	42	32	neutrophyl	neutrophyl	NOUN
easat-8115	42	33	lymphocyte	lymphocyte	NOUN
easat-8115	42	34	ratio	ratio	NOUN
easat-8115	42	35	,	,	PUNCT
easat-8115	42	36	monocyte	monocyte	ADJ
easat-8115	42	37	lymphocyte	lymphocyte	ADJ
easat-8115	42	38	ratio	ratio	NOUN
easat-8115	42	39	,	,	PUNCT
easat-8115	42	40	eosinophil	eosinophil	ADJ
easat-8115	42	41	,	,	PUNCT
easat-8115	42	42	albumin	albumin	NOUN
easat-8115	42	43	,	,	PUNCT
easat-8115	42	44	cd4	cd4	PROPN
easat-8115	42	45	and	and	CCONJ
easat-8115	42	46	aado2	aado2	ADJ
easat-8115	42	47	)	)	PUNCT
easat-8115	42	48	,	,	PUNCT
easat-8115	42	49	typical	typical	ADJ
easat-8115	42	50	chest	chest	NOUN
easat-8115	42	51	x	x	NOUN
easat-8115	42	52	-	-	NOUN
easat-8115	42	53	ray	ray	NOUN
easat-8115	42	54	parameters	parameter	NOUN
easat-8115	42	55	(	(	PUNCT
easat-8115	42	56	interstitial	interstitial	ADJ
easat-8115	42	57	infiltrate	infiltrate	NOUN
easat-8115	42	58	,	,	PUNCT
easat-8115	42	59	ground	ground	NOUN
easat-8115	42	60	glass	glass	NOUN
easat-8115	42	61	opacity	opacity	NOUN
easat-8115	42	62	,	,	PUNCT
easat-8115	42	63	and	and	CCONJ
easat-8115	42	64	atypical	atypical	ADJ
easat-8115	42	65	chest	chest	NOUN
easat-8115	42	66	x	x	NOUN
easat-8115	42	67	-	-	NOUN
easat-8115	42	68	ray	ray	NOUN
easat-8115	42	69	parameters	parameter	NOUN
easat-8115	42	70	(	(	PUNCT
easat-8115	42	71	infiltrate	infiltrate	ADJ
easat-8115	42	72	,	,	PUNCT
easat-8115	42	73	consolidation	consolidation	NOUN
easat-8115	42	74	,	,	PUNCT
easat-8115	42	75	pneumothorax	pneumothorax	NOUN
easat-8115	42	76	,	,	PUNCT
easat-8115	42	77	)	)	PUNCT
easat-8115	42	78	of	of	ADP
easat-8115	42	79	pcp	pcp	PROPN
easat-8115	42	80	patients	patient	NOUN
easat-8115	42	81	with	with	ADP
easat-8115	42	82	hiv	hiv	PROPN
easat-8115	42	83	.	.	PUNCT
easat-8115	43	1	pcr	pcr	PROPN
easat-8115	43	2	sputum	sputum	PROPN
easat-8115	43	3	results	result	NOUN
easat-8115	43	4	then	then	ADV
easat-8115	43	5	analysed	analyse	VERB
easat-8115	43	6	in	in	ADP
easat-8115	43	7	relation	relation	NOUN
easat-8115	43	8	to	to	ADP
easat-8115	43	9	these	these	DET
easat-8115	43	10	parameters	parameter	NOUN
easat-8115	43	11	.	.	PUNCT
easat-8115	44	1	2.1	2.1	NUM
easat-8115	44	2	.	.	PUNCT
easat-8115	45	1	inclusion	inclusion	NOUN
easat-8115	45	2	criteria	criterion	NOUN
easat-8115	45	3	patients	patient	NOUN
easat-8115	45	4	with	with	ADP
easat-8115	45	5	age	age	NOUN
easat-8115	45	6	above	above	ADP
easat-8115	45	7	18	18	NUM
easat-8115	45	8	years	year	NOUN
easat-8115	45	9	,	,	PUNCT
easat-8115	45	10	andd	andd	PROPN
easat-8115	45	11	hiv	hiv	PROPN
easat-8115	45	12	patients	patient	NOUN
easat-8115	45	13	with	with	ADP
easat-8115	45	14	suspected	suspect	VERB
easat-8115	45	15	pcp	pcp	NOUN
easat-8115	45	16	based	base	VERB
easat-8115	45	17	on	on	ADP
easat-8115	45	18	clinical	clinical	ADJ
easat-8115	45	19	,	,	PUNCT
easat-8115	45	20	laboratory	laboratory	NOUN
easat-8115	45	21	,	,	PUNCT
easat-8115	45	22	or	or	CCONJ
easat-8115	45	23	radiological	radiological	ADJ
easat-8115	45	24	criteria	criterion	NOUN
easat-8115	45	25	,	,	PUNCT
easat-8115	45	26	that	that	PRON
easat-8115	45	27	confirmed	confirm	VERB
easat-8115	45	28	by	by	ADP
easat-8115	45	29	tropical	tropical	ADJ
easat-8115	45	30	and	and	CCONJ
easat-8115	45	31	infectious	infectious	ADJ
easat-8115	45	32	medicine	medicine	NOUN
easat-8115	45	33	consultant	consultant	NOUN
easat-8115	45	34	specialist	specialist	NOUN
easat-8115	45	35	or	or	CCONJ
easat-8115	45	36	pulmonologist	pulmonologist	NOUN
easat-8115	45	37	.	.	PUNCT
easat-8115	46	1	2.2	2.2	NUM
easat-8115	46	2	.	.	PUNCT
easat-8115	46	3	exclusion	exclusion	NOUN
easat-8115	46	4	criteria	criterion	NOUN
easat-8115	46	5	having	have	VERB
easat-8115	46	6	pulmonary	pulmonary	ADJ
easat-8115	46	7	tuberculosis	tuberculosis	NOUN
easat-8115	46	8	disease	disease	NOUN
easat-8115	46	9	or	or	CCONJ
easat-8115	46	10	incomplete	incomplete	ADJ
easat-8115	46	11	medical	medical	ADJ
easat-8115	46	12	records	record	NOUN
easat-8115	46	13	.	.	PUNCT
easat-8115	47	1	2.3	2.3	NUM
easat-8115	47	2	.	.	PUNCT
easat-8115	48	1	data	datum	NOUN
easat-8115	48	2	analysis	analysis	NOUN
easat-8115	48	3	descriptive	descriptive	ADJ
easat-8115	48	4	analysis	analysis	NOUN
easat-8115	48	5	presents	present	NOUN
easat-8115	48	6	sample	sample	NOUN
easat-8115	48	7	characteristics	characteristic	NOUN
easat-8115	48	8	using	use	VERB
easat-8115	48	9	tables	table	NOUN
easat-8115	48	10	and	and	CCONJ
easat-8115	48	11	narratives	narrative	NOUN
easat-8115	48	12	.	.	PUNCT
easat-8115	49	1	normality	normality	NOUN
easat-8115	49	2	test	test	NOUN
easat-8115	49	3	analysis	analysis	NOUN
easat-8115	49	4	uses	use	VERB
easat-8115	49	5	kolmogorov	kolmogorov	ADJ
easat-8115	49	6	-	-	PUNCT
easat-8115	49	7	smirnov	smirnov	ADJ
easat-8115	49	8	test	test	NOUN
easat-8115	49	9	.	.	PUNCT
easat-8115	50	1	numeric	numeric	ADP
easat-8115	50	2	variables	variable	NOUN
easat-8115	50	3	(	(	PUNCT
easat-8115	50	4	laboratory	laboratory	NOUN
easat-8115	50	5	parameters	parameter	NOUN
easat-8115	50	6	)	)	PUNCT
easat-8115	50	7	are	be	AUX
easat-8115	50	8	compared	compare	VERB
easat-8115	50	9	using	use	VERB
easat-8115	50	10	independent	independent	ADJ
easat-8115	50	11	t	t	NOUN
easat-8115	50	12	-	-	PUNCT
easat-8115	50	13	test	test	NOUN
easat-8115	50	14	,	,	PUNCT
easat-8115	50	15	if	if	SCONJ
easat-8115	50	16	data	datum	NOUN
easat-8115	50	17	was	be	AUX
easat-8115	50	18	normally	normally	ADV
easat-8115	50	19	distributed	distribute	VERB
easat-8115	50	20	,	,	PUNCT
easat-8115	50	21	or	or	CCONJ
easat-8115	50	22	mann	mann	PROPN
easat-8115	50	23	whitney	whitney	PROPN
easat-8115	50	24	test	test	NOUN
easat-8115	50	25	if	if	SCONJ
easat-8115	50	26	data	datum	NOUN
easat-8115	50	27	not	not	PART
easat-8115	50	28	normally	normally	ADV
easat-8115	50	29	distributed	distribute	VERB
easat-8115	50	30	.	.	PUNCT
easat-8115	51	1	nominal	nominal	ADJ
easat-8115	51	2	variables	variable	NOUN
easat-8115	51	3	(	(	PUNCT
easat-8115	51	4	clinical	clinical	ADJ
easat-8115	51	5	and	and	CCONJ
easat-8115	51	6	radiological	radiological	ADJ
easat-8115	51	7	parameters	parameter	NOUN
easat-8115	51	8	)	)	PUNCT
easat-8115	51	9	are	be	AUX
easat-8115	51	10	compared	compare	VERB
easat-8115	51	11	using	use	VERB
easat-8115	51	12	chi	chi	ADJ
easat-8115	51	13	-	-	PUNCT
easat-8115	51	14	square	square	ADJ
easat-8115	51	15	test	test	NOUN
easat-8115	51	16	.	.	PUNCT
easat-8115	52	1	multivariate	multivariate	NOUN
easat-8115	52	2	analysis	analysis	NOUN
easat-8115	52	3	was	be	AUX
easat-8115	52	4	carried	carry	VERB
easat-8115	52	5	out	out	ADP
easat-8115	52	6	to	to	PART
easat-8115	52	7	control	control	VERB
easat-8115	52	8	confounding	confound	VERB
easat-8115	52	9	variables	variable	NOUN
easat-8115	52	10	using	use	VERB
easat-8115	52	11	logistic	logistic	ADJ
easat-8115	52	12	regression	regression	NOUN
easat-8115	52	13	.	.	PUNCT
easat-8115	53	1	the	the	DET
easat-8115	53	2	whole	whole	ADJ
easat-8115	53	3	analysis	analysis	NOUN
easat-8115	53	4	process	process	NOUN
easat-8115	53	5	was	be	AUX
easat-8115	53	6	using	use	VERB
easat-8115	53	7	statistical	statistical	ADJ
easat-8115	53	8	software	software	NOUN
easat-8115	53	9	statistical	statistical	ADJ
easat-8115	53	10	package	package	NOUN
easat-8115	53	11	for	for	ADP
easat-8115	53	12	the	the	DET
easat-8115	53	13	social	social	ADJ
easat-8115	53	14	sciences	sciences	PROPN
easat-8115	53	15	(	(	PUNCT
easat-8115	53	16	spss	spss	PROPN
easat-8115	53	17	)	)	PUNCT
easat-8115	53	18	version	version	NOUN
easat-8115	53	19	26.0	26.0	NUM
easat-8115	53	20	.	.	PUNCT
easat-8115	54	1	3	3	X
easat-8115	54	2	.	.	NOUN
easat-8115	54	3	results	result	NOUN
easat-8115	54	4	total	total	VERB
easat-8115	54	5	192	192	NUM
easat-8115	54	6	hiv	hiv	PROPN
easat-8115	54	7	patients	patient	NOUN
easat-8115	54	8	with	with	ADP
easat-8115	54	9	suspected	suspect	VERB
easat-8115	54	10	pcp	pcp	NOUN
easat-8115	54	11	was	be	AUX
easat-8115	54	12	obtained	obtain	VERB
easat-8115	54	13	from	from	ADP
easat-8115	54	14	medical	medical	ADJ
easat-8115	54	15	record	record	NOUN
easat-8115	54	16	data	datum	NOUN
easat-8115	54	17	.	.	PUNCT
easat-8115	55	1	of	of	ADP
easat-8115	55	2	this	this	PRON
easat-8115	55	3	,	,	PUNCT
easat-8115	55	4	80	80	NUM
easat-8115	55	5	subjects	subject	NOUN
easat-8115	55	6	met	meet	VERB
easat-8115	55	7	the	the	DET
easat-8115	55	8	inclusion	inclusion	NOUN
easat-8115	55	9	criteria	criterion	NOUN
easat-8115	55	10	,	,	PUNCT
easat-8115	55	11	92	92	NUM
easat-8115	55	12	subjects	subject	NOUN
easat-8115	55	13	were	be	AUX
easat-8115	55	14	excluded	exclude	VERB
easat-8115	55	15	because	because	SCONJ
easat-8115	55	16	of	of	ADP
easat-8115	55	17	pulmonary	pulmonary	ADJ
easat-8115	55	18	tuberculosis	tuberculosis	NOUN
easat-8115	55	19	,	,	PUNCT
easat-8115	55	20	and	and	CCONJ
easat-8115	55	21	20	20	NUM
easat-8115	55	22	subjects	subject	NOUN
easat-8115	55	23	were	be	AUX
easat-8115	55	24	excluded	exclude	VERB
easat-8115	55	25	because	because	SCONJ
easat-8115	55	26	of	of	ADP
easat-8115	55	27	incomplete	incomplete	ADJ
easat-8115	55	28	data	datum	NOUN
easat-8115	55	29	.	.	PUNCT
easat-8115	56	1	in	in	ADP
easat-8115	56	2	this	this	DET
easat-8115	56	3	study	study	NOUN
easat-8115	56	4	,	,	PUNCT
easat-8115	56	5	the	the	DET
easat-8115	56	6	mean	mean	ADJ
easat-8115	56	7	age	age	NOUN
easat-8115	56	8	of	of	ADP
easat-8115	56	9	hiv	hiv	PROPN
easat-8115	56	10	subjects	subject	NOUN
easat-8115	56	11	with	with	ADP
easat-8115	56	12	positive	positive	ADJ
easat-8115	56	13	pcr	pcr	PROPN
easat-8115	56	14	pcp	pcp	NOUN
easat-8115	56	15	was	be	AUX
easat-8115	56	16	41.46	41.46	NUM
easat-8115	56	17	years	year	NOUN
easat-8115	56	18	and	and	CCONJ
easat-8115	56	19	negative	negative	ADJ
easat-8115	56	20	pcr	pcr	PROPN
easat-8115	56	21	pcp	pcp	PROPN
easat-8115	56	22	was	be	AUX
easat-8115	56	23	37.7	37.7	NUM
easat-8115	56	24	years	year	NOUN
easat-8115	56	25	(	(	PUNCT
easat-8115	56	26	table	table	NOUN
easat-8115	56	27	1	1	NUM
easat-8115	56	28	)	)	PUNCT
easat-8115	56	29	.	.	PUNCT
easat-8115	57	1	male	male	NOUN
easat-8115	57	2	was	be	AUX
easat-8115	57	3	found	find	VERB
easat-8115	57	4	to	to	PART
easat-8115	57	5	be	be	AUX
easat-8115	57	6	more	more	ADV
easat-8115	57	7	common	common	ADJ
easat-8115	57	8	in	in	ADP
easat-8115	57	9	both	both	DET
easat-8115	57	10	groups	group	NOUN
easat-8115	57	11	.	.	PUNCT
easat-8115	58	1	majority	majority	NOUN
easat-8115	58	2	of	of	ADP
easat-8115	58	3	the	the	DET
easat-8115	58	4	subjects	subject	NOUN
easat-8115	58	5	were	be	AUX
easat-8115	58	6	diagnosed	diagnose	VERB
easat-8115	58	7	with	with	ADP
easat-8115	58	8	pcp	pcp	PROPN
easat-8115	58	9	for	for	ADP
easat-8115	58	10	the	the	DET
easat-8115	58	11	first	first	ADJ
easat-8115	58	12	time	time	NOUN
easat-8115	58	13	in	in	ADP
easat-8115	58	14	both	both	DET
easat-8115	58	15	groups	group	NOUN
easat-8115	58	16	as	as	ADV
easat-8115	58	17	well	well	ADV
easat-8115	58	18	.	.	PUNCT
easat-8115	59	1	meanwhile	meanwhile	ADV
easat-8115	59	2	,	,	PUNCT
easat-8115	59	3	more	more	ADJ
easat-8115	59	4	than	than	ADP
easat-8115	59	5	half	half	NOUN
easat-8115	59	6	of	of	ADP
easat-8115	59	7	the	the	DET
easat-8115	59	8	patients	patient	NOUN
easat-8115	59	9	were	be	AUX
easat-8115	59	10	not	not	PART
easat-8115	59	11	receiving	receive	VERB
easat-8115	59	12	arv	arv	NOUN
easat-8115	59	13	therapy	therapy	NOUN
easat-8115	59	14	either	either	CCONJ
easat-8115	59	15	in	in	ADP
easat-8115	59	16	positive	positive	ADJ
easat-8115	59	17	pcr	pcr	ADJ
easat-8115	59	18	pcp	pcp	PROPN
easat-8115	59	19	group	group	NOUN
easat-8115	59	20	(	(	PUNCT
easat-8115	59	21	84	84	NUM
easat-8115	59	22	%	%	NOUN
easat-8115	59	23	)	)	PUNCT
easat-8115	59	24	or	or	CCONJ
easat-8115	59	25	negative	negative	ADJ
easat-8115	59	26	pcr	pcr	PROPN
easat-8115	59	27	pcp	pcp	PROPN
easat-8115	59	28	group	group	NOUN
easat-8115	59	29	(	(	PUNCT
easat-8115	59	30	53.3	53.3	NUM
easat-8115	59	31	%	%	NOUN
easat-8115	59	32	)	)	PUNCT
easat-8115	59	33	.	.	PUNCT
easat-8115	60	1	1333	1333	NUM
easat-8115	60	2	edelweiss	edelweiss	PROPN
easat-8115	60	3	applied	apply	VERB
easat-8115	60	4	science	science	NOUN
easat-8115	60	5	and	and	CCONJ
easat-8115	60	6	technology	technology	NOUN
easat-8115	60	7	issn	issn	PROPN
easat-8115	60	8	:	:	PUNCT
easat-8115	60	9	2576	2576	NUM
easat-8115	60	10	-	-	SYM
easat-8115	60	11	8484	8484	NUM
easat-8115	60	12	vol	vol	NOUN
easat-8115	60	13	.	.	PROPN
easat-8115	61	1	9	9	NUM
easat-8115	61	2	,	,	PUNCT
easat-8115	61	3	no	no	INTJ
easat-8115	61	4	.	.	NOUN
easat-8115	62	1	6	6	NUM
easat-8115	62	2	:	:	SYM
easat-8115	62	3	1331	1331	NUM
easat-8115	62	4	-	-	SYM
easat-8115	62	5	1341	1341	NUM
easat-8115	62	6	,	,	PUNCT
easat-8115	62	7	2025	2025	NUM
easat-8115	62	8	doi	doi	NOUN
easat-8115	62	9	:	:	PUNCT
easat-8115	62	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	62	11	©	©	PROPN
easat-8115	62	12	2025	2025	NUM
easat-8115	62	13	by	by	ADP
easat-8115	62	14	the	the	DET
easat-8115	62	15	authors	author	NOUN
easat-8115	62	16	;	;	PUNCT
easat-8115	63	1	licensee	licensee	PROPN
easat-8115	63	2	learning	learn	VERB
easat-8115	63	3	gate	gate	NOUN
easat-8115	63	4	table	table	NOUN
easat-8115	63	5	1	1	NUM
easat-8115	63	6	.	.	PUNCT
easat-8115	63	7	study	study	NOUN
easat-8115	63	8	subjects	subject	NOUN
easat-8115	63	9	’	'	PUNCT
easat-8115	63	10	characteristics	characteristic	NOUN
easat-8115	63	11	.	.	PUNCT
easat-8115	64	1	characteristics	characteristics	PROPN
easat-8115	64	2	sputum	sputum	PROPN
easat-8115	64	3	pcr	pcr	PROPN
easat-8115	64	4	p	p	PROPN
easat-8115	64	5	value	value	NOUN
easat-8115	64	6	positive	positive	ADJ
easat-8115	64	7	(	(	PUNCT
easat-8115	64	8	n	n	NOUN
easat-8115	64	9	=	=	SYM
easat-8115	64	10	50	50	NUM
easat-8115	64	11	)	)	PUNCT
easat-8115	64	12	negative	negative	ADJ
easat-8115	64	13	(	(	PUNCT
easat-8115	64	14	n	n	NOUN
easat-8115	64	15	=	=	SYM
easat-8115	64	16	30	30	NUM
easat-8115	64	17	)	)	PUNCT
easat-8115	64	18	age	age	NOUN
easat-8115	64	19	(	(	PUNCT
easat-8115	64	20	years	year	NOUN
easat-8115	64	21	)	)	PUNCT
easat-8115	64	22	mean	mean	VERB
easat-8115	65	1			PROPN
easat-8115	65	2	sd	sd	ADP
easat-8115	65	3	41.46	41.46	NUM
easat-8115	65	4			PROPN
easat-8115	65	5	10.3	10.3	NUM
easat-8115	65	6	37.70	37.70	NUM
easat-8115	65	7	11.046	11.046	NUM
easat-8115	65	8	0.87	0.87	NUM
easat-8115	65	9	gender	gender	NOUN
easat-8115	65	10	male	male	NOUN
easat-8115	65	11	36	36	NUM
easat-8115	65	12	(	(	PUNCT
easat-8115	65	13	72	72	NUM
easat-8115	65	14	%	%	NOUN
easat-8115	65	15	)	)	PUNCT
easat-8115	65	16	22	22	NUM
easat-8115	65	17	(	(	PUNCT
easat-8115	65	18	73.3	73.3	NUM
easat-8115	65	19	%	%	NOUN
easat-8115	65	20	)	)	PUNCT
easat-8115	65	21	0.94	0.94	NUM
easat-8115	65	22	female	female	NOUN
easat-8115	65	23	14	14	NUM
easat-8115	65	24	(	(	PUNCT
easat-8115	65	25	28	28	NUM
easat-8115	65	26	%	%	NOUN
easat-8115	65	27	)	)	PUNCT
easat-8115	65	28	8	8	NUM
easat-8115	65	29	(	(	PUNCT
easat-8115	65	30	26.7	26.7	NUM
easat-8115	65	31	%	%	NOUN
easat-8115	65	32	)	)	PUNCT
easat-8115	66	1	hiv	hiv	PROPN
easat-8115	66	2	diagnosis	diagnosis	NOUN
easat-8115	66	3	first	first	ADJ
easat-8115	66	4	time	time	NOUN
easat-8115	66	5	48	48	NUM
easat-8115	66	6	(	(	PUNCT
easat-8115	66	7	96	96	NUM
easat-8115	66	8	%	%	NOUN
easat-8115	66	9	)	)	PUNCT
easat-8115	66	10	20	20	NUM
easat-8115	66	11	(	(	PUNCT
easat-8115	66	12	66.7	66.7	NUM
easat-8115	66	13	)	)	PUNCT
easat-8115	66	14	<	<	X
easat-8115	66	15	5	5	NUM
easat-8115	66	16	years	year	NOUN
easat-8115	66	17	2	2	NUM
easat-8115	66	18	(	(	PUNCT
easat-8115	66	19	4	4	NUM
easat-8115	66	20	%	%	NOUN
easat-8115	66	21	)	)	PUNCT
easat-8115	66	22	5	5	NUM
easat-8115	66	23	(	(	PUNCT
easat-8115	66	24	16.7	16.7	NUM
easat-8115	66	25	%	%	NOUN
easat-8115	66	26	)	)	PUNCT
easat-8115	66	27	0.21	0.21	NUM
easat-8115	66	28	≥	≥	NOUN
easat-8115	66	29	5	5	NUM
easat-8115	66	30	years	year	NOUN
easat-8115	66	31	0	0	NUM
easat-8115	66	32	(	(	PUNCT
easat-8115	66	33	0	0	NUM
easat-8115	66	34	%	%	NOUN
easat-8115	66	35	5	5	NUM
easat-8115	66	36	(	(	PUNCT
easat-8115	66	37	16.7	16.7	NUM
easat-8115	66	38	%	%	NOUN
easat-8115	66	39	)	)	PUNCT
easat-8115	66	40	arv	arv	NOUN
easat-8115	66	41	duration	duration	NOUN
easat-8115	66	42	not	not	PART
easat-8115	66	43	receive	receive	VERB
easat-8115	66	44	42	42	NUM
easat-8115	66	45	(	(	PUNCT
easat-8115	66	46	84	84	NUM
easat-8115	66	47	%	%	NOUN
easat-8115	66	48	)	)	PUNCT
easat-8115	66	49	16	16	NUM
easat-8115	66	50	(	(	PUNCT
easat-8115	66	51	53.3	53.3	NUM
easat-8115	66	52	%	%	NOUN
easat-8115	66	53	)	)	PUNCT
easat-8115	66	54	0.71	0.71	NUM
easat-8115	66	55	<	<	SYM
easat-8115	66	56	6	6	NUM
easat-8115	66	57	months	month	NOUN
easat-8115	66	58	8	8	NUM
easat-8115	66	59	(	(	PUNCT
easat-8115	66	60	16	16	NUM
easat-8115	66	61	%	%	NOUN
easat-8115	66	62	)	)	PUNCT
easat-8115	66	63	7	7	NUM
easat-8115	66	64	(	(	PUNCT
easat-8115	66	65	23.3	23.3	NUM
easat-8115	66	66	%	%	NOUN
easat-8115	66	67	)	)	PUNCT
easat-8115	66	68	≥	≥	NOUN
easat-8115	66	69	6	6	NUM
easat-8115	66	70	months	month	NOUN
easat-8115	66	71	0	0	NUM
easat-8115	66	72	(	(	PUNCT
easat-8115	66	73	0	0	NUM
easat-8115	66	74	%	%	NOUN
easat-8115	66	75	)	)	PUNCT
easat-8115	66	76	7	7	NUM
easat-8115	66	77	(	(	PUNCT
easat-8115	66	78	23.3	23.3	NUM
easat-8115	66	79	%	%	NOUN
easat-8115	66	80	)	)	PUNCT
easat-8115	66	81	pcp	pcp	PROPN
easat-8115	67	1	prophylaxis	prophylaxis	ADJ
easat-8115	68	1	yes	yes	INTJ
easat-8115	68	2	1	1	NUM
easat-8115	68	3	(	(	PUNCT
easat-8115	68	4	2	2	NUM
easat-8115	68	5	%	%	NOUN
easat-8115	68	6	)	)	PUNCT
easat-8115	68	7	2	2	NUM
easat-8115	68	8	(	(	PUNCT
easat-8115	68	9	6.7	6.7	NUM
easat-8115	68	10	%	%	NOUN
easat-8115	68	11	)	)	PUNCT
easat-8115	69	1	no	no	DET
easat-8115	69	2	49	49	NUM
easat-8115	69	3	(	(	PUNCT
easat-8115	69	4	98	98	NUM
easat-8115	69	5	%	%	NOUN
easat-8115	69	6	)	)	PUNCT
easat-8115	69	7	28	28	NUM
easat-8115	69	8	(	(	PUNCT
easat-8115	69	9	93.3	93.3	NUM
easat-8115	69	10	%	%	NOUN
easat-8115	69	11	)	)	PUNCT
easat-8115	69	12	0.28	0.28	NUM
easat-8115	69	13	pneumonia	pneumonia	NOUN
easat-8115	69	14	yes	yes	INTJ
easat-8115	69	15	30	30	NUM
easat-8115	69	16	(	(	PUNCT
easat-8115	69	17	60	60	NUM
easat-8115	69	18	%	%	NOUN
easat-8115	69	19	)	)	PUNCT
easat-8115	69	20	16	16	NUM
easat-8115	69	21	(	(	PUNCT
easat-8115	69	22	53.3	53.3	NUM
easat-8115	69	23	%	%	NOUN
easat-8115	69	24	)	)	PUNCT
easat-8115	69	25	0.56	0.56	NUM
easat-8115	69	26	no	no	DET
easat-8115	69	27	20	20	NUM
easat-8115	69	28	(	(	PUNCT
easat-8115	69	29	40	40	NUM
easat-8115	69	30	%	%	NOUN
easat-8115	69	31	)	)	PUNCT
easat-8115	69	32	14	14	NUM
easat-8115	69	33	(	(	PUNCT
easat-8115	69	34	46.7	46.7	NUM
easat-8115	69	35	%	%	NOUN
easat-8115	69	36	)	)	PUNCT
easat-8115	69	37	note	note	NOUN
easat-8115	69	38	:	:	PUNCT
easat-8115	69	39	sd=	sd=	PROPN
easat-8115	69	40	standard	standard	ADJ
easat-8115	69	41	deviation	deviation	NOUN
easat-8115	69	42	roc	roc	NOUN
easat-8115	69	43	analysis	analysis	NOUN
easat-8115	69	44	was	be	AUX
easat-8115	69	45	performed	perform	VERB
easat-8115	69	46	to	to	PART
easat-8115	69	47	determine	determine	VERB
easat-8115	69	48	the	the	DET
easat-8115	69	49	cut	cut	NOUN
easat-8115	69	50	off	off	ADP
easat-8115	69	51	value	value	NOUN
easat-8115	69	52	of	of	ADP
easat-8115	69	53	spo2	spo2	PROPN
easat-8115	69	54	/	/	SYM
easat-8115	69	55	fio2	fio2	PROPN
easat-8115	69	56	.	.	PUNCT
easat-8115	70	1	we	we	PRON
easat-8115	70	2	found	find	VERB
easat-8115	70	3	the	the	DET
easat-8115	70	4	cut	cut	NOUN
easat-8115	70	5	off	off	ADP
easat-8115	70	6	was	be	AUX
easat-8115	70	7	450	450	NUM
easat-8115	70	8	with	with	ADP
easat-8115	70	9	auc	auc	NOUN
easat-8115	70	10	0.692	0.692	NUM
easat-8115	70	11	(	(	PUNCT
easat-8115	70	12	95%ci	95%ci	NUM
easat-8115	70	13	0.573	0.573	NUM
easat-8115	70	14	-	-	SYM
easat-8115	70	15	0.811	0.811	NUM
easat-8115	70	16	;	;	PUNCT
easat-8115	70	17	p	p	NOUN
easat-8115	70	18	0.004	0.004	NUM
easat-8115	70	19	)	)	PUNCT
easat-8115	70	20	.	.	PUNCT
easat-8115	71	1	detailed	detailed	ADJ
easat-8115	71	2	clinical	clinical	ADJ
easat-8115	71	3	parameters	parameter	NOUN
easat-8115	71	4	with	with	ADP
easat-8115	71	5	sputum	sputum	PROPN
easat-8115	71	6	pcr	pcr	PROPN
easat-8115	71	7	positivity	positivity	NOUN
easat-8115	71	8	presented	present	VERB
easat-8115	71	9	in	in	ADP
easat-8115	71	10	table	table	NOUN
easat-8115	71	11	3	3	NUM
easat-8115	71	12	.	.	PUNCT
easat-8115	71	13	logistic	logistic	ADJ
easat-8115	71	14	regression	regression	NOUN
easat-8115	71	15	analysis	analysis	NOUN
easat-8115	71	16	on	on	ADP
easat-8115	71	17	clinical	clinical	ADJ
easat-8115	71	18	parameters	parameter	NOUN
easat-8115	71	19	found	find	VERB
easat-8115	71	20	that	that	SCONJ
easat-8115	71	21	low	low	ADJ
easat-8115	71	22	-	-	PUNCT
easat-8115	71	23	grade	grade	NOUN
easat-8115	71	24	fever	fever	NOUN
easat-8115	71	25	and	and	CCONJ
easat-8115	71	26	oral	oral	ADJ
easat-8115	71	27	candidiasis	candidiasis	NOUN
easat-8115	71	28	demonstrated	demonstrate	VERB
easat-8115	71	29	a	a	DET
easat-8115	71	30	significant	significant	ADJ
easat-8115	71	31	relationship	relationship	NOUN
easat-8115	71	32	with	with	ADP
easat-8115	71	33	sputum	sputum	PROPN
easat-8115	71	34	pcr	pcr	PROPN
easat-8115	71	35	positivity	positivity	NOUN
easat-8115	71	36	.	.	PUNCT
easat-8115	72	1	the	the	DET
easat-8115	72	2	risk	risk	NOUN
easat-8115	72	3	for	for	ADP
easat-8115	72	4	positive	positive	ADJ
easat-8115	72	5	sputum	sputum	NOUN
easat-8115	72	6	pcr	pcr	NOUN
easat-8115	72	7	in	in	ADP
easat-8115	72	8	subjects	subject	NOUN
easat-8115	72	9	with	with	ADP
easat-8115	72	10	low	low	ADJ
easat-8115	72	11	-	-	PUNCT
easat-8115	72	12	grade	grade	NOUN
easat-8115	72	13	fever	fever	NOUN
easat-8115	72	14	was	be	AUX
easat-8115	72	15	23.9	23.9	NUM
easat-8115	72	16	times	time	NOUN
easat-8115	72	17	greater	great	ADJ
easat-8115	72	18	than	than	ADP
easat-8115	72	19	those	those	PRON
easat-8115	72	20	without	without	ADP
easat-8115	72	21	low	low	ADJ
easat-8115	72	22	-	-	PUNCT
easat-8115	72	23	grade	grade	NOUN
easat-8115	72	24	fever	fever	NOUN
easat-8115	72	25	.	.	PUNCT
easat-8115	73	1	subjects	subject	NOUN
easat-8115	73	2	with	with	ADP
easat-8115	73	3	oral	oral	ADJ
easat-8115	73	4	candidiasis	candidiasis	NOUN
easat-8115	73	5	were	be	AUX
easat-8115	73	6	8.81	8.81	NUM
easat-8115	73	7	times	time	NOUN
easat-8115	73	8	at	at	ADP
easat-8115	73	9	risk	risk	NOUN
easat-8115	73	10	having	have	VERB
easat-8115	73	11	positive	positive	ADJ
easat-8115	73	12	sputum	sputum	NOUN
easat-8115	73	13	pcr	pcr	NOUN
easat-8115	73	14	result	result	NOUN
easat-8115	73	15	than	than	ADP
easat-8115	73	16	those	those	PRON
easat-8115	73	17	without	without	ADP
easat-8115	73	18	oral	oral	ADJ
easat-8115	73	19	candidiasis	candidiasis	NOUN
easat-8115	73	20	,	,	PUNCT
easat-8115	73	21	and	and	CCONJ
easat-8115	73	22	subjects	subject	NOUN
easat-8115	73	23	with	with	ADP
easat-8115	73	24	non	non	ADJ
easat-8115	73	25	-	-	ADJ
easat-8115	73	26	productive	productive	ADJ
easat-8115	73	27	cough	cough	NOUN
easat-8115	73	28	were	be	AUX
easat-8115	73	29	at	at	ADP
easat-8115	73	30	risk	risk	NOUN
easat-8115	73	31	of	of	ADP
easat-8115	73	32	having	have	VERB
easat-8115	73	33	positive	positive	ADJ
easat-8115	73	34	sputum	sputum	NOUN
easat-8115	73	35	pcr	pcr	PROPN
easat-8115	73	36	result	result	NOUN
easat-8115	73	37	7.108	7.108	NUM
easat-8115	73	38	times	time	NOUN
easat-8115	73	39	greater	great	ADJ
easat-8115	73	40	than	than	ADP
easat-8115	73	41	patients	patient	NOUN
easat-8115	73	42	with	with	ADP
easat-8115	73	43	productive	productive	ADJ
easat-8115	73	44	cough	cough	NOUN
easat-8115	73	45	.	.	PUNCT
easat-8115	74	1	the	the	DET
easat-8115	74	2	nagelkerke	nagelkerke	PROPN
easat-8115	74	3	r	r	NOUN
easat-8115	74	4	square	square	ADJ
easat-8115	74	5	value	value	NOUN
easat-8115	74	6	of	of	ADP
easat-8115	74	7	0.803	0.803	NUM
easat-8115	74	8	showed	show	VERB
easat-8115	74	9	the	the	DET
easat-8115	74	10	ability	ability	NOUN
easat-8115	74	11	of	of	ADP
easat-8115	74	12	the	the	DET
easat-8115	74	13	total	total	ADJ
easat-8115	74	14	clinical	clinical	ADJ
easat-8115	74	15	parameters	parameter	NOUN
easat-8115	74	16	score	score	VERB
easat-8115	74	17	to	to	PART
easat-8115	74	18	explain	explain	VERB
easat-8115	74	19	pcr	pcr	ADJ
easat-8115	74	20	positivity	positivity	NOUN
easat-8115	74	21	of	of	ADP
easat-8115	74	22	80.3	80.3	NUM
easat-8115	74	23	%	%	NOUN
easat-8115	74	24	,	,	PUNCT
easat-8115	74	25	meanwhile	meanwhile	ADV
easat-8115	74	26	the	the	DET
easat-8115	74	27	rest	rest	NOUN
easat-8115	74	28	(	(	PUNCT
easat-8115	74	29	19.7	19.7	NUM
easat-8115	74	30	%	%	NOUN
easat-8115	74	31	)	)	PUNCT
easat-8115	74	32	was	be	AUX
easat-8115	74	33	influenced	influence	VERB
easat-8115	74	34	by	by	ADP
easat-8115	74	35	other	other	ADJ
easat-8115	74	36	factors	factor	NOUN
easat-8115	74	37	outside	outside	ADP
easat-8115	74	38	the	the	DET
easat-8115	74	39	model	model	NOUN
easat-8115	74	40	.	.	PUNCT
easat-8115	75	1	1334	1334	NUM
easat-8115	75	2	edelweiss	edelweiss	PROPN
easat-8115	75	3	applied	apply	VERB
easat-8115	75	4	science	science	NOUN
easat-8115	75	5	and	and	CCONJ
easat-8115	75	6	technology	technology	NOUN
easat-8115	75	7	issn	issn	PROPN
easat-8115	75	8	:	:	PUNCT
easat-8115	75	9	2576	2576	NUM
easat-8115	75	10	-	-	SYM
easat-8115	75	11	8484	8484	NUM
easat-8115	75	12	vol	vol	NOUN
easat-8115	75	13	.	.	PROPN
easat-8115	76	1	9	9	NUM
easat-8115	76	2	,	,	PUNCT
easat-8115	76	3	no	no	INTJ
easat-8115	76	4	.	.	NOUN
easat-8115	77	1	6	6	NUM
easat-8115	77	2	:	:	SYM
easat-8115	77	3	1331	1331	NUM
easat-8115	77	4	-	-	SYM
easat-8115	77	5	1341	1341	NUM
easat-8115	77	6	,	,	PUNCT
easat-8115	77	7	2025	2025	NUM
easat-8115	77	8	doi	doi	NOUN
easat-8115	77	9	:	:	PUNCT
easat-8115	77	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	77	11	©	©	PROPN
easat-8115	77	12	2025	2025	NUM
easat-8115	77	13	by	by	ADP
easat-8115	77	14	the	the	DET
easat-8115	77	15	authors	author	NOUN
easat-8115	77	16	;	;	PUNCT
easat-8115	78	1	licensee	licensee	PROPN
easat-8115	78	2	learning	learn	VERB
easat-8115	78	3	gate	gate	NOUN
easat-8115	78	4	table	table	NOUN
easat-8115	78	5	3	3	NUM
easat-8115	78	6	.	.	X
easat-8115	78	7	relationship	relationship	NOUN
easat-8115	78	8	of	of	ADP
easat-8115	78	9	of	of	ADP
easat-8115	78	10	clinical	clinical	ADJ
easat-8115	78	11	parameters	parameter	NOUN
easat-8115	78	12	with	with	ADP
easat-8115	78	13	sputum	sputum	PROPN
easat-8115	78	14	pcr	pcr	PROPN
easat-8115	78	15	positivity	positivity	NOUN
easat-8115	78	16	in	in	ADP
easat-8115	78	17	study	study	NOUN
easat-8115	78	18	subjects	subject	NOUN
easat-8115	78	19	.	.	PUNCT
easat-8115	79	1	bivariate	bivariate	ADJ
easat-8115	79	2	analysis	analysis	NOUN
easat-8115	79	3	multivariate	multivariate	NOUN
easat-8115	79	4	analysis	analysis	NOUN
easat-8115	79	5	clinical	clinical	ADJ
easat-8115	79	6	parameters	parameter	NOUN
easat-8115	79	7	sputum	sputum	PROPN
easat-8115	79	8	pcr	pcr	PROPN
easat-8115	79	9	p	p	NOUN
easat-8115	79	10	-	-	PUNCT
easat-8115	79	11	value	value	NOUN
easat-8115	79	12	pr	pr	NOUN
easat-8115	79	13	(	(	PUNCT
easat-8115	79	14	95%ci	95%ci	NUM
easat-8115	79	15	)	)	PUNCT
easat-8115	79	16	p	p	NOUN
easat-8115	79	17	-	-	PUNCT
easat-8115	79	18	value	value	NOUN
easat-8115	79	19	pr	pr	NOUN
easat-8115	79	20	(	(	PUNCT
easat-8115	79	21	95%ci	95%ci	NUM
easat-8115	79	22	)	)	PUNCT
easat-8115	79	23	positive	positive	ADJ
easat-8115	79	24	(	(	PUNCT
easat-8115	79	25	n	n	NOUN
easat-8115	79	26	=	=	SYM
easat-8115	79	27	50	50	NUM
easat-8115	79	28	)	)	PUNCT
easat-8115	79	29	negative	negative	ADJ
easat-8115	79	30	(	(	PUNCT
easat-8115	79	31	n	n	NOUN
easat-8115	79	32	=	=	SYM
easat-8115	79	33	30	30	NUM
easat-8115	79	34	)	)	PUNCT
easat-8115	79	35	low	low	ADJ
easat-8115	79	36	grade	grade	NOUN
easat-8115	79	37	fever	fever	NOUN
easat-8115	79	38	<	<	X
easat-8115	79	39	0.001	0.001	NUM
easat-8115	79	40	4.88	4.88	NUM
easat-8115	79	41	(	(	PUNCT
easat-8115	79	42	2.36	2.36	NUM
easat-8115	79	43	–	–	PUNCT
easat-8115	79	44	10.1	10.1	NUM
easat-8115	79	45	)	)	PUNCT
easat-8115	79	46	<	<	X
easat-8115	79	47	0.001	0.001	NUM
easat-8115	79	48	23,9	23,9	PRON
easat-8115	79	49	(	(	PUNCT
easat-8115	79	50	4,06	4,06	NUM
easat-8115	79	51	-	-	NOUN
easat-8115	79	52	141,01	141,01	NUM
easat-8115	79	53	)	)	PUNCT
easat-8115	80	1	yes	yes	INTJ
easat-8115	80	2	44	44	NUM
easat-8115	80	3	(	(	PUNCT
easat-8115	80	4	88	88	NUM
easat-8115	80	5	%	%	NOUN
easat-8115	80	6	)	)	PUNCT
easat-8115	80	7	4	4	NUM
easat-8115	80	8	(	(	PUNCT
easat-8115	80	9	13.3	13.3	NUM
easat-8115	80	10	%	%	NOUN
easat-8115	80	11	)	)	PUNCT
easat-8115	81	1	no	no	DET
easat-8115	81	2	6	6	NUM
easat-8115	81	3	(	(	PUNCT
easat-8115	81	4	12	12	NUM
easat-8115	81	5	%	%	NOUN
easat-8115	81	6	)	)	PUNCT
easat-8115	81	7	26	26	NUM
easat-8115	81	8	(	(	PUNCT
easat-8115	81	9	86.7	86.7	NUM
easat-8115	81	10	%	%	NOUN
easat-8115	81	11	)	)	PUNCT
easat-8115	81	12	cough	cough	NOUN
easat-8115	81	13	<	<	X
easat-8115	81	14	0.001	0.001	NUM
easat-8115	81	15	8.28	8.28	NUM
easat-8115	81	16	(	(	PUNCT
easat-8115	81	17	2.92	2.92	NUM
easat-8115	81	18	–	–	PUNCT
easat-8115	81	19	23.48	23.48	NUM
easat-8115	81	20	)	)	PUNCT
easat-8115	81	21	0.027	0.027	NUM
easat-8115	81	22	7,108	7,108	NUM
easat-8115	81	23	(	(	PUNCT
easat-8115	81	24	1,25	1,25	NUM
easat-8115	81	25	–	–	PUNCT
easat-8115	81	26	40,1	40,1	NUM
easat-8115	81	27	)	)	PUNCT
easat-8115	81	28	non	non	ADJ
easat-8115	81	29	-	-	ADJ
easat-8115	81	30	productive	productive	ADJ
easat-8115	81	31	22	22	NUM
easat-8115	81	32	(	(	PUNCT
easat-8115	81	33	44	44	NUM
easat-8115	81	34	%	%	NOUN
easat-8115	81	35	)	)	PUNCT
easat-8115	81	36	18	18	NUM
easat-8115	81	37	(	(	PUNCT
easat-8115	81	38	60	60	NUM
easat-8115	81	39	%	%	NOUN
easat-8115	81	40	)	)	PUNCT
easat-8115	81	41	productive	productive	ADJ
easat-8115	81	42	28	28	NUM
easat-8115	81	43	(	(	PUNCT
easat-8115	81	44	56	56	NUM
easat-8115	81	45	%	%	NOUN
easat-8115	81	46	)	)	PUNCT
easat-8115	81	47	12	12	NUM
easat-8115	81	48	(	(	PUNCT
easat-8115	81	49	40	40	NUM
easat-8115	81	50	%	%	NOUN
easat-8115	81	51	)	)	PUNCT
easat-8115	81	52	dyspnoea	dyspnoea	PROPN
easat-8115	81	53	0.65	0.65	NUM
easat-8115	81	54	1.75	1.75	NUM
easat-8115	81	55	(	(	PUNCT
easat-8115	81	56	0.86	0.86	NUM
easat-8115	81	57	–	–	PUNCT
easat-8115	81	58	3.54	3.54	NUM
easat-8115	81	59	)	)	PUNCT
easat-8115	81	60	0.665	0.665	NUM
easat-8115	81	61	0.55	0.55	NUM
easat-8115	81	62	(	(	PUNCT
easat-8115	81	63	0.037	0.037	NUM
easat-8115	81	64	–	–	PUNCT
easat-8115	81	65	8.26	8.26	NUM
easat-8115	81	66	)	)	PUNCT
easat-8115	82	1	yes	yes	INTJ
easat-8115	82	2	45	45	NUM
easat-8115	82	3	(	(	PUNCT
easat-8115	82	4	90	90	NUM
easat-8115	82	5	%	%	NOUN
easat-8115	82	6	)	)	PUNCT
easat-8115	82	7	22	22	NUM
easat-8115	82	8	(	(	PUNCT
easat-8115	82	9	73.3	73.3	NUM
easat-8115	82	10	%	%	NOUN
easat-8115	82	11	)	)	PUNCT
easat-8115	83	1	no	no	DET
easat-8115	83	2	5	5	NUM
easat-8115	83	3	(	(	PUNCT
easat-8115	83	4	10	10	NUM
easat-8115	83	5	%	%	NOUN
easat-8115	83	6	)	)	PUNCT
easat-8115	83	7	8	8	NUM
easat-8115	83	8	(	(	PUNCT
easat-8115	83	9	26.7	26.7	NUM
easat-8115	83	10	)	)	PUNCT
easat-8115	83	11	oral	oral	ADJ
easat-8115	83	12	candidiasis	candidiasis	NOUN
easat-8115	83	13	<	<	X
easat-8115	83	14	0.001	0.001	NUM
easat-8115	83	15	2.73	2.73	NUM
easat-8115	83	16	(	(	PUNCT
easat-8115	83	17	1.69	1.69	NUM
easat-8115	83	18	–	–	PUNCT
easat-8115	83	19	4.39	4.39	NUM
easat-8115	83	20	)	)	PUNCT
easat-8115	83	21	yes	yes	INTJ
easat-8115	83	22	38	38	NUM
easat-8115	83	23	(	(	PUNCT
easat-8115	83	24	76	76	NUM
easat-8115	83	25	%	%	NOUN
easat-8115	83	26	)	)	PUNCT
easat-8115	83	27	5	5	NUM
easat-8115	83	28	(	(	PUNCT
easat-8115	83	29	11.6	11.6	NUM
easat-8115	83	30	%	%	NOUN
easat-8115	83	31	)	)	PUNCT
easat-8115	83	32	0.012	0.012	NUM
easat-8115	83	33	8,81	8,81	NUM
easat-8115	83	34	(	(	PUNCT
easat-8115	83	35	1,62	1,62	PROPN
easat-8115	83	36	-	-	PUNCT
easat-8115	83	37	47,8	47,8	NUM
easat-8115	83	38	)	)	PUNCT
easat-8115	83	39	no	no	DET
easat-8115	83	40	12	12	NUM
easat-8115	83	41	(	(	PUNCT
easat-8115	83	42	24	24	NUM
easat-8115	83	43	%	%	NOUN
easat-8115	83	44	)	)	PUNCT
easat-8115	83	45	25	25	NUM
easat-8115	83	46	(	(	PUNCT
easat-8115	83	47	67.6	67.6	NUM
easat-8115	83	48	%	%	NOUN
easat-8115	83	49	)	)	PUNCT
easat-8115	83	50	spo2	spo2	PROPN
easat-8115	83	51	/	/	SYM
easat-8115	83	52	fio2	fio2	PROPN
easat-8115	83	53	0.202	0.202	NUM
easat-8115	83	54	4.36	4.36	NUM
easat-8115	83	55	(	(	PUNCT
easat-8115	83	56	0.453	0.453	NUM
easat-8115	83	57	-	-	SYM
easat-8115	83	58	42.13	42.13	NUM
easat-8115	83	59	)	)	PUNCT
easat-8115	83	60			NOUN
easat-8115	83	61	450	450	NUM
easat-8115	83	62	34	34	NUM
easat-8115	83	63	(	(	PUNCT
easat-8115	83	64	68	68	NUM
easat-8115	83	65	%	%	NOUN
easat-8115	83	66	)	)	PUNCT
easat-8115	83	67	10	10	NUM
easat-8115	83	68	(	(	PUNCT
easat-8115	83	69	33.3	33.3	NUM
easat-8115	83	70	%	%	NOUN
easat-8115	83	71	)	)	PUNCT
easat-8115	83	72	0.005	0.005	NUM
easat-8115	83	73	1.74	1.74	NUM
easat-8115	83	74	(	(	PUNCT
easat-8115	83	75	1.17	1.17	NUM
easat-8115	83	76	–	–	PUNCT
easat-8115	83	77	2.59	2.59	NUM
easat-8115	83	78	)	)	PUNCT
easat-8115	83	79	>	>	X
easat-8115	84	1	450	450	NUM
easat-8115	84	2	16	16	NUM
easat-8115	84	3	(	(	PUNCT
easat-8115	84	4	32	32	NUM
easat-8115	84	5	%	%	NOUN
easat-8115	84	6	)	)	PUNCT
easat-8115	84	7	20	20	NUM
easat-8115	84	8	(	(	PUNCT
easat-8115	84	9	66.7	66.7	NUM
easat-8115	84	10	%	%	NOUN
easat-8115	84	11	)	)	PUNCT
easat-8115	84	12	analysis	analysis	NOUN
easat-8115	84	13	on	on	ADP
easat-8115	84	14	laboratory	laboratory	NOUN
easat-8115	84	15	marker	marker	NOUN
easat-8115	84	16	found	find	VERB
easat-8115	84	17	that	that	SCONJ
easat-8115	84	18	nlr	nlr	PROPN
easat-8115	84	19	,	,	PUNCT
easat-8115	84	20	lymphocytes	lymphocyte	NOUN
easat-8115	84	21	,	,	PUNCT
easat-8115	84	22	albumin	albumin	NOUN
easat-8115	84	23	,	,	PUNCT
easat-8115	84	24	and	and	CCONJ
easat-8115	84	25	cd4	cd4	PROPN
easat-8115	84	26	was	be	AUX
easat-8115	84	27	found	find	VERB
easat-8115	84	28	significant	significant	ADJ
easat-8115	84	29	between	between	ADP
easat-8115	84	30	positive	positive	ADJ
easat-8115	84	31	pcr	pcr	ADJ
easat-8115	84	32	group	group	NOUN
easat-8115	84	33	and	and	CCONJ
easat-8115	84	34	negative	negative	ADJ
easat-8115	84	35	pcr	pcr	ADJ
easat-8115	84	36	group	group	NOUN
easat-8115	84	37	(	(	PUNCT
easat-8115	84	38	table	table	NOUN
easat-8115	84	39	4	4	NUM
easat-8115	84	40	)	)	PUNCT
easat-8115	84	41	.	.	PUNCT
easat-8115	85	1	variables	variable	NOUN
easat-8115	85	2	with	with	ADP
easat-8115	85	3	significant	significant	ADJ
easat-8115	85	4	mean	mean	ADJ
easat-8115	85	5	difference	difference	NOUN
easat-8115	85	6	were	be	AUX
easat-8115	85	7	than	than	SCONJ
easat-8115	85	8	analysed	analyse	VERB
easat-8115	85	9	in	in	ADP
easat-8115	85	10	bivariate	bivariate	ADJ
easat-8115	85	11	analysis	analysis	NOUN
easat-8115	85	12	.	.	PUNCT
easat-8115	86	1	nlr	nlr	PROPN
easat-8115	86	2	and	and	CCONJ
easat-8115	86	3	albumin	albumin	PROPN
easat-8115	86	4	cut	cut	VERB
easat-8115	86	5	off	off	ADP
easat-8115	86	6	was	be	AUX
easat-8115	86	7	obtained	obtain	VERB
easat-8115	86	8	from	from	ADP
easat-8115	86	9	roc	roc	PROPN
easat-8115	86	10	curve	curve	NOUN
easat-8115	86	11	,	,	PUNCT
easat-8115	86	12	for	for	ADP
easat-8115	86	13	nlr	nlr	PROPN
easat-8115	86	14	7.175	7.175	NUM
easat-8115	86	15	(	(	PUNCT
easat-8115	86	16	auc	auc	NOUN
easat-8115	86	17	0.650	0.650	NUM
easat-8115	86	18	,	,	PUNCT
easat-8115	86	19	p	p	X
easat-8115	86	20	<	<	X
easat-8115	86	21	0.025	0.025	NUM
easat-8115	86	22	)	)	PUNCT
easat-8115	86	23	;	;	PUNCT
easat-8115	86	24	and	and	CCONJ
easat-8115	86	25	albumin	albumin	NOUN
easat-8115	86	26	3.1	3.1	NUM
easat-8115	86	27	(	(	PUNCT
easat-8115	86	28	auc	auc	NOUN
easat-8115	86	29	0.813	0.813	NUM
easat-8115	86	30	;	;	PUNCT
easat-8115	86	31	p	p	X
easat-8115	86	32	<	<	NOUN
easat-8115	86	33	0.001	0.001	NUM
easat-8115	86	34	)	)	PUNCT
easat-8115	86	35	;	;	PUNCT
easat-8115	86	36	while	while	SCONJ
easat-8115	86	37	cd4	cd4	PROPN
easat-8115	86	38	cut	cut	VERB
easat-8115	86	39	off	off	ADP
easat-8115	86	40	≤200	≤200	DET
easat-8115	86	41	cells/µl	cells/µl	NOUN
easat-8115	86	42	and	and	CCONJ
easat-8115	86	43	lymphocytes	lymphocyte	NOUN
easat-8115	86	44	cut	cut	VERB
easat-8115	86	45	off	off	ADP
easat-8115	86	46	≤1.2	≤1.2	NOUN
easat-8115	87	1	x	x	SYM
easat-8115	87	2	103/µl	103/µl	NUM
easat-8115	87	3	were	be	AUX
easat-8115	87	4	used	use	VERB
easat-8115	87	5	(	(	PUNCT
easat-8115	87	6	table	table	NOUN
easat-8115	87	7	5	5	NUM
easat-8115	87	8	)	)	PUNCT
easat-8115	87	9	.	.	PUNCT
easat-8115	88	1	laboratory	laboratory	NOUN
easat-8115	88	2	parameters	parameter	NOUN
easat-8115	88	3	with	with	ADP
easat-8115	88	4	significant	significant	ADJ
easat-8115	88	5	relationship	relationship	NOUN
easat-8115	88	6	(	(	PUNCT
easat-8115	88	7	table	table	NOUN
easat-8115	88	8	5	5	NUM
easat-8115	88	9	)	)	PUNCT
easat-8115	88	10	included	include	VERB
easat-8115	88	11	for	for	ADP
easat-8115	88	12	multivariate	multivariate	NOUN
easat-8115	88	13	analysis	analysis	NOUN
easat-8115	88	14	.	.	PUNCT
easat-8115	89	1	multivariate	multivariate	NOUN
easat-8115	89	2	analysis	analysis	NOUN
easat-8115	89	3	on	on	ADP
easat-8115	89	4	laboratory	laboratory	NOUN
easat-8115	89	5	parameters	parameter	NOUN
easat-8115	89	6	demonstrated	demonstrate	VERB
easat-8115	89	7	limphocytes	limphocyte	NOUN
easat-8115	89	8	,	,	PUNCT
easat-8115	89	9	albumin	albumin	NOUN
easat-8115	89	10	and	and	CCONJ
easat-8115	89	11	cd4	cd4	PROPN
easat-8115	89	12	affected	affect	VERB
easat-8115	89	13	sputum	sputum	PROPN
easat-8115	89	14	pcr	pcr	PROPN
easat-8115	89	15	positivity	positivity	NOUN
easat-8115	89	16	.	.	PUNCT
easat-8115	90	1	subjects	subject	NOUN
easat-8115	90	2	with	with	ADP
easat-8115	90	3	albumin	albumin	NOUN
easat-8115	90	4	≤3.10	≤3.10	ADJ
easat-8115	90	5	g	g	PROPN
easat-8115	90	6	/	/	SYM
easat-8115	90	7	dl	dl	PROPN
easat-8115	90	8	at	at	ADP
easat-8115	90	9	risk	risk	NOUN
easat-8115	90	10	having	have	VERB
easat-8115	90	11	positive	positive	ADJ
easat-8115	90	12	sputum	sputum	NOUN
easat-8115	90	13	pcr	pcr	NOUN
easat-8115	90	14	5.59	5.59	NUM
easat-8115	90	15	times	time	NOUN
easat-8115	90	16	greater	great	ADJ
easat-8115	90	17	than	than	ADP
easat-8115	90	18	those	those	PRON
easat-8115	90	19	with	with	ADP
easat-8115	90	20	albumin	albumin	NOUN
easat-8115	90	21	>	>	X
easat-8115	90	22	3.10	3.10	NUM
easat-8115	90	23	.	.	PUNCT
easat-8115	91	1	subjects	subject	NOUN
easat-8115	91	2	with	with	ADP
easat-8115	91	3	cd4	cd4	PROPN
easat-8115	91	4	≤200	≤200	PROPN
easat-8115	91	5	cells/µl	cells/µl	NOUN
easat-8115	91	6	at	at	ADP
easat-8115	91	7	risk	risk	NOUN
easat-8115	91	8	having	have	VERB
easat-8115	91	9	positive	positive	ADJ
easat-8115	91	10	sputum	sputum	NOUN
easat-8115	91	11	pcr	pcr	NOUN
easat-8115	91	12	14.3	14.3	NUM
easat-8115	91	13	times	time	NOUN
easat-8115	91	14	greater	great	ADJ
easat-8115	91	15	than	than	ADP
easat-8115	91	16	those	those	PRON
easat-8115	91	17	with	with	ADP
easat-8115	91	18	cd4	cd4	PROPN
easat-8115	91	19	>	>	X
easat-8115	91	20	200	200	NUM
easat-8115	91	21	.	.	PUNCT
easat-8115	92	1	subjects	subject	NOUN
easat-8115	92	2	with	with	ADP
easat-8115	92	3	lymphocytes	lymphocyte	NOUN
easat-8115	92	4	≤	≤	NOUN
easat-8115	92	5	1.2x103µ/l	1.2x103µ/l	NUM
easat-8115	92	6	at	at	ADP
easat-8115	92	7	risk	risk	NOUN
easat-8115	92	8	having	have	VERB
easat-8115	92	9	positive	positive	ADJ
easat-8115	92	10	sputum	sputum	NOUN
easat-8115	92	11	pcr	pcr	PROPN
easat-8115	92	12	19.4	19.4	NUM
easat-8115	92	13	times	time	NOUN
easat-8115	92	14	greater	great	ADJ
easat-8115	92	15	than	than	ADP
easat-8115	92	16	those	those	PRON
easat-8115	92	17	with	with	ADP
easat-8115	92	18	albumin	albumin	NOUN
easat-8115	92	19	>	>	X
easat-8115	92	20	3.10	3.10	NUM
easat-8115	92	21	.	.	PUNCT
easat-8115	93	1	the	the	DET
easat-8115	93	2	nagelkerke	nagelkerke	PROPN
easat-8115	93	3	r	r	NOUN
easat-8115	93	4	square	square	ADJ
easat-8115	93	5	value	value	NOUN
easat-8115	93	6	of	of	ADP
easat-8115	93	7	0.759	0.759	NUM
easat-8115	93	8	showed	show	VERB
easat-8115	93	9	the	the	DET
easat-8115	93	10	ability	ability	NOUN
easat-8115	93	11	of	of	ADP
easat-8115	93	12	independent	independent	ADJ
easat-8115	93	13	variables	variable	NOUN
easat-8115	93	14	to	to	PART
easat-8115	93	15	explain	explain	VERB
easat-8115	93	16	the	the	DET
easat-8115	93	17	dependent	dependent	ADJ
easat-8115	93	18	variable	variable	NOUN
easat-8115	93	19	by	by	ADP
easat-8115	93	20	75.9	75.9	NUM
easat-8115	93	21	%	%	NOUN
easat-8115	93	22	,	,	PUNCT
easat-8115	93	23	the	the	DET
easat-8115	93	24	rest	rest	NOUN
easat-8115	93	25	(	(	PUNCT
easat-8115	93	26	24.1	24.1	NUM
easat-8115	93	27	%	%	NOUN
easat-8115	93	28	)	)	PUNCT
easat-8115	93	29	influenced	influence	VERB
easat-8115	93	30	other	other	ADJ
easat-8115	93	31	factors	factor	NOUN
easat-8115	93	32	outside	outside	ADP
easat-8115	93	33	the	the	DET
easat-8115	93	34	model	model	NOUN
easat-8115	93	35	.	.	PUNCT
easat-8115	94	1	1335	1335	NUM
easat-8115	94	2	edelweiss	edelweiss	PROPN
easat-8115	94	3	applied	apply	VERB
easat-8115	94	4	science	science	NOUN
easat-8115	94	5	and	and	CCONJ
easat-8115	94	6	technology	technology	NOUN
easat-8115	94	7	issn	issn	PROPN
easat-8115	94	8	:	:	PUNCT
easat-8115	94	9	2576	2576	NUM
easat-8115	94	10	-	-	SYM
easat-8115	94	11	8484	8484	NUM
easat-8115	94	12	vol	vol	NOUN
easat-8115	94	13	.	.	PROPN
easat-8115	95	1	9	9	NUM
easat-8115	95	2	,	,	PUNCT
easat-8115	95	3	no	no	INTJ
easat-8115	95	4	.	.	NOUN
easat-8115	96	1	6	6	NUM
easat-8115	96	2	:	:	SYM
easat-8115	96	3	1331	1331	NUM
easat-8115	96	4	-	-	SYM
easat-8115	96	5	1341	1341	NUM
easat-8115	96	6	,	,	PUNCT
easat-8115	96	7	2025	2025	NUM
easat-8115	96	8	doi	doi	NOUN
easat-8115	96	9	:	:	PUNCT
easat-8115	96	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	96	11	©	©	PROPN
easat-8115	96	12	2025	2025	NUM
easat-8115	96	13	by	by	ADP
easat-8115	96	14	the	the	DET
easat-8115	96	15	authors	author	NOUN
easat-8115	96	16	;	;	PUNCT
easat-8115	97	1	licensee	licensee	PROPN
easat-8115	97	2	learning	learn	VERB
easat-8115	97	3	gate	gate	NOUN
easat-8115	97	4	table	table	NOUN
easat-8115	97	5	4	4	NUM
easat-8115	97	6	.	.	PUNCT
easat-8115	97	7	differences	difference	NOUN
easat-8115	97	8	in	in	ADP
easat-8115	97	9	laboratory	laboratory	NOUN
easat-8115	97	10	parameters	parameter	NOUN
easat-8115	97	11	with	with	ADP
easat-8115	97	12	sputum	sputum	PROPN
easat-8115	97	13	pcr	pcr	PROPN
easat-8115	97	14	positivity	positivity	NOUN
easat-8115	97	15	in	in	ADP
easat-8115	97	16	study	study	NOUN
easat-8115	97	17	subjects	subject	NOUN
easat-8115	97	18	.	.	PUNCT
easat-8115	98	1	sputum	sputum	PROPN
easat-8115	98	2	pcr	pcr	PROPN
easat-8115	98	3	p	p	NOUN
easat-8115	98	4	-	-	PUNCT
easat-8115	98	5	value	value	NOUN
easat-8115	98	6	positive	positive	ADJ
easat-8115	98	7	(	(	PUNCT
easat-8115	98	8	n	n	NOUN
easat-8115	98	9	=	=	SYM
easat-8115	98	10	50	50	NUM
easat-8115	98	11	)	)	PUNCT
easat-8115	98	12	negative	negative	ADJ
easat-8115	98	13	(	(	PUNCT
easat-8115	98	14	n	n	NOUN
easat-8115	98	15	=	=	SYM
easat-8115	98	16	30	30	NUM
easat-8115	98	17	)	)	PUNCT
easat-8115	98	18	haemoglobin	haemoglobin	NOUN
easat-8115	98	19	(	(	PUNCT
easat-8115	98	20	g	g	PROPN
easat-8115	98	21	/	/	SYM
easat-8115	98	22	dl	dl	NOUN
easat-8115	98	23	)	)	PUNCT
easat-8115	98	24	mean	mean	NOUN
easat-8115	98	25	sd	sd	ADP
easat-8115	98	26	11.49	11.49	NUM
easat-8115	98	27			PROPN
easat-8115	98	28	2.156	2.156	NUM
easat-8115	98	29	11.49	11.49	NUM
easat-8115	98	30			PROPN
easat-8115	98	31	3.082	3.082	NUM
easat-8115	98	32	0.990	0.990	NUM
easat-8115	98	33	platelet	platelet	NOUN
easat-8115	98	34	(	(	PUNCT
easat-8115	98	35	103/µl	103/µl	X
easat-8115	98	36	)	)	PUNCT
easat-8115	98	37	mean	mean	NOUN
easat-8115	98	38	sd	sd	ADP
easat-8115	98	39	294.13	294.13	NUM
easat-8115	98	40			PROPN
easat-8115	98	41	134.946	134.946	NUM
easat-8115	98	42	283.67	283.67	NUM
easat-8115	98	43			PROPN
easat-8115	98	44	131.565	131.565	NUM
easat-8115	98	45	0.736	0.736	NUM
easat-8115	98	46	lymphocytes(103/µl	lymphocytes(103/µl	PROPN
easat-8115	98	47	)	)	PUNCT
easat-8115	98	48	median	median	NOUN
easat-8115	98	49	(	(	PUNCT
easat-8115	98	50	min	min	NOUN
easat-8115	98	51	-max	-max	NUM
easat-8115	98	52	)	)	PUNCT
easat-8115	98	53	0.78	0.78	NUM
easat-8115	98	54	(	(	PUNCT
easat-8115	98	55	0.17	0.17	NUM
easat-8115	98	56	-	-	SYM
easat-8115	98	57	1.65	1.65	NUM
easat-8115	98	58	)	)	PUNCT
easat-8115	98	59	1.65	1.65	NUM
easat-8115	98	60	(	(	PUNCT
easat-8115	98	61	0.60	0.60	NUM
easat-8115	98	62	-	-	SYM
easat-8115	98	63	5.32	5.32	NUM
easat-8115	98	64	)	)	PUNCT
easat-8115	98	65	<	<	X
easat-8115	98	66	0.001	0.001	NUM
easat-8115	98	67	nlr	nlr	PROPN
easat-8115	98	68	median	median	PROPN
easat-8115	98	69	(	(	PUNCT
easat-8115	98	70	min	min	PROPN
easat-8115	98	71	–	–	PUNCT
easat-8115	98	72	max	max	PROPN
easat-8115	98	73	)	)	PUNCT
easat-8115	98	74	8.53	8.53	NUM
easat-8115	98	75	(	(	PUNCT
easat-8115	98	76	0.91	0.91	NUM
easat-8115	98	77	–	–	PUNCT
easat-8115	98	78	127.65	127.65	NUM
easat-8115	98	79	)	)	PUNCT
easat-8115	98	80	5.36	5.36	NUM
easat-8115	98	81	(	(	PUNCT
easat-8115	98	82	0.71	0.71	NUM
easat-8115	98	83	–	–	PUNCT
easat-8115	98	84	40.43	40.43	NUM
easat-8115	98	85	)	)	PUNCT
easat-8115	98	86	0.025	0.025	NUM
easat-8115	98	87	mlr	mlr	NOUN
easat-8115	98	88	median	median	NOUN
easat-8115	98	89	(	(	PUNCT
easat-8115	98	90	min	min	PROPN
easat-8115	98	91	–	–	PUNCT
easat-8115	98	92	max	max	PROPN
easat-8115	98	93	)	)	PUNCT
easat-8115	98	94	0.575	0.575	NUM
easat-8115	98	95	(	(	PUNCT
easat-8115	98	96	0.03	0.03	NUM
easat-8115	98	97	–	–	PUNCT
easat-8115	98	98	3.35	3.35	NUM
easat-8115	98	99	)	)	PUNCT
easat-8115	98	100	0.550	0.550	NUM
easat-8115	98	101	(	(	PUNCT
easat-8115	98	102	0.05	0.05	NUM
easat-8115	98	103	–	–	PUNCT
easat-8115	98	104	2.37	2.37	NUM
easat-8115	98	105	)	)	PUNCT
easat-8115	98	106	0.929	0.929	NUM
easat-8115	98	107	eosinofil	eosinofil	X
easat-8115	98	108	(	(	PUNCT
easat-8115	98	109	103/µl	103/µl	X
easat-8115	98	110	)	)	PUNCT
easat-8115	98	111	median	median	NOUN
easat-8115	98	112	(	(	PUNCT
easat-8115	98	113	min	min	PROPN
easat-8115	98	114	–	–	PUNCT
easat-8115	98	115	max	max	PROPN
easat-8115	98	116	)	)	PUNCT
easat-8115	98	117	0.02	0.02	NUM
easat-8115	98	118	(	(	PUNCT
easat-8115	98	119	0	0	NUM
easat-8115	98	120	–	–	PUNCT
easat-8115	98	121	0.4	0.4	NUM
easat-8115	98	122	)	)	PUNCT
easat-8115	98	123	0.06	0.06	NUM
easat-8115	98	124	(	(	PUNCT
easat-8115	98	125	0	0	NUM
easat-8115	98	126	–	–	PUNCT
easat-8115	98	127	0.62	0.62	NUM
easat-8115	98	128	)	)	PUNCT
easat-8115	98	129	0.086	0.086	NUM
easat-8115	98	130	albumin	albumin	ADJ
easat-8115	98	131	mean	mean	PROPN
easat-8115	98	132	sd	sd	ADP
easat-8115	98	133	2.87	2.87	NUM
easat-8115	98	134			PROPN
easat-8115	98	135	0.456	0.456	NUM
easat-8115	98	136	3.48	3.48	NUM
easat-8115	98	137			PROPN
easat-8115	98	138	0.570	0.570	NUM
easat-8115	98	139	<	<	X
easat-8115	98	140	0.001	0.001	NUM
easat-8115	98	141	cd4	cd4	PROPN
easat-8115	98	142	median	median	NOUN
easat-8115	98	143	(	(	PUNCT
easat-8115	98	144	min	min	PROPN
easat-8115	98	145	–	–	PUNCT
easat-8115	98	146	max	max	PROPN
easat-8115	98	147	)	)	PUNCT
easat-8115	98	148	18.5	18.5	NUM
easat-8115	98	149	(	(	PUNCT
easat-8115	98	150	1	1	NUM
easat-8115	98	151	–	–	SYM
easat-8115	98	152	218	218	NUM
easat-8115	98	153	)	)	PUNCT
easat-8115	98	154	266.5	266.5	NUM
easat-8115	98	155	(	(	PUNCT
easat-8115	98	156	85	85	NUM
easat-8115	98	157	–	–	PUNCT
easat-8115	98	158	1131	1131	NUM
easat-8115	98	159	)	)	PUNCT
easat-8115	98	160	<	<	X
easat-8115	98	161	0.001	0.001	NUM
easat-8115	98	162	cd8	cd8	PROPN
easat-8115	98	163	median	median	NOUN
easat-8115	98	164	(	(	PUNCT
easat-8115	98	165	min	min	PROPN
easat-8115	98	166	–	–	PUNCT
easat-8115	98	167	max	max	PROPN
easat-8115	98	168	)	)	PUNCT
easat-8115	98	169	327.5	327.5	NUM
easat-8115	98	170	(	(	PUNCT
easat-8115	98	171	56	56	NUM
easat-8115	98	172	–	–	SYM
easat-8115	98	173	2486	2486	NUM
easat-8115	98	174	)	)	PUNCT
easat-8115	98	175	400(47	400(47	NUM
easat-8115	98	176	–	–	PUNCT
easat-8115	98	177	1857	1857	NUM
easat-8115	98	178	)	)	PUNCT
easat-8115	98	179	0.773	0.773	NUM
easat-8115	98	180	aado2	aado2	PROPN
easat-8115	98	181	median	median	NOUN
easat-8115	98	182	(	(	PUNCT
easat-8115	98	183	min	min	PROPN
easat-8115	98	184	–	–	PUNCT
easat-8115	98	185	max	max	PROPN
easat-8115	98	186	)	)	PUNCT
easat-8115	98	187	37.6	37.6	NUM
easat-8115	98	188	(	(	PUNCT
easat-8115	98	189	3.7	3.7	NUM
easat-8115	98	190	–	–	PUNCT
easat-8115	98	191	156.8	156.8	NUM
easat-8115	98	192	)	)	PUNCT
easat-8115	98	193	31.6	31.6	NUM
easat-8115	98	194	(	(	PUNCT
easat-8115	98	195	11	11	NUM
easat-8115	98	196	–	–	SYM
easat-8115	98	197	165	165	NUM
easat-8115	98	198	)	)	PUNCT
easat-8115	98	199	0.243	0.243	NUM
easat-8115	98	200	table	table	NOUN
easat-8115	98	201	5	5	NUM
easat-8115	98	202	.	.	PUNCT
easat-8115	98	203	relationship	relationship	NOUN
easat-8115	98	204	of	of	ADP
easat-8115	98	205	laboratory	laboratory	NOUN
easat-8115	98	206	parameters	parameter	NOUN
easat-8115	98	207	with	with	ADP
easat-8115	98	208	sputum	sputum	PROPN
easat-8115	98	209	pcr	pcr	PROPN
easat-8115	98	210	positivity	positivity	NOUN
easat-8115	98	211	in	in	ADP
easat-8115	98	212	study	study	NOUN
easat-8115	98	213	subjects	subject	NOUN
easat-8115	98	214	.	.	PUNCT
easat-8115	99	1	laboratory	laboratory	NOUN
easat-8115	99	2	parameters	parameter	NOUN
easat-8115	99	3	sputum	sputum	PROPN
easat-8115	99	4	pcr	pcr	PROPN
easat-8115	99	5	bivariate	bivariate	ADJ
easat-8115	99	6	analysis	analysis	NOUN
easat-8115	99	7	multivariate	multivariate	NOUN
easat-8115	99	8	analysis	analysis	NOUN
easat-8115	99	9	p	p	NOUN
easat-8115	99	10	-	-	PUNCT
easat-8115	99	11	value	value	NOUN
easat-8115	99	12	pr	pr	NOUN
easat-8115	99	13	(	(	PUNCT
easat-8115	99	14	95%ci	95%ci	NUM
easat-8115	99	15	)	)	PUNCT
easat-8115	99	16	p	p	NOUN
easat-8115	99	17	-	-	PUNCT
easat-8115	99	18	value	value	NOUN
easat-8115	99	19	pr	pr	NOUN
easat-8115	99	20	(	(	PUNCT
easat-8115	99	21	95%ci	95%ci	NUM
easat-8115	99	22	)	)	PUNCT
easat-8115	99	23	positive	positive	ADJ
easat-8115	99	24	(	(	PUNCT
easat-8115	99	25	n	n	NOUN
easat-8115	99	26	=	=	SYM
easat-8115	99	27	50	50	NUM
easat-8115	99	28	)	)	PUNCT
easat-8115	99	29	negative	negative	ADJ
easat-8115	99	30	(	(	PUNCT
easat-8115	99	31	n	n	NOUN
easat-8115	99	32	=	=	SYM
easat-8115	99	33	30	30	NUM
easat-8115	99	34	)	)	PUNCT
easat-8115	99	35	lymphocytes	lymphocyte	VERB
easat-8115	99	36	4.09	4.09	NUM
easat-8115	99	37	(	(	PUNCT
easat-8115	99	38	2.11	2.11	NUM
easat-8115	99	39	-7	-7	NOUN
easat-8115	99	40	.	.	PROPN
easat-8115	99	41	93	93	NUM
easat-8115	99	42	)	)	PUNCT
easat-8115	99	43	0.004	0.004	NUM
easat-8115	99	44	19.4	19.4	NUM
easat-8115	99	45	(	(	PUNCT
easat-8115	99	46	2.5	2.5	NUM
easat-8115	99	47	149,3	149,3	NOUN
easat-8115	99	48	)	)	PUNCT
easat-8115	99	49			NUM
easat-8115	99	50	1.2	1.2	NUM
easat-8115	99	51	x10³/µl	x10³/µl	NUM
easat-8115	99	52	43	43	NUM
easat-8115	100	1	(	(	PUNCT
easat-8115	100	2	86	86	NUM
easat-8115	100	3	%	%	NOUN
easat-8115	100	4	)	)	PUNCT
easat-8115	100	5	5	5	NUM
easat-8115	100	6	(	(	PUNCT
easat-8115	100	7	16.7	16.7	NUM
easat-8115	100	8	%	%	NOUN
easat-8115	100	9	)	)	PUNCT
easat-8115	101	1	<	<	X
easat-8115	101	2	0.001	0.001	NUM
easat-8115	101	3	>	>	SYM
easat-8115	101	4	1.2	1.2	NUM
easat-8115	101	5	x10³/µl	x10³/µl	X
easat-8115	101	6	7	7	NUM
easat-8115	101	7	(	(	PUNCT
easat-8115	101	8	14	14	NUM
easat-8115	101	9	%	%	NOUN
easat-8115	101	10	)	)	PUNCT
easat-8115	101	11	25	25	NUM
easat-8115	101	12	(	(	PUNCT
easat-8115	101	13	83.3	83.3	NUM
easat-8115	101	14	%	%	NOUN
easat-8115	101	15	)	)	PUNCT
easat-8115	101	16	nlr	nlr	PROPN
easat-8115	101	17	0.107	0.107	NUM
easat-8115	101	18	0.737	0.737	NUM
easat-8115	101	19	(	(	PUNCT
easat-8115	101	20	0.516	0.516	NUM
easat-8115	101	21	–	–	PUNCT
easat-8115	101	22	1.053	1.053	NUM
easat-8115	101	23	)	)	PUNCT
easat-8115	101	24	0.94	0.94	NUM
easat-8115	101	25	22.4	22.4	NUM
easat-8115	101	26	(	(	PUNCT
easat-8115	101	27	0.42	0.42	NUM
easat-8115	101	28	19.48	19.48	NUM
easat-8115	101	29	)	)	PUNCT
easat-8115	101	30			NUM
easat-8115	101	31	7.175	7.175	NUM
easat-8115	101	32	20	20	NUM
easat-8115	101	33	(	(	PUNCT
easat-8115	101	34	40	40	NUM
easat-8115	101	35	%	%	NOUN
easat-8115	101	36	)	)	PUNCT
easat-8115	101	37	18	18	NUM
easat-8115	101	38	(	(	PUNCT
easat-8115	101	39	60	60	NUM
easat-8115	101	40	%	%	NOUN
easat-8115	101	41	)	)	PUNCT
easat-8115	101	42	<	<	X
easat-8115	102	1	7.175	7.175	NUM
easat-8115	102	2	30	30	NUM
easat-8115	102	3	(	(	PUNCT
easat-8115	102	4	60	60	NUM
easat-8115	102	5	%	%	NOUN
easat-8115	102	6	)	)	PUNCT
easat-8115	102	7	12	12	NUM
easat-8115	102	8	(	(	PUNCT
easat-8115	102	9	40	40	NUM
easat-8115	102	10	%	%	NOUN
easat-8115	102	11	)	)	PUNCT
easat-8115	102	12	albumin	albumin	NOUN
easat-8115	102	13	<	<	X
easat-8115	102	14	0.001	0.001	NUM
easat-8115	102	15	8.542	8.542	NUM
easat-8115	102	16	(	(	PUNCT
easat-8115	102	17	2.27	2.27	NUM
easat-8115	102	18	–	–	PUNCT
easat-8115	102	19	32.103	32.103	NUM
easat-8115	102	20	)	)	PUNCT
easat-8115	102	21	0.042	0.042	NUM
easat-8115	102	22	5,59	5,59	NUM
easat-8115	102	23	(	(	PUNCT
easat-8115	102	24	1,062	1,062	NUM
easat-8115	102	25	–	–	PUNCT
easat-8115	102	26	29,4	29,4	NUM
easat-8115	102	27	)	)	PUNCT
easat-8115	102	28			NOUN
easat-8115	102	29	3.1	3.1	NUM
easat-8115	102	30	g	g	NOUN
easat-8115	102	31	/	/	SYM
easat-8115	102	32	dl	dl	PROPN
easat-8115	102	33	48	48	NUM
easat-8115	102	34	(	(	PUNCT
easat-8115	102	35	96	96	NUM
easat-8115	102	36	%	%	NOUN
easat-8115	102	37	)	)	PUNCT
easat-8115	102	38	11	11	NUM
easat-8115	102	39	(	(	PUNCT
easat-8115	102	40	18.6	18.6	NUM
easat-8115	102	41	%	%	NOUN
easat-8115	102	42	)	)	PUNCT
easat-8115	102	43	>	>	X
easat-8115	102	44	3.1	3.1	NUM
easat-8115	102	45	g	g	NOUN
easat-8115	102	46	/	/	SYM
easat-8115	102	47	dl	dl	PROPN
easat-8115	102	48	2	2	NUM
easat-8115	102	49	(	(	PUNCT
easat-8115	102	50	4	4	NUM
easat-8115	102	51	%	%	NOUN
easat-8115	102	52	)	)	PUNCT
easat-8115	102	53	19	19	NUM
easat-8115	102	54	(	(	PUNCT
easat-8115	102	55	63.3	63.3	NUM
easat-8115	102	56	%	%	NOUN
easat-8115	102	57	)	)	PUNCT
easat-8115	103	1	cd4	cd4	PROPN
easat-8115	103	2	<	<	X
easat-8115	103	3	0.001	0.001	NUM
easat-8115	103	4	4.235	4.235	NUM
easat-8115	103	5	(	(	PUNCT
easat-8115	103	6	1.184	1.184	NUM
easat-8115	103	7	–	–	PUNCT
easat-8115	103	8	15.148	15.148	NUM
easat-8115	103	9	)	)	PUNCT
easat-8115	103	10	0.007	0.007	NUM
easat-8115	103	11	14,3	14,3	NUM
easat-8115	103	12	(	(	PUNCT
easat-8115	103	13	2.06	2.06	NUM
easat-8115	103	14	–	–	SYM
easat-8115	103	15	99.69	99.69	NUM
easat-8115	103	16	)	)	PUNCT
easat-8115	103	17			NOUN
easat-8115	103	18	200	200	NUM
easat-8115	103	19	cells/µl	cells/µl	NOUN
easat-8115	103	20	48	48	NUM
easat-8115	103	21	(	(	PUNCT
easat-8115	103	22	96	96	NUM
easat-8115	103	23	%	%	NOUN
easat-8115	103	24	)	)	PUNCT
easat-8115	103	25	20	20	NUM
easat-8115	103	26	(	(	PUNCT
easat-8115	103	27	66.7	66.7	NUM
easat-8115	103	28	%	%	NOUN
easat-8115	103	29	)	)	PUNCT
easat-8115	103	30	>	>	X
easat-8115	104	1	200	200	NUM
easat-8115	104	2	cells	cell	NOUN
easat-8115	104	3	/µl	/µl	PUNCT
easat-8115	104	4	2	2	NUM
easat-8115	104	5	(	(	PUNCT
easat-8115	104	6	4	4	NUM
easat-8115	104	7	%	%	NOUN
easat-8115	104	8	)	)	PUNCT
easat-8115	104	9	10	10	NUM
easat-8115	104	10	(	(	PUNCT
easat-8115	104	11	33.3	33.3	NUM
easat-8115	104	12	%	%	NOUN
easat-8115	104	13	)	)	PUNCT
easat-8115	104	14	analysis	analysis	NOUN
easat-8115	104	15	on	on	ADP
easat-8115	104	16	radiology	radiology	NOUN
easat-8115	104	17	parameters	parameter	NOUN
easat-8115	104	18	demonstrated	demonstrate	VERB
easat-8115	104	19	that	that	SCONJ
easat-8115	104	20	typical	typical	ADJ
easat-8115	104	21	radiological	radiological	ADJ
easat-8115	104	22	group	group	NOUN
easat-8115	104	23	,	,	PUNCT
easat-8115	104	24	subjects	subject	NOUN
easat-8115	104	25	were	be	AUX
easat-8115	104	26	at	at	ADP
easat-8115	104	27	risk	risk	NOUN
easat-8115	104	28	of	of	ADP
easat-8115	104	29	having	have	VERB
easat-8115	104	30	positive	positive	ADJ
easat-8115	104	31	sputum	sputum	NOUN
easat-8115	104	32	pcr	pcr	NOUN
easat-8115	104	33	results	result	VERB
easat-8115	104	34	20.6	20.6	NUM
easat-8115	104	35	times	time	NOUN
easat-8115	104	36	greater	great	ADJ
easat-8115	104	37	than	than	ADP
easat-8115	104	38	those	those	PRON
easat-8115	104	39	with	with	ADP
easat-8115	104	40	normal	normal	ADJ
easat-8115	104	41	radiology	radiology	NOUN
easat-8115	104	42	,	,	PUNCT
easat-8115	104	43	while	while	SCONJ
easat-8115	104	44	subjects	subject	NOUN
easat-8115	104	45	with	with	ADP
easat-8115	104	46	atypical	atypical	ADJ
easat-8115	104	47	radiological	radiological	ADJ
easat-8115	104	48	results	result	NOUN
easat-8115	104	49	were	be	AUX
easat-8115	104	50	at	at	ADP
easat-8115	104	51	risk	risk	NOUN
easat-8115	104	52	of	of	ADP
easat-8115	104	53	having	have	VERB
easat-8115	104	54	positive	positive	ADJ
easat-8115	104	55	sputum	sputum	NOUN
easat-8115	104	56	pcr	pcr	NOUN
easat-8115	104	57	results	result	VERB
easat-8115	104	58	5.43	5.43	NUM
easat-8115	104	59	times	time	NOUN
easat-8115	104	60	greater	great	ADJ
easat-8115	104	61	than	than	ADP
easat-8115	104	62	those	those	PRON
easat-8115	104	63	with	with	ADP
easat-8115	104	64	normal	normal	ADJ
easat-8115	104	65	radiology	radiology	NOUN
easat-8115	104	66	.	.	PUNCT
easat-8115	105	1	the	the	DET
easat-8115	105	2	nagelkerke	nagelkerke	PROPN
easat-8115	105	3	r	r	NOUN
easat-8115	105	4	square	square	ADJ
easat-8115	105	5	value	value	NOUN
easat-8115	105	6	of	of	ADP
easat-8115	105	7	0.39	0.39	NUM
easat-8115	105	8	indicates	indicate	VERB
easat-8115	105	9	the	the	DET
easat-8115	105	10	ability	ability	NOUN
easat-8115	105	11	of	of	ADP
easat-8115	105	12	independent	independent	ADJ
easat-8115	105	13	variables	variable	NOUN
easat-8115	105	14	to	to	PART
easat-8115	105	15	explain	explain	VERB
easat-8115	105	16	the	the	DET
easat-8115	105	17	dependent	dependent	ADJ
easat-8115	105	18	variable	variable	NOUN
easat-8115	105	19	by	by	ADP
easat-8115	105	20	39	39	NUM
easat-8115	105	21	%	%	NOUN
easat-8115	105	22	,	,	PUNCT
easat-8115	105	23	the	the	DET
easat-8115	105	24	rest	rest	NOUN
easat-8115	105	25	(	(	PUNCT
easat-8115	105	26	71	71	NUM
easat-8115	105	27	%	%	NOUN
easat-8115	105	28	)	)	PUNCT
easat-8115	105	29	is	be	AUX
easat-8115	105	30	influenced	influence	VERB
easat-8115	105	31	by	by	ADP
easat-8115	105	32	other	other	ADJ
easat-8115	105	33	factors	factor	NOUN
easat-8115	105	34	outside	outside	ADP
easat-8115	105	35	the	the	DET
easat-8115	105	36	model	model	NOUN
easat-8115	105	37	.	.	PUNCT
easat-8115	106	1	4	4	X
easat-8115	106	2	.	.	X
easat-8115	106	3	discussion	discussion	NOUN
easat-8115	106	4	the	the	DET
easat-8115	106	5	mean	mean	ADJ
easat-8115	106	6	age	age	NOUN
easat-8115	106	7	of	of	ADP
easat-8115	106	8	patients	patient	NOUN
easat-8115	106	9	with	with	ADP
easat-8115	106	10	positive	positive	ADJ
easat-8115	106	11	sputum	sputum	NOUN
easat-8115	106	12	pcr	pcr	NOUN
easat-8115	106	13	in	in	ADP
easat-8115	106	14	this	this	DET
easat-8115	106	15	study	study	NOUN
easat-8115	106	16	was	be	AUX
easat-8115	106	17	41.46	41.46	NUM
easat-8115	106	18	±	±	NUM
easat-8115	106	19	10.3	10.3	NUM
easat-8115	106	20	years	year	NOUN
easat-8115	106	21	.	.	PUNCT
easat-8115	107	1	male	male	ADJ
easat-8115	107	2	predominance	predominance	NOUN
easat-8115	107	3	was	be	AUX
easat-8115	107	4	found	find	VERB
easat-8115	107	5	in	in	ADP
easat-8115	107	6	both	both	DET
easat-8115	107	7	groups	group	NOUN
easat-8115	107	8	(	(	PUNCT
easat-8115	107	9	positive	positive	ADJ
easat-8115	107	10	and	and	CCONJ
easat-8115	107	11	negative	negative	ADJ
easat-8115	107	12	pcr	pcr	ADJ
easat-8115	107	13	results	result	NOUN
easat-8115	107	14	)	)	PUNCT
easat-8115	107	15	.	.	PUNCT
easat-8115	108	1	these	these	DET
easat-8115	108	2	results	result	NOUN
easat-8115	108	3	are	be	AUX
easat-8115	108	4	in	in	ADP
easat-8115	108	5	line	line	NOUN
easat-8115	108	6	1336	1336	NUM
easat-8115	108	7	edelweiss	edelweiss	PROPN
easat-8115	108	8	applied	apply	VERB
easat-8115	108	9	science	science	NOUN
easat-8115	108	10	and	and	CCONJ
easat-8115	108	11	technology	technology	NOUN
easat-8115	108	12	issn	issn	PROPN
easat-8115	108	13	:	:	PUNCT
easat-8115	108	14	2576	2576	NUM
easat-8115	108	15	-	-	SYM
easat-8115	108	16	8484	8484	NUM
easat-8115	108	17	vol	vol	NOUN
easat-8115	108	18	.	.	PROPN
easat-8115	109	1	9	9	NUM
easat-8115	109	2	,	,	PUNCT
easat-8115	109	3	no	no	INTJ
easat-8115	109	4	.	.	NOUN
easat-8115	110	1	6	6	NUM
easat-8115	110	2	:	:	SYM
easat-8115	110	3	1331	1331	NUM
easat-8115	110	4	-	-	SYM
easat-8115	110	5	1341	1341	NUM
easat-8115	110	6	,	,	PUNCT
easat-8115	110	7	2025	2025	NUM
easat-8115	110	8	doi	doi	NOUN
easat-8115	110	9	:	:	PUNCT
easat-8115	110	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	110	11	©	©	PROPN
easat-8115	110	12	2025	2025	NUM
easat-8115	110	13	by	by	ADP
easat-8115	110	14	the	the	DET
easat-8115	110	15	authors	author	NOUN
easat-8115	110	16	;	;	PUNCT
easat-8115	110	17	licensee	licensee	PROPN
easat-8115	110	18	learning	learning	NOUN
easat-8115	110	19	gate	gate	NOUN
easat-8115	110	20	with	with	ADP
easat-8115	110	21	previous	previous	ADJ
easat-8115	110	22	study	study	NOUN
easat-8115	110	23	by	by	ADP
easat-8115	110	24	yustin	yustin	PROPN
easat-8115	110	25	,	,	PUNCT
easat-8115	110	26	et	et	PROPN
easat-8115	110	27	al	al	PROPN
easat-8115	110	28	.	.	PUNCT
easat-8115	111	1	[	[	X
easat-8115	111	2	3	3	X
easat-8115	111	3	]	]	PUNCT
easat-8115	111	4	where	where	SCONJ
easat-8115	111	5	the	the	DET
easat-8115	111	6	mean	mean	ADJ
easat-8115	111	7	age	age	NOUN
easat-8115	111	8	of	of	ADP
easat-8115	111	9	hiv	hiv	PROPN
easat-8115	111	10	patients	patient	NOUN
easat-8115	111	11	was	be	AUX
easat-8115	111	12	36.79	36.79	NUM
easat-8115	111	13	±	±	NUM
easat-8115	111	14	10.45	10.45	NUM
easat-8115	111	15	with	with	ADP
easat-8115	111	16	male	male	ADJ
easat-8115	111	17	predominance	predominance	NOUN
easat-8115	111	18	as	as	ADV
easat-8115	111	19	well	well	ADV
easat-8115	111	20	.	.	PUNCT
easat-8115	112	1	majority	majority	NOUN
easat-8115	112	2	of	of	ADP
easat-8115	112	3	the	the	DET
easat-8115	112	4	subjects	subject	NOUN
easat-8115	112	5	suspected	suspect	VERB
easat-8115	112	6	with	with	ADP
easat-8115	112	7	pcp	pcp	PROPN
easat-8115	112	8	were	be	AUX
easat-8115	112	9	first	first	ADV
easat-8115	112	10	diagnosed	diagnose	VERB
easat-8115	112	11	with	with	ADP
easat-8115	112	12	hiv	hiv	PROPN
easat-8115	112	13	.	.	PUNCT
easat-8115	113	1	this	this	PRON
easat-8115	113	2	might	might	AUX
easat-8115	113	3	occur	occur	VERB
easat-8115	113	4	because	because	SCONJ
easat-8115	113	5	most	most	ADJ
easat-8115	113	6	subjects	subject	NOUN
easat-8115	113	7	only	only	ADV
easat-8115	113	8	seek	seek	VERB
easat-8115	113	9	for	for	ADP
easat-8115	113	10	medical	medical	ADJ
easat-8115	113	11	attention	attention	NOUN
easat-8115	113	12	after	after	ADP
easat-8115	113	13	having	have	VERB
easat-8115	113	14	pcp	pcp	NOUN
easat-8115	113	15	symptoms	symptom	NOUN
easat-8115	113	16	such	such	ADJ
easat-8115	113	17	as	as	ADP
easat-8115	113	18	shortness	shortness	NOUN
easat-8115	113	19	of	of	ADP
easat-8115	113	20	breath	breath	NOUN
easat-8115	113	21	and	and	CCONJ
easat-8115	113	22	worsening	worsen	VERB
easat-8115	113	23	cough	cough	NOUN
easat-8115	113	24	to	to	ADP
easat-8115	113	25	the	the	DET
easat-8115	113	26	point	point	NOUN
easat-8115	113	27	of	of	ADP
easat-8115	113	28	disrupting	disrupt	VERB
easat-8115	113	29	their	their	PRON
easat-8115	113	30	activities	activity	NOUN
easat-8115	113	31	.	.	PUNCT
easat-8115	114	1	therefore	therefore	ADV
easat-8115	114	2	,	,	PUNCT
easat-8115	114	3	majority	majority	NOUN
easat-8115	114	4	of	of	ADP
easat-8115	114	5	the	the	DET
easat-8115	114	6	subjects	subject	NOUN
easat-8115	114	7	also	also	ADV
easat-8115	114	8	had	have	AUX
easat-8115	114	9	not	not	PART
easat-8115	114	10	received	receive	VERB
easat-8115	114	11	arv	arv	NOUN
easat-8115	114	12	therapy	therapy	NOUN
easat-8115	114	13	and	and	CCONJ
easat-8115	114	14	pcp	pcp	PROPN
easat-8115	114	15	prophylaxis	prophylaxis	NOUN
easat-8115	114	16	.	.	PUNCT
easat-8115	115	1	hiv	hiv	PROPN
easat-8115	115	2	patients	patient	NOUN
easat-8115	115	3	have	have	VERB
easat-8115	115	4	a	a	DET
easat-8115	115	5	higher	high	ADJ
easat-8115	115	6	prevalence	prevalence	NOUN
easat-8115	115	7	of	of	ADP
easat-8115	115	8	pcp	pcp	PROPN
easat-8115	115	9	colonization	colonization	NOUN
easat-8115	115	10	than	than	ADP
easat-8115	115	11	immunocompetent	immunocompetent	ADJ
easat-8115	115	12	individuals	individual	NOUN
easat-8115	115	13	(	(	PUNCT
easat-8115	115	14	68	68	NUM
easat-8115	115	15	%	%	NOUN
easat-8115	115	16	vs.	vs.	ADP
easat-8115	115	17	24	24	NUM
easat-8115	115	18	%	%	NOUN
easat-8115	115	19	)	)	PUNCT
easat-8115	115	20	.	.	PUNCT
easat-8115	116	1	in	in	ADP
easat-8115	116	2	addition	addition	NOUN
easat-8115	116	3	,	,	PUNCT
easat-8115	116	4	pcp	pcp	PROPN
easat-8115	116	5	colonization	colonization	NOUN
easat-8115	116	6	rate	rate	NOUN
easat-8115	116	7	will	will	AUX
easat-8115	116	8	increase	increase	VERB
easat-8115	116	9	in	in	ADP
easat-8115	116	10	hiv	hiv	PROPN
easat-8115	116	11	patients	patient	NOUN
easat-8115	116	12	with	with	ADP
easat-8115	116	13	cd4	cd4	PROPN
easat-8115	116	14	≤	≤	ADV
easat-8115	116	15	50	50	NUM
easat-8115	116	16	/	/	SYM
easat-8115	116	17	μl	μl	CCONJ
easat-8115	116	18	,	,	PUNCT
easat-8115	116	19	and	and	CCONJ
easat-8115	116	20	have	have	AUX
easat-8115	116	21	not	not	PART
easat-8115	116	22	received	receive	VERB
easat-8115	116	23	prophylaxis	prophylaxis	NOUN
easat-8115	116	24	[	[	X
easat-8115	116	25	4	4	NUM
easat-8115	116	26	]	]	PUNCT
easat-8115	116	27	.	.	PUNCT
easat-8115	117	1	positive	positive	ADJ
easat-8115	117	2	sputum	sputum	PROPN
easat-8115	117	3	pcr	pcr	PROPN
easat-8115	117	4	was	be	AUX
easat-8115	117	5	found	find	VERB
easat-8115	117	6	higher	high	ADJ
easat-8115	117	7	in	in	ADP
easat-8115	117	8	hiv	hiv	PROPN
easat-8115	117	9	subjects	subject	NOUN
easat-8115	117	10	with	with	ADP
easat-8115	117	11	pneumonia	pneumonia	NOUN
easat-8115	117	12	in	in	ADP
easat-8115	117	13	this	this	DET
easat-8115	117	14	study	study	NOUN
easat-8115	117	15	.	.	PUNCT
easat-8115	118	1	clinical	clinical	ADJ
easat-8115	118	2	characteristics	characteristic	NOUN
easat-8115	118	3	of	of	ADP
easat-8115	118	4	pcp	pcp	PROPN
easat-8115	118	5	in	in	ADP
easat-8115	118	6	hiv	hiv	PROPN
easat-8115	118	7	patients	patient	NOUN
easat-8115	118	8	includes	include	VERB
easat-8115	118	9	fever	fever	NOUN
easat-8115	118	10	,	,	PUNCT
easat-8115	118	11	shortness	shortness	NOUN
easat-8115	118	12	of	of	ADP
easat-8115	118	13	breath	breath	NOUN
easat-8115	118	14	,	,	PUNCT
easat-8115	118	15	and	and	CCONJ
easat-8115	118	16	non	non	ADJ
easat-8115	118	17	-	-	ADJ
easat-8115	118	18	productive	productive	ADJ
easat-8115	118	19	cough	cough	NOUN
easat-8115	118	20	.	.	PUNCT
easat-8115	119	1	symptoms	symptom	NOUN
easat-8115	119	2	become	become	VERB
easat-8115	119	3	progressive	progressive	ADJ
easat-8115	119	4	3	3	NUM
easat-8115	119	5	-	-	SYM
easat-8115	119	6	4	4	NUM
easat-8115	119	7	weeks	week	NOUN
easat-8115	119	8	before	before	ADP
easat-8115	119	9	hospitalization	hospitalization	NOUN
easat-8115	119	10	[	[	X
easat-8115	119	11	5	5	NUM
easat-8115	119	12	]	]	PUNCT
easat-8115	119	13	.	.	PUNCT
easat-8115	120	1	on	on	ADP
easat-8115	120	2	physical	physical	ADJ
easat-8115	120	3	examination	examination	NOUN
easat-8115	120	4	,	,	PUNCT
easat-8115	120	5	pcp	pcp	PROPN
easat-8115	120	6	patients	patient	NOUN
easat-8115	120	7	classically	classically	ADV
easat-8115	120	8	have	have	VERB
easat-8115	120	9	tachypnea	tachypnea	NOUN
easat-8115	120	10	,	,	PUNCT
easat-8115	120	11	tachycardia	tachycardia	NOUN
easat-8115	120	12	,	,	PUNCT
easat-8115	120	13	and	and	CCONJ
easat-8115	120	14	abnormalities	abnormality	NOUN
easat-8115	120	15	on	on	ADP
easat-8115	120	16	lung	lung	NOUN
easat-8115	120	17	auscultation	auscultation	NOUN
easat-8115	120	18	.	.	PUNCT
easat-8115	121	1	weight	weight	NOUN
easat-8115	121	2	loss	loss	NOUN
easat-8115	121	3	,	,	PUNCT
easat-8115	121	4	recurrent	recurrent	ADJ
easat-8115	121	5	bacterial	bacterial	ADJ
easat-8115	121	6	pneumonia	pneumonia	NOUN
easat-8115	121	7	,	,	PUNCT
easat-8115	121	8	and	and	CCONJ
easat-8115	121	9	oral	oral	ADJ
easat-8115	121	10	thrush	thrush	NOUN
easat-8115	121	11	are	be	AUX
easat-8115	121	12	also	also	ADV
easat-8115	121	13	common	common	ADJ
easat-8115	121	14	findings	finding	NOUN
easat-8115	121	15	[	[	X
easat-8115	121	16	6	6	NUM
easat-8115	121	17	]	]	PUNCT
easat-8115	121	18	.	.	PUNCT
easat-8115	122	1	this	this	PRON
easat-8115	122	2	is	be	AUX
easat-8115	122	3	supported	support	VERB
easat-8115	122	4	by	by	ADP
easat-8115	122	5	a	a	DET
easat-8115	122	6	study	study	NOUN
easat-8115	122	7	in	in	ADP
easat-8115	122	8	three	three	NUM
easat-8115	122	9	government	government	NOUN
easat-8115	122	10	hospitals	hospital	NOUN
easat-8115	122	11	in	in	ADP
easat-8115	122	12	jakarta	jakarta	PROPN
easat-8115	122	13	that	that	PRON
easat-8115	122	14	found	find	VERB
easat-8115	122	15	all	all	DET
easat-8115	122	16	pcp	pcp	NOUN
easat-8115	122	17	patients	patient	NOUN
easat-8115	122	18	had	have	VERB
easat-8115	122	19	clinical	clinical	ADJ
easat-8115	122	20	manifestation	manifestation	NOUN
easat-8115	122	21	of	of	ADP
easat-8115	122	22	fever	fever	NOUN
easat-8115	122	23	,	,	PUNCT
easat-8115	122	24	cough	cough	NOUN
easat-8115	122	25	,	,	PUNCT
easat-8115	122	26	shortness	shortness	NOUN
easat-8115	122	27	of	of	ADP
easat-8115	122	28	breath	breath	NOUN
easat-8115	122	29	,	,	PUNCT
easat-8115	122	30	rhonchi	rhonchi	NOUN
easat-8115	122	31	,	,	PUNCT
easat-8115	122	32	and	and	CCONJ
easat-8115	122	33	weight	weight	NOUN
easat-8115	122	34	loss	loss	NOUN
easat-8115	122	35	[	[	X
easat-8115	122	36	7	7	NUM
easat-8115	122	37	]	]	PUNCT
easat-8115	122	38	.	.	PUNCT
easat-8115	123	1	a	a	DET
easat-8115	123	2	systematic	systematic	ADJ
easat-8115	123	3	review	review	NOUN
easat-8115	123	4	and	and	CCONJ
easat-8115	123	5	meta	meta	NOUN
easat-8115	123	6	-	-	PUNCT
easat-8115	123	7	analysis	analysis	NOUN
easat-8115	123	8	by	by	ADP
easat-8115	123	9	wills	will	NOUN
easat-8115	123	10	,	,	PUNCT
easat-8115	123	11	et	et	PROPN
easat-8115	123	12	al	al	PROPN
easat-8115	123	13	.	.	PUNCT
easat-8115	124	1	[	[	X
easat-8115	124	2	8	8	NUM
easat-8115	124	3	]	]	PUNCT
easat-8115	124	4	reported	report	VERB
easat-8115	124	5	hiv	hiv	PROPN
easat-8115	124	6	patients	patient	NOUN
easat-8115	124	7	with	with	ADP
easat-8115	124	8	pcp	pcp	PROPN
easat-8115	124	9	have	have	VERB
easat-8115	124	10	interstitial	interstitial	ADJ
easat-8115	124	11	infiltrates	infiltrate	NOUN
easat-8115	124	12	(	(	PUNCT
easat-8115	124	13	59	59	NUM
easat-8115	124	14	%	%	NOUN
easat-8115	124	15	;	;	PUNCT
easat-8115	124	16	95	95	NUM
easat-8115	124	17	%	%	NOUN
easat-8115	124	18	ci	ci	NOUN
easat-8115	124	19	,	,	PUNCT
easat-8115	124	20	52%–66	52%–66	NUM
easat-8115	124	21	%	%	NOUN
easat-8115	124	22	;	;	PUNCT
easat-8115	124	23	36	36	NUM
easat-8115	124	24	studies	study	NOUN
easat-8115	124	25	,	,	PUNCT
easat-8115	124	26	n	n	PROPN
easat-8115	124	27	=	=	SYM
easat-8115	124	28	1380	1380	NUM
easat-8115	124	29	;	;	PUNCT
easat-8115	124	30	i2	i2	PROPN
easat-8115	124	31	=	=	PUNCT
easat-8115	124	32	85	85	NUM
easat-8115	124	33	%	%	NOUN
easat-8115	124	34	)	)	PUNCT
easat-8115	124	35	and	and	CCONJ
easat-8115	124	36	ggo	ggo	PROPN
easat-8115	124	37	pattern	pattern	NOUN
easat-8115	124	38	(	(	PUNCT
easat-8115	124	39	48	48	NUM
easat-8115	124	40	%	%	NOUN
easat-8115	124	41	;	;	PUNCT
easat-8115	124	42	95	95	NUM
easat-8115	124	43	%	%	NOUN
easat-8115	124	44	ci	ci	NOUN
easat-8115	124	45	,	,	PUNCT
easat-8115	124	46	15%–83	15%–83	NUM
easat-8115	124	47	%	%	NOUN
easat-8115	124	48	;	;	PUNCT
easat-8115	124	49	4	4	NUM
easat-8115	124	50	studies	study	NOUN
easat-8115	124	51	,	,	PUNCT
easat-8115	124	52	n=	n=	ADJ
easat-8115	124	53	57	57	NUM
easat-8115	124	54	;	;	PUNCT
easat-8115	124	55	i2=	i2=	PROPN
easat-8115	124	56	86	86	NUM
easat-8115	124	57	%	%	NOUN
easat-8115	124	58	)	)	PUNCT
easat-8115	124	59	on	on	ADP
easat-8115	124	60	chest	chest	NOUN
easat-8115	124	61	x	x	NOUN
easat-8115	124	62	-	-	NOUN
easat-8115	124	63	ray	ray	NOUN
easat-8115	124	64	examination	examination	NOUN
easat-8115	124	65	.	.	PUNCT
easat-8115	125	1	based	base	VERB
easat-8115	125	2	on	on	ADP
easat-8115	125	3	laboratory	laboratory	NOUN
easat-8115	125	4	parameters	parameter	NOUN
easat-8115	125	5	characteristic	characteristic	ADJ
easat-8115	125	6	,	,	PUNCT
easat-8115	125	7	similar	similar	ADJ
easat-8115	125	8	results	result	NOUN
easat-8115	125	9	are	be	AUX
easat-8115	125	10	reported	report	VERB
easat-8115	125	11	in	in	ADP
easat-8115	125	12	previous	previous	ADJ
easat-8115	125	13	studies	study	NOUN
easat-8115	125	14	yustin	yustin	ADJ
easat-8115	125	15	,	,	PUNCT
easat-8115	125	16	et	et	PROPN
easat-8115	125	17	al	al	PROPN
easat-8115	125	18	.	.	PUNCT
easat-8115	126	1	[	[	X
easat-8115	126	2	3	3	NUM
easat-8115	126	3	]	]	PUNCT
easat-8115	126	4	and	and	CCONJ
easat-8115	126	5	mulyani	mulyani	PROPN
easat-8115	126	6	,	,	PUNCT
easat-8115	126	7	et	et	PROPN
easat-8115	126	8	al	al	PROPN
easat-8115	126	9	.	.	PUNCT
easat-8115	127	1	[	[	X
easat-8115	127	2	9	9	NUM
easat-8115	127	3	]	]	PUNCT
easat-8115	127	4	.	.	PUNCT
easat-8115	128	1	hiv	hiv	PROPN
easat-8115	128	2	infection	infection	NOUN
easat-8115	128	3	is	be	AUX
easat-8115	128	4	characterized	characterize	VERB
easat-8115	128	5	by	by	ADP
easat-8115	128	6	a	a	DET
easat-8115	128	7	decrease	decrease	NOUN
easat-8115	128	8	of	of	ADP
easat-8115	128	9	cd4	cd4	PROPN
easat-8115	128	10	t	t	PROPN
easat-8115	128	11	cells	cell	NOUN
easat-8115	128	12	,	,	PUNCT
easat-8115	128	13	an	an	DET
easat-8115	128	14	increase	increase	NOUN
easat-8115	128	15	in	in	ADP
easat-8115	128	16	cd8	cd8	PROPN
easat-8115	128	17	t	t	PROPN
easat-8115	128	18	cells	cell	NOUN
easat-8115	128	19	,	,	PUNCT
easat-8115	128	20	and	and	CCONJ
easat-8115	128	21	chronic	chronic	ADJ
easat-8115	128	22	immune	immune	ADJ
easat-8115	128	23	activation	activation	NOUN
easat-8115	128	24	that	that	PRON
easat-8115	128	25	causes	cause	VERB
easat-8115	128	26	immune	immune	ADJ
easat-8115	128	27	dysfunction	dysfunction	NOUN
easat-8115	128	28	[	[	X
easat-8115	128	29	10	10	NUM
easat-8115	128	30	]	]	PUNCT
easat-8115	128	31	.	.	PUNCT
easat-8115	129	1	in	in	ADP
easat-8115	129	2	this	this	DET
easat-8115	129	3	study	study	NOUN
easat-8115	129	4	,	,	PUNCT
easat-8115	129	5	hypoalbuminemia	hypoalbuminemia	X
easat-8115	129	6	(	(	PUNCT
easat-8115	129	7	3.41	3.41	NUM
easat-8115	129	8	g	g	NOUN
easat-8115	129	9	/	/	SYM
easat-8115	129	10	dl	dl	NOUN
easat-8115	129	11	)	)	PUNCT
easat-8115	129	12	was	be	AUX
easat-8115	129	13	reported	report	VERB
easat-8115	129	14	.	.	PUNCT
easat-8115	130	1	tang	tang	PROPN
easat-8115	131	1	[	[	X
easat-8115	131	2	2	2	X
easat-8115	131	3	]	]	PUNCT
easat-8115	131	4	found	find	VERB
easat-8115	131	5	serum	serum	NOUN
easat-8115	131	6	albumin	albumin	ADJ
easat-8115	131	7	level	level	NOUN
easat-8115	131	8	differences	difference	NOUN
easat-8115	131	9	in	in	ADP
easat-8115	131	10	pcp	pcp	NOUN
easat-8115	131	11	patients	patient	NOUN
easat-8115	131	12	undergoing	undergo	VERB
easat-8115	131	13	immunosuppressive	immunosuppressive	ADJ
easat-8115	131	14	therapy	therapy	NOUN
easat-8115	131	15	compared	compare	VERB
easat-8115	131	16	to	to	ADP
easat-8115	131	17	controls	control	NOUN
easat-8115	131	18	.	.	PUNCT
easat-8115	132	1	pcp	pcp	PROPN
easat-8115	132	2	patients	patient	NOUN
easat-8115	132	3	had	have	VERB
easat-8115	132	4	lower	low	ADJ
easat-8115	132	5	albumin	albumin	NOUN
easat-8115	132	6	than	than	ADP
easat-8115	132	7	patients	patient	NOUN
easat-8115	132	8	with	with	ADP
easat-8115	132	9	immunosuppressive	immunosuppressive	ADJ
easat-8115	132	10	therapy	therapy	NOUN
easat-8115	132	11	without	without	ADP
easat-8115	132	12	pcp	pcp	PROPN
easat-8115	132	13	(	(	PUNCT
easat-8115	132	14	2.87	2.87	NUM
easat-8115	132	15	g	g	NOUN
easat-8115	132	16	/	/	SYM
easat-8115	132	17	dl	dl	PROPN
easat-8115	132	18	versus	versus	ADP
easat-8115	132	19	3.69	3.69	NUM
easat-8115	132	20	g	g	NOUN
easat-8115	132	21	/	/	SYM
easat-8115	132	22	dl	dl	PROPN
easat-8115	132	23	;	;	PUNCT
easat-8115	132	24	p	p	X
easat-8115	132	25	<	<	NOUN
easat-8115	132	26	0.001	0.001	NUM
easat-8115	132	27	)	)	PUNCT
easat-8115	132	28	.	.	PUNCT
easat-8115	133	1	in	in	ADP
easat-8115	133	2	this	this	DET
easat-8115	133	3	study	study	NOUN
easat-8115	133	4	,	,	PUNCT
easat-8115	133	5	majority	majority	NOUN
easat-8115	133	6	(	(	PUNCT
easat-8115	133	7	63.8	63.8	NUM
easat-8115	133	8	%	%	NOUN
easat-8115	133	9	)	)	PUNCT
easat-8115	133	10	of	of	ADP
easat-8115	133	11	subjects	subject	NOUN
easat-8115	133	12	had	have	VERB
easat-8115	133	13	atypical	atypical	ADJ
easat-8115	133	14	chest	chest	NOUN
easat-8115	133	15	x	x	NOUN
easat-8115	133	16	-	-	NOUN
easat-8115	133	17	ray	ray	NOUN
easat-8115	133	18	(	(	PUNCT
easat-8115	133	19	infiltrates	infiltrate	NOUN
easat-8115	133	20	and	and	CCONJ
easat-8115	133	21	consolidation	consolidation	NOUN
easat-8115	133	22	)	)	PUNCT
easat-8115	133	23	.	.	PUNCT
easat-8115	134	1	this	this	PRON
easat-8115	134	2	is	be	AUX
easat-8115	134	3	also	also	ADV
easat-8115	134	4	in	in	ADP
easat-8115	134	5	accordance	accordance	NOUN
easat-8115	134	6	with	with	ADP
easat-8115	134	7	literature	literature	NOUN
easat-8115	134	8	.	.	PUNCT
easat-8115	135	1	radiological	radiological	ADJ
easat-8115	135	2	findings	finding	NOUN
easat-8115	135	3	commonly	commonly	ADV
easat-8115	135	4	reported	report	VERB
easat-8115	135	5	are	be	AUX
easat-8115	135	6	diffuse	diffuse	ADJ
easat-8115	135	7	and	and	CCONJ
easat-8115	135	8	homogeneous	homogeneous	ADJ
easat-8115	135	9	bilateral	bilateral	ADJ
easat-8115	135	10	interstitial	interstitial	ADJ
easat-8115	135	11	patterns	pattern	NOUN
easat-8115	135	12	.	.	PUNCT
easat-8115	136	1	other	other	ADJ
easat-8115	136	2	features	feature	NOUN
easat-8115	136	3	that	that	PRON
easat-8115	136	4	can	can	AUX
easat-8115	136	5	be	be	AUX
easat-8115	136	6	found	find	VERB
easat-8115	136	7	are	be	AUX
easat-8115	136	8	cystic	cystic	ADJ
easat-8115	136	9	lesions	lesion	NOUN
easat-8115	136	10	,	,	PUNCT
easat-8115	136	11	central	central	ADJ
easat-8115	136	12	lymphadenopathy	lymphadenopathy	ADJ
easat-8115	136	13	,	,	PUNCT
easat-8115	136	14	spontaneous	spontaneous	ADJ
easat-8115	136	15	pneumothorax	pneumothorax	NOUN
easat-8115	136	16	,	,	PUNCT
easat-8115	136	17	and	and	CCONJ
easat-8115	136	18	although	although	SCONJ
easat-8115	136	19	rare	rare	ADJ
easat-8115	136	20	,	,	PUNCT
easat-8115	136	21	pleural	pleural	ADJ
easat-8115	136	22	effusion	effusion	NOUN
easat-8115	136	23	.	.	PUNCT
easat-8115	137	1	normal	normal	ADJ
easat-8115	137	2	chest	chest	NOUN
easat-8115	137	3	x	x	NOUN
easat-8115	137	4	-	-	NOUN
easat-8115	137	5	ray	ray	NOUN
easat-8115	137	6	reported	report	VERB
easat-8115	137	7	in	in	ADP
easat-8115	137	8	one	one	NUM
easat-8115	137	9	third	third	ADJ
easat-8115	137	10	cases	case	NOUN
easat-8115	137	11	of	of	ADP
easat-8115	137	12	pcp	pcp	NOUN
easat-8115	138	1	[	[	X
easat-8115	138	2	5	5	NUM
easat-8115	138	3	,	,	PUNCT
easat-8115	138	4	8	8	NUM
easat-8115	138	5	]	]	PUNCT
easat-8115	138	6	.	.	PUNCT
easat-8115	139	1	this	this	DET
easat-8115	139	2	study	study	NOUN
easat-8115	139	3	found	find	VERB
easat-8115	139	4	a	a	DET
easat-8115	139	5	significant	significant	ADJ
easat-8115	139	6	relationship	relationship	NOUN
easat-8115	139	7	between	between	ADP
easat-8115	139	8	low	low	ADJ
easat-8115	139	9	grade	grade	NOUN
easat-8115	139	10	fever	fever	NOUN
easat-8115	139	11	,	,	PUNCT
easat-8115	139	12	non	non	ADJ
easat-8115	139	13	-	-	ADJ
easat-8115	139	14	productive	productive	ADJ
easat-8115	139	15	cough	cough	NOUN
easat-8115	139	16	and	and	CCONJ
easat-8115	139	17	oral	oral	ADJ
easat-8115	139	18	candidiasis	candidiasis	NOUN
easat-8115	139	19	with	with	ADP
easat-8115	139	20	sputum	sputum	PROPN
easat-8115	139	21	pcr	pcr	PROPN
easat-8115	139	22	positivity	positivity	NOUN
easat-8115	139	23	in	in	ADP
easat-8115	139	24	hiv	hiv	PROPN
easat-8115	139	25	patients	patient	NOUN
easat-8115	139	26	with	with	ADP
easat-8115	139	27	suspicion	suspicion	NOUN
easat-8115	139	28	of	of	ADP
easat-8115	139	29	pcp	pcp	PROPN
easat-8115	139	30	after	after	SCONJ
easat-8115	139	31	other	other	ADJ
easat-8115	139	32	independent	independent	ADJ
easat-8115	139	33	variables	variable	NOUN
easat-8115	139	34	were	be	AUX
easat-8115	139	35	controlled	control	VERB
easat-8115	139	36	.	.	PUNCT
easat-8115	140	1	subjects	subject	NOUN
easat-8115	140	2	with	with	ADP
easat-8115	140	3	low	low	ADJ
easat-8115	140	4	grade	grade	NOUN
easat-8115	140	5	fever	fever	NOUN
easat-8115	140	6	were	be	AUX
easat-8115	140	7	at	at	ADP
easat-8115	140	8	risk	risk	NOUN
easat-8115	140	9	of	of	ADP
easat-8115	140	10	having	have	VERB
easat-8115	140	11	positive	positive	ADJ
easat-8115	140	12	sputum	sputum	NOUN
easat-8115	140	13	pcr	pcr	PROPN
easat-8115	140	14	result	result	NOUN
easat-8115	140	15	23.9	23.9	NUM
easat-8115	140	16	times	time	NOUN
easat-8115	140	17	greater	great	ADJ
easat-8115	140	18	than	than	ADP
easat-8115	140	19	those	those	PRON
easat-8115	140	20	without	without	ADP
easat-8115	140	21	low	low	ADJ
easat-8115	140	22	grade	grade	NOUN
easat-8115	140	23	fever	fever	NOUN
easat-8115	140	24	(	(	PUNCT
easat-8115	140	25	95	95	NUM
easat-8115	140	26	%	%	NOUN
easat-8115	140	27	ci	ci	NOUN
easat-8115	140	28	4.06	4.06	NUM
easat-8115	140	29	141	141	NUM
easat-8115	140	30	;	;	PUNCT
easat-8115	140	31	p	p	X
easat-8115	140	32	<	<	X
easat-8115	140	33	0.001	0.001	NUM
easat-8115	140	34	)	)	PUNCT
easat-8115	140	35	;	;	PUNCT
easat-8115	140	36	meanwhile	meanwhile	ADV
easat-8115	140	37	subjects	subject	NOUN
easat-8115	140	38	with	with	ADP
easat-8115	140	39	non	non	ADJ
easat-8115	140	40	-	-	ADJ
easat-8115	140	41	productive	productive	ADJ
easat-8115	140	42	cough	cough	NOUN
easat-8115	140	43	have	have	VERB
easat-8115	140	44	7.108	7.108	NUM
easat-8115	140	45	times	time	NOUN
easat-8115	140	46	greater	great	ADJ
easat-8115	140	47	risk	risk	NOUN
easat-8115	140	48	than	than	ADP
easat-8115	140	49	patients	patient	NOUN
easat-8115	140	50	with	with	ADP
easat-8115	140	51	productive	productive	ADJ
easat-8115	140	52	cough	cough	NOUN
easat-8115	140	53	(	(	PUNCT
easat-8115	140	54	95	95	NUM
easat-8115	140	55	%	%	NOUN
easat-8115	140	56	ci	ci	NOUN
easat-8115	140	57	1.25	1.25	NUM
easat-8115	140	58	40.19	40.19	NUM
easat-8115	140	59	;	;	PUNCT
easat-8115	140	60	p=	p=	NOUN
easat-8115	140	61	0.027	0.027	NUM
easat-8115	140	62	)	)	PUNCT
easat-8115	140	63	.	.	PUNCT
easat-8115	141	1	this	this	PRON
easat-8115	141	2	is	be	AUX
easat-8115	141	3	in	in	ADP
easat-8115	141	4	line	line	NOUN
easat-8115	141	5	with	with	ADP
easat-8115	141	6	the	the	DET
easat-8115	141	7	study	study	NOUN
easat-8115	141	8	by	by	ADP
easat-8115	141	9	siegel	siegel	PROPN
easat-8115	141	10	,	,	PUNCT
easat-8115	141	11	et	et	PROPN
easat-8115	141	12	al	al	PROPN
easat-8115	141	13	.	.	PUNCT
easat-8115	142	1	[	[	X
easat-8115	142	2	11	11	NUM
easat-8115	142	3	]	]	PUNCT
easat-8115	142	4	which	which	PRON
easat-8115	142	5	demonstrated	demonstrate	VERB
easat-8115	142	6	hiv	hiv	PROPN
easat-8115	142	7	patients	patient	NOUN
easat-8115	142	8	infected	infect	VERB
easat-8115	142	9	with	with	ADP
easat-8115	142	10	pcp	pcp	PROPN
easat-8115	142	11	are	be	AUX
easat-8115	142	12	likely	likely	ADJ
easat-8115	142	13	to	to	PART
easat-8115	142	14	experience	experience	VERB
easat-8115	142	15	slower	slow	ADJ
easat-8115	142	16	and	and	CCONJ
easat-8115	142	17	less	less	ADV
easat-8115	142	18	obvious	obvious	ADJ
easat-8115	142	19	symptoms	symptom	NOUN
easat-8115	142	20	such	such	ADJ
easat-8115	142	21	as	as	ADP
easat-8115	142	22	mild	mild	ADJ
easat-8115	142	23	fever	fever	NOUN
easat-8115	142	24	(	(	PUNCT
easat-8115	142	25	>	>	X
easat-8115	142	26	80	80	NUM
easat-8115	142	27	%	%	NOUN
easat-8115	142	28	)	)	PUNCT
easat-8115	142	29	,	,	PUNCT
easat-8115	142	30	and	and	CCONJ
easat-8115	142	31	non	non	ADJ
easat-8115	142	32	-	-	ADJ
easat-8115	142	33	productive	productive	ADJ
easat-8115	142	34	cough	cough	NOUN
easat-8115	142	35	and	and	CCONJ
easat-8115	142	36	dry	dry	ADJ
easat-8115	142	37	cough	cough	NOUN
easat-8115	142	38	(	(	PUNCT
easat-8115	142	39	95	95	NUM
easat-8115	142	40	%	%	NOUN
easat-8115	142	41	)	)	PUNCT
easat-8115	142	42	for	for	ADP
easat-8115	142	43	several	several	ADJ
easat-8115	142	44	weeks	week	NOUN
easat-8115	143	1	[	[	X
easat-8115	143	2	11	11	NUM
easat-8115	143	3	]	]	PUNCT
easat-8115	143	4	.	.	PUNCT
easat-8115	144	1	patients	patient	NOUN
easat-8115	144	2	are	be	AUX
easat-8115	144	3	likely	likely	ADJ
easat-8115	144	4	to	to	PART
easat-8115	144	5	experience	experience	VERB
easat-8115	144	6	fever	fever	NOUN
easat-8115	144	7	,	,	PUNCT
easat-8115	144	8	often	often	ADV
easat-8115	144	9	no	no	ADV
easat-8115	144	10	higher	high	ADJ
easat-8115	144	11	than	than	ADP
easat-8115	144	12	38.10c	38.10c	PROPN
easat-8115	145	1	[	[	X
easat-8115	145	2	12	12	NUM
easat-8115	145	3	]	]	PUNCT
easat-8115	145	4	.	.	PUNCT
easat-8115	146	1	oral	oral	ADJ
easat-8115	146	2	candidiasis	candidiasis	NOUN
easat-8115	146	3	is	be	AUX
easat-8115	146	4	a	a	DET
easat-8115	146	5	common	common	ADJ
easat-8115	146	6	co	co	NOUN
easat-8115	146	7	-	-	NOUN
easat-8115	146	8	infection	infection	NOUN
easat-8115	146	9	found	find	VERB
easat-8115	146	10	in	in	ADP
easat-8115	146	11	hiv	hiv	PROPN
easat-8115	146	12	patients	patient	NOUN
easat-8115	146	13	with	with	ADP
easat-8115	146	14	pcp	pcp	PROPN
easat-8115	146	15	.	.	PUNCT
easat-8115	147	1	oral	oral	ADJ
easat-8115	147	2	candidiasis	candidiasis	NOUN
easat-8115	147	3	and	and	CCONJ
easat-8115	147	4	hairy	hairy	ADJ
easat-8115	147	5	leucoplakia	leucoplakia	NOUN
easat-8115	147	6	are	be	AUX
easat-8115	147	7	highly	highly	ADV
easat-8115	147	8	predictive	predictive	ADJ
easat-8115	147	9	in	in	ADP
easat-8115	147	10	patients	patient	NOUN
easat-8115	147	11	with	with	ADP
easat-8115	147	12	cd4	cd4	PROPN
easat-8115	147	13	values	value	NOUN
easat-8115	147	14	<	<	X
easat-8115	147	15	200	200	NUM
easat-8115	147	16	.	.	PUNCT
easat-8115	148	1	in	in	ADP
easat-8115	148	2	this	this	DET
easat-8115	148	3	study	study	NOUN
easat-8115	148	4	,	,	PUNCT
easat-8115	148	5	subjects	subject	NOUN
easat-8115	148	6	with	with	ADP
easat-8115	148	7	oral	oral	ADJ
easat-8115	148	8	candidiasis	candidiasis	NOUN
easat-8115	148	9	at	at	ADP
easat-8115	148	10	8.81	8.81	NUM
easat-8115	148	11	times	time	NOUN
easat-8115	148	12	greater	great	ADJ
easat-8115	148	13	risk	risk	NOUN
easat-8115	148	14	having	have	VERB
easat-8115	148	15	positive	positive	ADJ
easat-8115	148	16	sputum	sputum	NOUN
easat-8115	148	17	pcr	pcr	NOUN
easat-8115	148	18	result	result	NOUN
easat-8115	148	19	than	than	ADP
easat-8115	148	20	group	group	NOUN
easat-8115	148	21	without	without	ADP
easat-8115	148	22	oral	oral	ADJ
easat-8115	148	23	candidiasis	candidiasis	NOUN
easat-8115	148	24	(	(	PUNCT
easat-8115	148	25	95	95	NUM
easat-8115	148	26	%	%	NOUN
easat-8115	148	27	ci	ci	NOUN
easat-8115	148	28	1.62	1.62	NUM
easat-8115	148	29	47.8	47.8	NUM
easat-8115	148	30	;	;	PUNCT
easat-8115	148	31	p=	p=	PROPN
easat-8115	148	32	0.012	0.012	NUM
easat-8115	148	33	)	)	PUNCT
easat-8115	148	34	.	.	PUNCT
easat-8115	149	1	oral	oral	ADJ
easat-8115	149	2	candidiasis	candidiasis	NOUN
easat-8115	149	3	was	be	AUX
easat-8115	149	4	found	find	VERB
easat-8115	149	5	in	in	ADP
easat-8115	149	6	4.2	4.2	NUM
easat-8115	149	7	%	%	NOUN
easat-8115	149	8	hiv	hiv	PROPN
easat-8115	149	9	and	and	CCONJ
easat-8115	149	10	11.6	11.6	NUM
easat-8115	149	11	%	%	NOUN
easat-8115	149	12	in	in	ADP
easat-8115	149	13	aids	aid	NOUN
easat-8115	149	14	patients	patient	NOUN
easat-8115	149	15	.	.	PUNCT
easat-8115	150	1	cd4	cd4	PROPN
easat-8115	150	2	+	+	PRON
easat-8115	150	3	plays	play	VERB
easat-8115	150	4	a	a	DET
easat-8115	150	5	role	role	NOUN
easat-8115	150	6	in	in	ADP
easat-8115	150	7	immunity	immunity	NOUN
easat-8115	150	8	related	relate	VERB
easat-8115	150	9	to	to	ADP
easat-8115	150	10	candida	candida	PROPN
easat-8115	150	11	infection	infection	NOUN
easat-8115	150	12	,	,	PUNCT
easat-8115	150	13	via	via	ADP
easat-8115	150	14	induction	induction	NOUN
easat-8115	150	15	of	of	ADP
easat-8115	150	16	b	b	PROPN
easat-8115	150	17	lymphocyte	lymphocyte	ADJ
easat-8115	150	18	iga	iga	PROPN
easat-8115	150	19	secretion	secretion	NOUN
easat-8115	150	20	and	and	CCONJ
easat-8115	150	21	activation	activation	NOUN
easat-8115	150	22	of	of	ADP
easat-8115	150	23	th17	th17	NOUN
easat-8115	150	24	cells	cell	NOUN
easat-8115	150	25	,	,	PUNCT
easat-8115	150	26	low	low	ADJ
easat-8115	150	27	cd4	cd4	PROPN
easat-8115	150	28	levels	level	NOUN
easat-8115	150	29	interfere	interfere	VERB
easat-8115	150	30	with	with	ADP
easat-8115	150	31	this	this	DET
easat-8115	150	32	defense	defense	NOUN
easat-8115	150	33	mechanism	mechanism	NOUN
easat-8115	150	34	[	[	X
easat-8115	150	35	13	13	NUM
easat-8115	150	36	]	]	PUNCT
easat-8115	150	37	.	.	PUNCT
easat-8115	151	1	oral	oral	ADJ
easat-8115	151	2	candidiasis	candidiasis	NOUN
easat-8115	151	3	has	have	AUX
easat-8115	151	4	been	be	AUX
easat-8115	151	5	reported	report	VERB
easat-8115	151	6	associated	associate	VERB
easat-8115	151	7	with	with	ADP
easat-8115	151	8	an	an	DET
easat-8115	151	9	increased	increase	VERB
easat-8115	151	10	likelihood	likelihood	NOUN
easat-8115	151	11	of	of	ADP
easat-8115	151	12	pcp	pcp	PROPN
easat-8115	151	13	compared	compare	VERB
easat-8115	151	14	to	to	ADP
easat-8115	151	15	tuberculosis	tuberculosis	NOUN
easat-8115	151	16	or	or	CCONJ
easat-8115	151	17	bacterial	bacterial	ADJ
easat-8115	151	18	pneumonia	pneumonia	NOUN
easat-8115	151	19	in	in	ADP
easat-8115	151	20	hiv	hiv	PROPN
easat-8115	151	21	patients.12	patients.12	PROPN
easat-8115	151	22	pcp	pcp	PROPN
easat-8115	151	23	symptoms	symptom	NOUN
easat-8115	151	24	were	be	AUX
easat-8115	151	25	varied	varied	ADJ
easat-8115	151	26	in	in	ADP
easat-8115	151	27	each	each	DET
easat-8115	151	28	individual	individual	NOUN
easat-8115	151	29	and	and	CCONJ
easat-8115	151	30	7	7	NUM
easat-8115	151	31	%	%	NOUN
easat-8115	151	32	were	be	AUX
easat-8115	151	33	asymptomatic	asymptomatic	ADJ
easat-8115	151	34	[	[	X
easat-8115	151	35	14	14	NUM
easat-8115	151	36	]	]	PUNCT
easat-8115	151	37	.	.	PUNCT
easat-8115	152	1	this	this	DET
easat-8115	152	2	study	study	NOUN
easat-8115	152	3	found	find	VERB
easat-8115	152	4	no	no	DET
easat-8115	152	5	significant	significant	ADJ
easat-8115	152	6	relationship	relationship	NOUN
easat-8115	152	7	between	between	ADP
easat-8115	152	8	shortness	shortness	NOUN
easat-8115	152	9	of	of	ADP
easat-8115	152	10	breath	breath	NOUN
easat-8115	152	11	(	(	PUNCT
easat-8115	152	12	dyspnea	dyspnea	NOUN
easat-8115	152	13	)	)	PUNCT
easat-8115	152	14	symptoms	symptom	NOUN
easat-8115	152	15	and	and	CCONJ
easat-8115	152	16	spo2	spo2	PROPN
easat-8115	152	17	/	/	SYM
easat-8115	152	18	fio2	fio2	PROPN
easat-8115	152	19	ratio	ratio	NOUN
easat-8115	152	20	with	with	ADP
easat-8115	152	21	sputum	sputum	PROPN
easat-8115	152	22	pcr	pcr	PROPN
easat-8115	152	23	positivity	positivity	NOUN
easat-8115	152	24	.	.	PUNCT
easat-8115	153	1	this	this	DET
easat-8115	153	2	result	result	NOUN
easat-8115	153	3	may	may	AUX
easat-8115	153	4	be	be	AUX
easat-8115	153	5	due	due	ADJ
easat-8115	153	6	to	to	ADP
easat-8115	153	7	early	early	ADJ
easat-8115	153	8	phase	phase	NOUN
easat-8115	153	9	of	of	ADP
easat-8115	153	10	the	the	DET
easat-8115	153	11	disease	disease	NOUN
easat-8115	153	12	and/or	and/or	CCONJ
easat-8115	153	13	different	different	ADJ
easat-8115	153	14	individual	individual	ADJ
easat-8115	153	15	perceptions	perception	NOUN
easat-8115	153	16	of	of	ADP
easat-8115	153	17	dyspnea	dyspnea	NOUN
easat-8115	153	18	.	.	PUNCT
easat-8115	154	1	this	this	DET
easat-8115	154	2	symptom	symptom	NOUN
easat-8115	154	3	may	may	AUX
easat-8115	154	4	not	not	PART
easat-8115	154	5	reported	report	VERB
easat-8115	154	6	in	in	ADP
easat-8115	154	7	early	early	ADJ
easat-8115	154	8	phase	phase	NOUN
easat-8115	154	9	of	of	ADP
easat-8115	154	10	1337	1337	NUM
easat-8115	154	11	edelweiss	edelweiss	PROPN
easat-8115	154	12	applied	apply	VERB
easat-8115	154	13	science	science	NOUN
easat-8115	154	14	and	and	CCONJ
easat-8115	154	15	technology	technology	NOUN
easat-8115	154	16	issn	issn	PROPN
easat-8115	154	17	:	:	PUNCT
easat-8115	154	18	2576	2576	NUM
easat-8115	154	19	-	-	SYM
easat-8115	154	20	8484	8484	NUM
easat-8115	154	21	vol	vol	NOUN
easat-8115	154	22	.	.	PROPN
easat-8115	155	1	9	9	NUM
easat-8115	155	2	,	,	PUNCT
easat-8115	155	3	no	no	INTJ
easat-8115	155	4	.	.	NOUN
easat-8115	156	1	6	6	NUM
easat-8115	156	2	:	:	SYM
easat-8115	156	3	1331	1331	NUM
easat-8115	156	4	-	-	SYM
easat-8115	156	5	1341	1341	NUM
easat-8115	156	6	,	,	PUNCT
easat-8115	156	7	2025	2025	NUM
easat-8115	156	8	doi	doi	NOUN
easat-8115	156	9	:	:	PUNCT
easat-8115	156	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	156	11	©	©	PROPN
easat-8115	156	12	2025	2025	NUM
easat-8115	156	13	by	by	ADP
easat-8115	156	14	the	the	DET
easat-8115	156	15	authors	author	NOUN
easat-8115	156	16	;	;	PUNCT
easat-8115	156	17	licensee	licensee	PROPN
easat-8115	156	18	learning	learning	NOUN
easat-8115	156	19	gate	gate	PROPN
easat-8115	156	20	pcp	pcp	PROPN
easat-8115	156	21	infection	infection	NOUN
easat-8115	156	22	,	,	PUNCT
easat-8115	156	23	low	low	ADJ
easat-8115	156	24	fungal	fungal	ADJ
easat-8115	156	25	load	load	NOUN
easat-8115	156	26	values	value	NOUN
easat-8115	156	27	may	may	AUX
easat-8115	156	28	be	be	AUX
easat-8115	156	29	found	find	VERB
easat-8115	156	30	in	in	ADP
easat-8115	156	31	early	early	ADJ
easat-8115	156	32	phase	phase	NOUN
easat-8115	156	33	of	of	ADP
easat-8115	156	34	disease	disease	NOUN
easat-8115	156	35	,	,	PUNCT
easat-8115	156	36	especially	especially	ADV
easat-8115	156	37	in	in	ADP
easat-8115	156	38	hiv	hiv	PROPN
easat-8115	156	39	patients	patient	NOUN
easat-8115	156	40	,	,	PUNCT
easat-8115	156	41	thus	thus	ADV
easat-8115	156	42	symptoms	symptom	NOUN
easat-8115	156	43	develop	develop	VERB
easat-8115	156	44	in	in	ADP
easat-8115	156	45	the	the	DET
easat-8115	156	46	following	follow	VERB
easat-8115	156	47	weeks	week	NOUN
easat-8115	157	1	[	[	X
easat-8115	157	2	15	15	NUM
easat-8115	157	3	]	]	PUNCT
easat-8115	157	4	.	.	PUNCT
easat-8115	158	1	the	the	DET
easat-8115	158	2	spo2	spo2	PROPN
easat-8115	158	3	/	/	SYM
easat-8115	158	4	fio2	fio2	PROPN
easat-8115	158	5	ratio	ratio	NOUN
easat-8115	158	6	is	be	AUX
easat-8115	158	7	an	an	DET
easat-8115	158	8	alternative	alternative	NOUN
easat-8115	158	9	to	to	ADP
easat-8115	158	10	alveolararterial	alveolararterial	ADJ
easat-8115	158	11	oxygen	oxygen	NOUN
easat-8115	158	12	gradient	gradient	NOUN
easat-8115	158	13	(	(	PUNCT
easat-8115	158	14	aado2	aado2	ADJ
easat-8115	158	15	)	)	PUNCT
easat-8115	158	16	parameter	parameter	NOUN
easat-8115	158	17	.	.	PUNCT
easat-8115	159	1	it	it	PRON
easat-8115	159	2	is	be	AUX
easat-8115	159	3	a	a	DET
easat-8115	159	4	well	well	ADV
easat-8115	159	5	-	-	PUNCT
easat-8115	159	6	known	know	VERB
easat-8115	159	7	parameter	parameter	NOUN
easat-8115	159	8	to	to	PART
easat-8115	159	9	help	help	VERB
easat-8115	159	10	increased	increase	VERB
easat-8115	159	11	suspicion	suspicion	NOUN
easat-8115	159	12	of	of	ADP
easat-8115	159	13	pcp	pcp	PROPN
easat-8115	160	1	[	[	X
easat-8115	160	2	16	16	NUM
easat-8115	160	3	,	,	PUNCT
easat-8115	160	4	17	17	NUM
easat-8115	160	5	]	]	PUNCT
easat-8115	160	6	.	.	PUNCT
easat-8115	161	1	the	the	DET
easat-8115	161	2	spo2	spo2	PROPN
easat-8115	161	3	/	/	SYM
easat-8115	161	4	fio2	fio2	PROPN
easat-8115	161	5	ratio	ratio	NOUN
easat-8115	161	6	does	do	AUX
easat-8115	161	7	not	not	PART
easat-8115	161	8	require	require	VERB
easat-8115	161	9	invasive	invasive	ADJ
easat-8115	161	10	procedure	procedure	NOUN
easat-8115	161	11	[	[	X
easat-8115	161	12	18	18	NUM
easat-8115	161	13	]	]	PUNCT
easat-8115	161	14	.	.	PUNCT
easat-8115	162	1	clinical	clinical	ADJ
easat-8115	162	2	studies	study	NOUN
easat-8115	162	3	consistently	consistently	ADV
easat-8115	162	4	demonstrated	demonstrate	VERB
easat-8115	162	5	hypoxia	hypoxia	NOUN
easat-8115	162	6	and	and	CCONJ
easat-8115	162	7	inflammatory	inflammatory	ADJ
easat-8115	162	8	or	or	CCONJ
easat-8115	162	9	tissue	tissue	NOUN
easat-8115	162	10	injury	injury	NOUN
easat-8115	162	11	markers	marker	NOUN
easat-8115	162	12	are	be	AUX
easat-8115	162	13	associated	associate	VERB
easat-8115	162	14	with	with	ADP
easat-8115	162	15	poor	poor	ADJ
easat-8115	162	16	outcomes	outcome	NOUN
easat-8115	162	17	in	in	ADP
easat-8115	162	18	pcp	pcp	PROPN
easat-8115	162	19	patients	patient	NOUN
easat-8115	162	20	[	[	X
easat-8115	162	21	8	8	NUM
easat-8115	162	22	]	]	PUNCT
easat-8115	162	23	.	.	PUNCT
easat-8115	163	1	prognostic	prognostic	ADJ
easat-8115	163	2	implications	implication	NOUN
easat-8115	163	3	of	of	ADP
easat-8115	163	4	the	the	DET
easat-8115	163	5	spo2	spo2	PROPN
easat-8115	163	6	/	/	SYM
easat-8115	163	7	fio2	fio2	PROPN
easat-8115	163	8	in	in	ADP
easat-8115	163	9	pneumonia	pneumonia	NOUN
easat-8115	163	10	patients	patient	NOUN
easat-8115	163	11	including	include	VERB
easat-8115	163	12	pcp	pcp	PROPN
easat-8115	163	13	found	find	VERB
easat-8115	163	14	that	that	SCONJ
easat-8115	163	15	spo2	spo2	PROPN
easat-8115	163	16	/	/	SYM
easat-8115	163	17	fio2	fio2	PROPN
easat-8115	163	18	<	<	X
easat-8115	163	19	236	236	NUM
easat-8115	163	20	had	have	VERB
easat-8115	163	21	a	a	DET
easat-8115	163	22	higher	high	ADJ
easat-8115	163	23	risk	risk	NOUN
easat-8115	163	24	of	of	ADP
easat-8115	163	25	mortality	mortality	NOUN
easat-8115	163	26	compared	compare	VERB
easat-8115	163	27	to	to	ADP
easat-8115	163	28	control	control	VERB
easat-8115	163	29	(	(	PUNCT
easat-8115	163	30	p	p	NOUN
easat-8115	163	31	=	=	NOUN
easat-8115	163	32	0.002	0.002	NUM
easat-8115	163	33	)	)	PUNCT
easat-8115	163	34	,	,	PUNCT
easat-8115	163	35	in	in	ADP
easat-8115	163	36	this	this	DET
easat-8115	163	37	study	study	NOUN
easat-8115	163	38	although	although	SCONJ
easat-8115	163	39	spo2	spo2	PROPN
easat-8115	163	40	/	/	SYM
easat-8115	163	41	fio2	fio2	PROPN
easat-8115	163	42	was	be	AUX
easat-8115	163	43	found	find	VERB
easat-8115	163	44	significant	significant	ADJ
easat-8115	163	45	on	on	ADP
easat-8115	163	46	bivariate	bivariate	ADJ
easat-8115	163	47	analysis	analysis	NOUN
easat-8115	163	48	but	but	CCONJ
easat-8115	163	49	not	not	PART
easat-8115	163	50	in	in	ADP
easat-8115	163	51	multivariate	multivariate	NOUN
easat-8115	163	52	analysis	analysis	NOUN
easat-8115	163	53	,	,	PUNCT
easat-8115	163	54	this	this	PRON
easat-8115	163	55	could	could	AUX
easat-8115	163	56	be	be	AUX
easat-8115	163	57	caused	cause	VERB
easat-8115	163	58	by	by	ADP
easat-8115	163	59	decrease	decrease	NOUN
easat-8115	163	60	spo2	spo2	PROPN
easat-8115	163	61	/	/	SYM
easat-8115	163	62	fio2	fio2	PROPN
easat-8115	163	63	not	not	PART
easat-8115	163	64	only	only	ADV
easat-8115	163	65	caused	cause	VERB
easat-8115	163	66	by	by	ADP
easat-8115	163	67	pcp	pcp	PROPN
easat-8115	163	68	but	but	CCONJ
easat-8115	163	69	also	also	ADV
easat-8115	163	70	in	in	ADP
easat-8115	163	71	pneumonia	pneumonia	NOUN
easat-8115	163	72	[	[	X
easat-8115	163	73	19	19	NUM
easat-8115	163	74	]	]	PUNCT
easat-8115	163	75	.	.	PUNCT
easat-8115	164	1	anemia	anemia	NOUN
easat-8115	164	2	and	and	CCONJ
easat-8115	164	3	thrombocytopenia	thrombocytopenia	PROPN
easat-8115	164	4	in	in	ADP
easat-8115	164	5	hiv	hiv	PROPN
easat-8115	164	6	patients	patient	NOUN
easat-8115	164	7	occur	occur	VERB
easat-8115	164	8	due	due	ADJ
easat-8115	164	9	to	to	ADP
easat-8115	164	10	hematopoietic	hematopoietic	ADJ
easat-8115	164	11	process	process	NOUN
easat-8115	164	12	disorders	disorder	NOUN
easat-8115	164	13	.	.	PUNCT
easat-8115	165	1	thrombocytopenia	thrombocytopenia	PROPN
easat-8115	165	2	is	be	AUX
easat-8115	165	3	caused	cause	VERB
easat-8115	165	4	by	by	ADP
easat-8115	165	5	decreased	decrease	VERB
easat-8115	165	6	platelet	platelet	NOUN
easat-8115	165	7	survival	survival	NOUN
easat-8115	165	8	or	or	CCONJ
easat-8115	165	9	ineffective	ineffective	ADJ
easat-8115	165	10	production	production	NOUN
easat-8115	165	11	of	of	ADP
easat-8115	165	12	platelets	platelet	NOUN
easat-8115	165	13	and	and	CCONJ
easat-8115	165	14	their	their	PRON
easat-8115	165	15	precursors	precursor	NOUN
easat-8115	165	16	[	[	X
easat-8115	165	17	20	20	NUM
easat-8115	165	18	]	]	PUNCT
easat-8115	165	19	.	.	PUNCT
easat-8115	166	1	use	use	NOUN
easat-8115	166	2	of	of	ADP
easat-8115	166	3	myelosuppressive	myelosuppressive	ADJ
easat-8115	166	4	drugs	drug	NOUN
easat-8115	166	5	such	such	ADJ
easat-8115	166	6	as	as	ADP
easat-8115	166	7	zidovudine	zidovudine	PROPN
easat-8115	166	8	can	can	AUX
easat-8115	166	9	decreased	decrease	VERB
easat-8115	166	10	haemoglobin	haemoglobin	PROPN
easat-8115	166	11	levels	level	NOUN
easat-8115	166	12	in	in	ADP
easat-8115	166	13	hiv	hiv	PROPN
easat-8115	166	14	patients	patient	NOUN
easat-8115	166	15	[	[	X
easat-8115	166	16	21	21	NUM
easat-8115	166	17	]	]	PUNCT
easat-8115	166	18	.	.	PUNCT
easat-8115	167	1	this	this	DET
easat-8115	167	2	study	study	NOUN
easat-8115	167	3	found	find	VERB
easat-8115	167	4	no	no	DET
easat-8115	167	5	significant	significant	ADJ
easat-8115	167	6	difference	difference	NOUN
easat-8115	167	7	of	of	ADP
easat-8115	167	8	both	both	DET
easat-8115	167	9	parameters	parameter	NOUN
easat-8115	167	10	.	.	PUNCT
easat-8115	168	1	variations	variation	NOUN
easat-8115	168	2	in	in	ADP
easat-8115	168	3	subjects	subject	NOUN
easat-8115	168	4	,	,	PUNCT
easat-8115	168	5	majority	majority	NOUN
easat-8115	168	6	of	of	ADP
easat-8115	168	7	whom	whom	PRON
easat-8115	168	8	were	be	AUX
easat-8115	168	9	patients	patient	NOUN
easat-8115	168	10	newly	newly	ADV
easat-8115	168	11	diagnosed	diagnose	VERB
easat-8115	168	12	with	with	ADP
easat-8115	168	13	hiv	hiv	PROPN
easat-8115	168	14	and	and	CCONJ
easat-8115	168	15	had	have	AUX
easat-8115	168	16	not	not	PART
easat-8115	168	17	received	receive	VERB
easat-8115	168	18	arv	arv	NOUN
easat-8115	168	19	may	may	AUX
easat-8115	168	20	explain	explain	VERB
easat-8115	168	21	the	the	DET
easat-8115	168	22	results	result	NOUN
easat-8115	168	23	.	.	PUNCT
easat-8115	169	1	there	there	PRON
easat-8115	169	2	was	be	VERB
easat-8115	169	3	a	a	DET
easat-8115	169	4	significant	significant	ADJ
easat-8115	169	5	difference	difference	NOUN
easat-8115	169	6	in	in	ADP
easat-8115	169	7	the	the	DET
easat-8115	169	8	mean	mean	ADJ
easat-8115	169	9	albumin	albumin	ADJ
easat-8115	169	10	levels	level	NOUN
easat-8115	169	11	between	between	ADP
easat-8115	169	12	subjects	subject	NOUN
easat-8115	169	13	with	with	ADP
easat-8115	169	14	positive	positive	ADJ
easat-8115	169	15	and	and	CCONJ
easat-8115	169	16	negative	negative	ADJ
easat-8115	169	17	sputum	sputum	ADJ
easat-8115	169	18	pcr	pcr	PROPN
easat-8115	169	19	results	result	NOUN
easat-8115	169	20	(	(	PUNCT
easat-8115	169	21	p	p	X
easat-8115	169	22	<	<	X
easat-8115	169	23	0.05	0.05	NUM
easat-8115	169	24	)	)	PUNCT
easat-8115	169	25	in	in	ADP
easat-8115	169	26	this	this	DET
easat-8115	169	27	study	study	NOUN
easat-8115	169	28	.	.	PUNCT
easat-8115	170	1	subjects	subject	NOUN
easat-8115	170	2	with	with	ADP
easat-8115	170	3	albumin	albumin	ADJ
easat-8115	170	4	≤3.10	≤3.10	NOUN
easat-8115	170	5	were	be	AUX
easat-8115	170	6	at	at	ADP
easat-8115	170	7	risk	risk	NOUN
easat-8115	170	8	of	of	ADP
easat-8115	170	9	having	have	VERB
easat-8115	170	10	positive	positive	ADJ
easat-8115	170	11	sputum	sputum	NOUN
easat-8115	170	12	pcr	pcr	PROPN
easat-8115	170	13	result	result	VERB
easat-8115	170	14	35.3	35.3	NUM
easat-8115	170	15	times	time	NOUN
easat-8115	170	16	greater	great	ADJ
easat-8115	170	17	than	than	ADP
easat-8115	170	18	those	those	PRON
easat-8115	170	19	with	with	ADP
easat-8115	170	20	albumin	albumin	NOUN
easat-8115	170	21	>	>	X
easat-8115	170	22	3.10	3.10	NUM
easat-8115	170	23	.	.	PUNCT
easat-8115	170	24	tang	tang	PROPN
easat-8115	171	1	[	[	X
easat-8115	171	2	2	2	NUM
easat-8115	171	3	]	]	PUNCT
easat-8115	171	4	also	also	ADV
easat-8115	171	5	found	find	VERB
easat-8115	171	6	serum	serum	NOUN
easat-8115	171	7	albumin	albumin	ADJ
easat-8115	171	8	levels	level	NOUN
easat-8115	171	9	differences	difference	NOUN
easat-8115	171	10	in	in	ADP
easat-8115	171	11	pcp	pcp	NOUN
easat-8115	171	12	patients	patient	NOUN
easat-8115	171	13	undergoing	undergo	VERB
easat-8115	171	14	immunosuppressive	immunosuppressive	ADJ
easat-8115	171	15	therapy	therapy	NOUN
easat-8115	171	16	compared	compare	VERB
easat-8115	171	17	to	to	ADP
easat-8115	171	18	controls	control	NOUN
easat-8115	171	19	.	.	PUNCT
easat-8115	172	1	patients	patient	NOUN
easat-8115	172	2	with	with	ADP
easat-8115	172	3	pcp	pcp	PROPN
easat-8115	172	4	had	have	VERB
easat-8115	172	5	lower	low	ADJ
easat-8115	172	6	serum	serum	NOUN
easat-8115	172	7	albumin	albumin	ADJ
easat-8115	172	8	levels	level	NOUN
easat-8115	172	9	than	than	ADP
easat-8115	172	10	patients	patient	NOUN
easat-8115	172	11	with	with	ADP
easat-8115	172	12	immunosuppressive	immunosuppressive	ADJ
easat-8115	172	13	therapy	therapy	NOUN
easat-8115	172	14	without	without	ADP
easat-8115	172	15	pcp	pcp	PROPN
easat-8115	172	16	(	(	PUNCT
easat-8115	172	17	2.87	2.87	NUM
easat-8115	172	18	g	g	NOUN
easat-8115	172	19	/	/	SYM
easat-8115	172	20	dl	dl	PROPN
easat-8115	172	21	versus	versus	ADP
easat-8115	172	22	3.69	3.69	NUM
easat-8115	172	23	g	g	NOUN
easat-8115	172	24	/	/	SYM
easat-8115	172	25	dl	dl	PROPN
easat-8115	172	26	;	;	PUNCT
easat-8115	172	27	p	p	X
easat-8115	172	28	<	<	NOUN
easat-8115	172	29	0.001	0.001	NUM
easat-8115	172	30	)	)	PUNCT
easat-8115	173	1	[	[	X
easat-8115	173	2	2	2	NUM
easat-8115	173	3	]	]	PUNCT
easat-8115	173	4	.	.	PUNCT
easat-8115	174	1	depletion	depletion	NOUN
easat-8115	174	2	of	of	ADP
easat-8115	174	3	b	b	NOUN
easat-8115	174	4	lymphocytes	lymphocyte	NOUN
easat-8115	174	5	and	and	CCONJ
easat-8115	174	6	cd4	cd4	PROPN
easat-8115	174	7	t	t	PROPN
easat-8115	174	8	cells	cell	NOUN
easat-8115	174	9	in	in	ADP
easat-8115	174	10	mice	mouse	NOUN
easat-8115	174	11	with	with	ADP
easat-8115	174	12	pneumocystis	pneumocystis	ADJ
easat-8115	174	13	infection	infection	NOUN
easat-8115	174	14	,	,	PUNCT
easat-8115	174	15	induce	induce	VERB
easat-8115	174	16	strong	strong	ADJ
easat-8115	174	17	th1	th1	NOUN
easat-8115	174	18	inflammatory	inflammatory	ADJ
easat-8115	174	19	response	response	NOUN
easat-8115	174	20	,	,	PUNCT
easat-8115	174	21	associated	associate	VERB
easat-8115	174	22	with	with	ADP
easat-8115	174	23	edema	edema	NOUN
easat-8115	174	24	and	and	CCONJ
easat-8115	174	25	albumin	albumin	ADJ
easat-8115	174	26	release	release	NOUN
easat-8115	174	27	in	in	ADP
easat-8115	174	28	the	the	DET
easat-8115	174	29	alveoli	alveoli	NOUN
easat-8115	175	1	[	[	X
easat-8115	175	2	22	22	NUM
easat-8115	175	3	]	]	PUNCT
easat-8115	175	4	.	.	PUNCT
easat-8115	176	1	in	in	ADP
easat-8115	176	2	inflammatory	inflammatory	ADJ
easat-8115	176	3	conditions	condition	NOUN
easat-8115	176	4	,	,	PUNCT
easat-8115	176	5	there	there	PRON
easat-8115	176	6	is	be	VERB
easat-8115	176	7	an	an	DET
easat-8115	176	8	increase	increase	NOUN
easat-8115	176	9	of	of	ADP
easat-8115	176	10	albumin	albumin	ADJ
easat-8115	176	11	breakdown	breakdown	NOUN
easat-8115	176	12	.	.	PUNCT
easat-8115	177	1	combination	combination	NOUN
easat-8115	177	2	of	of	ADP
easat-8115	177	3	inflammatory	inflammatory	ADJ
easat-8115	177	4	responses	response	NOUN
easat-8115	177	5	and	and	CCONJ
easat-8115	177	6	increased	increase	VERB
easat-8115	177	7	albumin	albumin	ADJ
easat-8115	177	8	release	release	NOUN
easat-8115	177	9	through	through	ADP
easat-8115	177	10	capillaries	capillary	NOUN
easat-8115	177	11	also	also	ADV
easat-8115	177	12	causes	cause	VERB
easat-8115	177	13	hypoalbuminemia	hypoalbuminemia	ADV
easat-8115	177	14	[	[	X
easat-8115	177	15	23	23	NUM
easat-8115	177	16	]	]	PUNCT
easat-8115	177	17	.	.	PUNCT
easat-8115	178	1	this	this	DET
easat-8115	178	2	study	study	NOUN
easat-8115	178	3	found	find	VERB
easat-8115	178	4	no	no	DET
easat-8115	178	5	relationship	relationship	NOUN
easat-8115	178	6	between	between	ADP
easat-8115	178	7	nlr	nlr	PROPN
easat-8115	178	8	levels	level	NOUN
easat-8115	178	9	and	and	CCONJ
easat-8115	178	10	sputum	sputum	PROPN
easat-8115	178	11	pcr	pcr	PROPN
easat-8115	178	12	positivity	positivity	NOUN
easat-8115	178	13	in	in	ADP
easat-8115	178	14	hiv	hiv	PROPN
easat-8115	178	15	patients	patient	NOUN
easat-8115	178	16	with	with	ADP
easat-8115	178	17	suspicion	suspicion	NOUN
easat-8115	178	18	of	of	ADP
easat-8115	178	19	pcp	pcp	PROPN
easat-8115	178	20	(	(	PUNCT
easat-8115	178	21	pr	pr	NOUN
easat-8115	178	22	0.737	0.737	NUM
easat-8115	178	23	,	,	PUNCT
easat-8115	178	24	95	95	NUM
easat-8115	178	25	%	%	NOUN
easat-8115	178	26	ik	ik	PROPN
easat-8115	178	27	0.516	0.516	NUM
easat-8115	178	28	1.053	1.053	NUM
easat-8115	178	29	;	;	PUNCT
easat-8115	178	30	p	p	NOUN
easat-8115	178	31	value	value	NOUN
easat-8115	178	32	=	=	NOUN
easat-8115	178	33	0.107	0.107	NUM
easat-8115	178	34	)	)	PUNCT
easat-8115	178	35	.	.	PUNCT
easat-8115	179	1	non	non	PRON
easat-8115	179	2	significant	significant	ADJ
easat-8115	179	3	relationship	relationship	NOUN
easat-8115	179	4	could	could	AUX
easat-8115	179	5	be	be	AUX
easat-8115	179	6	caused	cause	VERB
easat-8115	179	7	by	by	ADP
easat-8115	179	8	neutrophil	neutrophil	ADJ
easat-8115	179	9	decrease	decrease	NOUN
easat-8115	179	10	early	early	ADV
easat-8115	179	11	in	in	ADP
easat-8115	179	12	hiv	hiv	PROPN
easat-8115	179	13	infection	infection	NOUN
easat-8115	179	14	but	but	CCONJ
easat-8115	179	15	will	will	AUX
easat-8115	179	16	increase	increase	VERB
easat-8115	179	17	as	as	SCONJ
easat-8115	179	18	the	the	DET
easat-8115	179	19	infection	infection	NOUN
easat-8115	179	20	progresses	progress	VERB
easat-8115	179	21	.	.	PUNCT
easat-8115	180	1	chemotactic	chemotactic	ADJ
easat-8115	180	2	agents	agent	NOUN
easat-8115	180	3	will	will	AUX
easat-8115	180	4	attract	attract	VERB
easat-8115	180	5	neutrophils	neutrophil	NOUN
easat-8115	180	6	to	to	ADP
easat-8115	180	7	infected	infected	ADJ
easat-8115	180	8	area	area	NOUN
easat-8115	180	9	to	to	PART
easat-8115	180	10	kill	kill	VERB
easat-8115	180	11	and	and	CCONJ
easat-8115	180	12	phagocytose	phagocytose	VERB
easat-8115	180	13	microorganisms	microorganism	NOUN
easat-8115	180	14	during	during	ADP
easat-8115	180	15	infection	infection	NOUN
easat-8115	180	16	.	.	PUNCT
easat-8115	181	1	hiv	hiv	PROPN
easat-8115	181	2	patients	patient	NOUN
easat-8115	181	3	who	who	PRON
easat-8115	181	4	experience	experience	VERB
easat-8115	181	5	neutrophil	neutrophil	ADJ
easat-8115	181	6	dysfunction	dysfunction	NOUN
easat-8115	181	7	will	will	AUX
easat-8115	181	8	be	be	AUX
easat-8115	181	9	more	more	ADV
easat-8115	181	10	susceptible	susceptible	ADJ
easat-8115	181	11	to	to	ADP
easat-8115	181	12	bacterial	bacterial	ADJ
easat-8115	181	13	infections	infection	NOUN
easat-8115	181	14	[	[	X
easat-8115	181	15	21	21	NUM
easat-8115	181	16	]	]	PUNCT
easat-8115	181	17	.	.	PUNCT
easat-8115	182	1	mlr	mlr	NOUN
easat-8115	182	2	is	be	AUX
easat-8115	182	3	often	often	ADV
easat-8115	182	4	used	use	VERB
easat-8115	182	5	as	as	ADP
easat-8115	182	6	an	an	DET
easat-8115	182	7	indicator	indicator	NOUN
easat-8115	182	8	of	of	ADP
easat-8115	182	9	inflammation	inflammation	NOUN
easat-8115	182	10	.	.	PUNCT
easat-8115	183	1	monocyte	monocyte	PROPN
easat-8115	183	2	count	count	NOUN
easat-8115	183	3	is	be	AUX
easat-8115	183	4	influenced	influence	VERB
easat-8115	183	5	by	by	ADP
easat-8115	183	6	gm	gm	PROPN
easat-8115	183	7	-	-	PUNCT
easat-8115	183	8	csf	csf	NOUN
easat-8115	183	9	which	which	PRON
easat-8115	183	10	is	be	AUX
easat-8115	183	11	a	a	DET
easat-8115	183	12	hematopoietic	hematopoietic	ADJ
easat-8115	183	13	growth	growth	NOUN
easat-8115	183	14	factor	factor	NOUN
easat-8115	183	15	.	.	PUNCT
easat-8115	184	1	gm	gm	PROPN
easat-8115	184	2	-	-	PUNCT
easat-8115	184	3	csf	csf	NOUN
easat-8115	184	4	causes	cause	VERB
easat-8115	184	5	an	an	DET
easat-8115	184	6	increase	increase	NOUN
easat-8115	184	7	in	in	ADP
easat-8115	184	8	the	the	DET
easat-8115	184	9	number	number	NOUN
easat-8115	184	10	of	of	ADP
easat-8115	184	11	serum	serum	NOUN
easat-8115	184	12	monocytes	monocyte	NOUN
easat-8115	184	13	and	and	CCONJ
easat-8115	184	14	pmns	pmn	NOUN
easat-8115	184	15	,	,	PUNCT
easat-8115	184	16	which	which	PRON
easat-8115	184	17	are	be	AUX
easat-8115	184	18	useful	useful	ADJ
easat-8115	184	19	in	in	ADP
easat-8115	184	20	immunity	immunity	NOUN
easat-8115	184	21	when	when	SCONJ
easat-8115	184	22	lung	lung	NOUN
easat-8115	184	23	infections	infection	NOUN
easat-8115	184	24	occur	occur	VERB
easat-8115	184	25	[	[	X
easat-8115	184	26	24	24	NUM
easat-8115	184	27	]	]	PUNCT
easat-8115	184	28	.	.	PUNCT
easat-8115	185	1	there	there	PRON
easat-8115	185	2	was	be	VERB
easat-8115	185	3	no	no	DET
easat-8115	185	4	significant	significant	ADJ
easat-8115	185	5	difference	difference	NOUN
easat-8115	185	6	of	of	ADP
easat-8115	185	7	mlr	mlr	NOUN
easat-8115	185	8	,	,	PUNCT
easat-8115	185	9	between	between	ADP
easat-8115	185	10	hiv	hiv	PROPN
easat-8115	185	11	subjects	subject	NOUN
easat-8115	185	12	with	with	ADP
easat-8115	185	13	positive	positive	ADJ
easat-8115	185	14	and	and	CCONJ
easat-8115	185	15	negative	negative	ADJ
easat-8115	185	16	sputum	sputum	ADJ
easat-8115	185	17	pcr	pcr	PROPN
easat-8115	185	18	results	result	NOUN
easat-8115	185	19	in	in	ADP
easat-8115	185	20	this	this	DET
easat-8115	185	21	study	study	NOUN
easat-8115	185	22	.	.	PUNCT
easat-8115	186	1	however	however	ADV
easat-8115	186	2	,	,	PUNCT
easat-8115	186	3	mlr	mlr	NOUN
easat-8115	186	4	values	value	NOUN
easat-8115	186	5	in	in	ADP
easat-8115	186	6	both	both	DET
easat-8115	186	7	groups	group	NOUN
easat-8115	186	8	were	be	AUX
easat-8115	186	9	higher	high	ADJ
easat-8115	186	10	than	than	ADP
easat-8115	186	11	normal	normal	ADJ
easat-8115	186	12	.	.	PUNCT
easat-8115	187	1	in	in	ADP
easat-8115	187	2	hiv	hiv	PROPN
easat-8115	187	3	patients	patient	NOUN
easat-8115	187	4	,	,	PUNCT
easat-8115	187	5	there	there	PRON
easat-8115	187	6	is	be	VERB
easat-8115	187	7	a	a	DET
easat-8115	187	8	disturbance	disturbance	NOUN
easat-8115	187	9	in	in	ADP
easat-8115	187	10	monocyte	monocyte	NOUN
easat-8115	187	11	activity	activity	NOUN
easat-8115	187	12	.	.	PUNCT
easat-8115	188	1	when	when	SCONJ
easat-8115	188	2	compared	compare	VERB
easat-8115	188	3	with	with	ADP
easat-8115	188	4	healthy	healthy	ADJ
easat-8115	188	5	individuals	individual	NOUN
easat-8115	188	6	,	,	PUNCT
easat-8115	188	7	hiv	hiv	PROPN
easat-8115	188	8	patients	patient	NOUN
easat-8115	188	9	reported	report	VERB
easat-8115	188	10	have	have	VERB
easat-8115	188	11	an	an	DET
easat-8115	188	12	increase	increase	NOUN
easat-8115	188	13	in	in	ADP
easat-8115	188	14	overall	overall	ADJ
easat-8115	188	15	number	number	NOUN
easat-8115	188	16	of	of	ADP
easat-8115	188	17	monocytes	monocyte	NOUN
easat-8115	188	18	.	.	PUNCT
easat-8115	189	1	hiv	hiv	PROPN
easat-8115	189	2	virus	virus	NOUN
easat-8115	189	3	replication	replication	NOUN
easat-8115	189	4	,	,	PUNCT
easat-8115	189	5	microbial	microbial	ADJ
easat-8115	189	6	translocation	translocation	NOUN
easat-8115	189	7	,	,	PUNCT
easat-8115	189	8	and	and	CCONJ
easat-8115	189	9	co	co	NOUN
easat-8115	189	10	-	-	NOUN
easat-8115	189	11	infection	infection	NOUN
easat-8115	189	12	with	with	ADP
easat-8115	189	13	infectious	infectious	ADJ
easat-8115	189	14	pathogens	pathogen	NOUN
easat-8115	189	15	can	can	AUX
easat-8115	189	16	activate	activate	VERB
easat-8115	189	17	monocytes	monocyte	NOUN
easat-8115	189	18	during	during	ADP
easat-8115	189	19	hiv	hiv	PROPN
easat-8115	189	20	infection	infection	NOUN
easat-8115	190	1	[	[	X
easat-8115	190	2	25	25	NUM
easat-8115	190	3	]	]	PUNCT
easat-8115	190	4	.	.	PUNCT
easat-8115	191	1	hiv	hiv	PROPN
easat-8115	191	2	infection	infection	NOUN
easat-8115	191	3	can	can	AUX
easat-8115	191	4	also	also	ADV
easat-8115	191	5	cause	cause	VERB
easat-8115	191	6	eosinophilic	eosinophilic	ADJ
easat-8115	191	7	inflammation	inflammation	NOUN
easat-8115	191	8	.	.	PUNCT
easat-8115	192	1	in	in	ADP
easat-8115	192	2	pcp	pcp	PROPN
easat-8115	192	3	infection	infection	NOUN
easat-8115	192	4	,	,	PUNCT
easat-8115	192	5	immune	immune	ADJ
easat-8115	192	6	response	response	NOUN
easat-8115	192	7	to	to	ADP
easat-8115	192	8	betad	betad	NOUN
easat-8115	192	9	-	-	PUNCT
easat-8115	192	10	glucan	glucan	NOUN
easat-8115	192	11	may	may	AUX
easat-8115	192	12	be	be	AUX
easat-8115	192	13	involved	involve	VERB
easat-8115	192	14	in	in	ADP
easat-8115	192	15	the	the	DET
easat-8115	192	16	mechanism	mechanism	NOUN
easat-8115	192	17	of	of	ADP
easat-8115	192	18	eosinophilia	eosinophilia	PROPN
easat-8115	192	19	in	in	ADP
easat-8115	192	20	the	the	DET
easat-8115	192	21	lungs	lung	NOUN
easat-8115	192	22	[	[	X
easat-8115	192	23	26	26	NUM
easat-8115	192	24	]	]	PUNCT
easat-8115	192	25	.	.	PUNCT
easat-8115	193	1	however	however	ADV
easat-8115	193	2	,	,	PUNCT
easat-8115	193	3	this	this	DET
easat-8115	193	4	study	study	NOUN
easat-8115	193	5	found	find	VERB
easat-8115	193	6	no	no	DET
easat-8115	193	7	significant	significant	ADJ
easat-8115	193	8	difference	difference	NOUN
easat-8115	193	9	in	in	ADP
easat-8115	193	10	eosinophil	eosinophil	ADJ
easat-8115	193	11	values	value	NOUN
easat-8115	193	12	between	between	ADP
easat-8115	193	13	positive	positive	ADJ
easat-8115	193	14	and	and	CCONJ
easat-8115	193	15	negative	negative	ADJ
easat-8115	193	16	pcr	pcr	ADJ
easat-8115	193	17	results	result	NOUN
easat-8115	193	18	.	.	PUNCT
easat-8115	194	1	this	this	DET
easat-8115	194	2	result	result	NOUN
easat-8115	194	3	may	may	AUX
easat-8115	194	4	be	be	AUX
easat-8115	194	5	because	because	SCONJ
easat-8115	194	6	,	,	PUNCT
easat-8115	194	7	eosinophils	eosinophil	NOUN
easat-8115	194	8	are	be	AUX
easat-8115	194	9	not	not	PART
easat-8115	194	10	the	the	DET
easat-8115	194	11	main	main	ADJ
easat-8115	194	12	cells	cell	NOUN
easat-8115	194	13	involved	involve	VERB
easat-8115	194	14	in	in	ADP
easat-8115	194	15	immune	immune	ADJ
easat-8115	194	16	response	response	NOUN
easat-8115	194	17	to	to	ADP
easat-8115	194	18	pcp	pcp	VERB
easat-8115	194	19	.	.	PUNCT
easat-8115	195	1	cd4	cd4	PROPN
easat-8115	195	2	count	count	NOUN
easat-8115	195	3	is	be	AUX
easat-8115	195	4	used	use	VERB
easat-8115	195	5	to	to	PART
easat-8115	195	6	assess	assess	VERB
easat-8115	195	7	immunological	immunological	ADJ
easat-8115	195	8	status	status	NOUN
easat-8115	195	9	at	at	ADP
easat-8115	195	10	the	the	DET
easat-8115	195	11	time	time	NOUN
easat-8115	195	12	of	of	ADP
easat-8115	195	13	hiv	hiv	PROPN
easat-8115	195	14	diagnosis	diagnosis	NOUN
easat-8115	195	15	[	[	X
easat-8115	195	16	27	27	NUM
easat-8115	195	17	]	]	PUNCT
easat-8115	195	18	.	.	PUNCT
easat-8115	196	1	we	we	PRON
easat-8115	196	2	reported	report	VERB
easat-8115	196	3	a	a	DET
easat-8115	196	4	significant	significant	ADJ
easat-8115	196	5	difference	difference	NOUN
easat-8115	196	6	and	and	CCONJ
easat-8115	196	7	relationship	relationship	NOUN
easat-8115	196	8	between	between	ADP
easat-8115	196	9	cd4	cd4	PROPN
easat-8115	196	10	values	value	NOUN
easat-8115	196	11	with	with	ADP
easat-8115	196	12	positive	positive	ADJ
easat-8115	196	13	sputum	sputum	NOUN
easat-8115	196	14	pcr	pcr	NOUN
easat-8115	196	15	results	result	NOUN
easat-8115	196	16	(	(	PUNCT
easat-8115	196	17	p<0.05	p<0.05	NOUN
easat-8115	196	18	)	)	PUNCT
easat-8115	196	19	.	.	PUNCT
easat-8115	197	1	progressive	progressive	PROPN
easat-8115	197	2	cd4	cd4	PROPN
easat-8115	197	3	t	t	PROPN
easat-8115	197	4	cells	cell	NOUN
easat-8115	197	5	decline	decline	NOUN
easat-8115	197	6	is	be	AUX
easat-8115	197	7	associated	associate	VERB
easat-8115	197	8	with	with	ADP
easat-8115	197	9	hiv	hiv	PROPN
easat-8115	197	10	progression	progression	NOUN
easat-8115	197	11	,	,	PUNCT
easat-8115	197	12	opportunistic	opportunistic	ADJ
easat-8115	197	13	infections	infection	NOUN
easat-8115	197	14	,	,	PUNCT
easat-8115	197	15	and	and	CCONJ
easat-8115	197	16	mortality	mortality	NOUN
easat-8115	197	17	.	.	PUNCT
easat-8115	198	1	increased	increase	VERB
easat-8115	198	2	risk	risk	NOUN
easat-8115	198	3	of	of	ADP
easat-8115	198	4	opportunistic	opportunistic	ADJ
easat-8115	198	5	infections	infection	NOUN
easat-8115	198	6	in	in	ADP
easat-8115	198	7	hiv	hiv	PROPN
easat-8115	198	8	patients	patient	NOUN
easat-8115	198	9	is	be	AUX
easat-8115	198	10	known	know	VERB
easat-8115	198	11	to	to	PART
easat-8115	198	12	occur	occur	VERB
easat-8115	198	13	when	when	SCONJ
easat-8115	198	14	cd4	cd4	PROPN
easat-8115	198	15	cells	cell	NOUN
easat-8115	198	16	fall	fall	VERB
easat-8115	198	17	below	below	ADP
easat-8115	198	18	200	200	NUM
easat-8115	198	19	cells	cell	NOUN
easat-8115	198	20	/	/	SYM
easat-8115	198	21	mm3	mm3	NOUN
easat-8115	199	1	[	[	X
easat-8115	199	2	28	28	NUM
easat-8115	199	3	]	]	PUNCT
easat-8115	199	4	.	.	PUNCT
easat-8115	200	1	subjects	subject	NOUN
easat-8115	200	2	with	with	ADP
easat-8115	200	3	cd4	cd4	PROPN
easat-8115	200	4	≤200	≤200	PROPN
easat-8115	200	5	cells	cell	NOUN
easat-8115	200	6	/	/	SYM
easat-8115	200	7	mm3	mm3	PROPN
easat-8115	200	8	had	have	VERB
easat-8115	200	9	12.29	12.29	NUM
easat-8115	200	10	times	time	NOUN
easat-8115	200	11	greater	great	ADJ
easat-8115	200	12	risk	risk	NOUN
easat-8115	200	13	of	of	ADP
easat-8115	200	14	1338	1338	NUM
easat-8115	200	15	edelweiss	edelweiss	PROPN
easat-8115	200	16	applied	apply	VERB
easat-8115	200	17	science	science	NOUN
easat-8115	200	18	and	and	CCONJ
easat-8115	200	19	technology	technology	NOUN
easat-8115	200	20	issn	issn	PROPN
easat-8115	200	21	:	:	PUNCT
easat-8115	200	22	2576	2576	NUM
easat-8115	200	23	-	-	SYM
easat-8115	200	24	8484	8484	NUM
easat-8115	200	25	vol	vol	NOUN
easat-8115	200	26	.	.	PROPN
easat-8115	201	1	9	9	NUM
easat-8115	201	2	,	,	PUNCT
easat-8115	201	3	no	no	INTJ
easat-8115	201	4	.	.	NOUN
easat-8115	202	1	6	6	NUM
easat-8115	202	2	:	:	SYM
easat-8115	202	3	1331	1331	NUM
easat-8115	202	4	-	-	SYM
easat-8115	202	5	1341	1341	NUM
easat-8115	202	6	,	,	PUNCT
easat-8115	202	7	2025	2025	NUM
easat-8115	202	8	doi	doi	NOUN
easat-8115	202	9	:	:	PUNCT
easat-8115	202	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	202	11	©	©	PROPN
easat-8115	202	12	2025	2025	NUM
easat-8115	202	13	by	by	ADP
easat-8115	202	14	the	the	DET
easat-8115	202	15	authors	author	NOUN
easat-8115	202	16	;	;	PUNCT
easat-8115	202	17	licensee	licensee	PROPN
easat-8115	202	18	learning	learning	NOUN
easat-8115	202	19	gate	gate	NOUN
easat-8115	202	20	having	have	VERB
easat-8115	202	21	positive	positive	ADJ
easat-8115	202	22	sputum	sputum	NOUN
easat-8115	202	23	pcr	pcr	NOUN
easat-8115	202	24	results	result	NOUN
easat-8115	202	25	in	in	ADP
easat-8115	202	26	our	our	PRON
easat-8115	202	27	study	study	NOUN
easat-8115	202	28	.	.	PUNCT
easat-8115	203	1	previous	previous	ADJ
easat-8115	203	2	study	study	NOUN
easat-8115	203	3	have	have	AUX
easat-8115	203	4	shown	show	VERB
easat-8115	203	5	that	that	SCONJ
easat-8115	203	6	initial	initial	ADJ
easat-8115	203	7	cd4	cd4	PROPN
easat-8115	203	8	count	count	NOUN
easat-8115	203	9	was	be	AUX
easat-8115	203	10	significantly	significantly	ADV
easat-8115	203	11	lower	low	ADJ
easat-8115	203	12	in	in	ADP
easat-8115	203	13	pcp	pcp	NOUN
easat-8115	203	14	patients	patient	NOUN
easat-8115	203	15	(	(	PUNCT
easat-8115	203	16	14	14	NUM
easat-8115	203	17	vs	vs	ADP
easat-8115	203	18	24	24	NUM
easat-8115	203	19	cells/µl	cells/µl	NOUN
easat-8115	203	20	;	;	PUNCT
easat-8115	203	21	p	p	X
easat-8115	203	22	<	<	X
easat-8115	203	23	0.001	0.001	NUM
easat-8115	203	24	)	)	PUNCT
easat-8115	203	25	and	and	CCONJ
easat-8115	203	26	decreased	decrease	VERB
easat-8115	203	27	with	with	ADP
easat-8115	203	28	increasing	increase	VERB
easat-8115	203	29	severity	severity	NOUN
easat-8115	203	30	of	of	ADP
easat-8115	203	31	pcp	pcp	PROPN
easat-8115	204	1	[	[	X
easat-8115	204	2	29	29	NUM
easat-8115	204	3	]	]	PUNCT
easat-8115	204	4	.	.	PUNCT
easat-8115	205	1	in	in	ADP
easat-8115	205	2	pcp	pcp	PROPN
easat-8115	205	3	infection	infection	NOUN
easat-8115	205	4	,	,	PUNCT
easat-8115	205	5	there	there	PRON
easat-8115	205	6	is	be	VERB
easat-8115	205	7	a	a	DET
easat-8115	205	8	significant	significant	ADJ
easat-8115	205	9	increase	increase	NOUN
easat-8115	205	10	in	in	ADP
easat-8115	205	11	cd8	cd8	PROPN
easat-8115	205	12	t	t	PROPN
easat-8115	205	13	cells	cell	NOUN
easat-8115	205	14	number	number	NOUN
easat-8115	205	15	in	in	ADP
easat-8115	205	16	the	the	DET
easat-8115	205	17	lungs	lung	NOUN
easat-8115	205	18	,	,	PUNCT
easat-8115	205	19	especially	especially	ADV
easat-8115	205	20	when	when	SCONJ
easat-8115	205	21	there	there	PRON
easat-8115	205	22	is	be	VERB
easat-8115	205	23	significant	significant	ADJ
easat-8115	205	24	cd4	cd4	PROPN
easat-8115	205	25	t	t	PROPN
easat-8115	205	26	cell	cell	NOUN
easat-8115	205	27	depletion	depletion	NOUN
easat-8115	205	28	.	.	PUNCT
easat-8115	206	1	in	in	ADP
easat-8115	206	2	the	the	DET
easat-8115	206	3	absence	absence	NOUN
easat-8115	206	4	of	of	ADP
easat-8115	206	5	cd4	cd4	PROPN
easat-8115	206	6	+	+	PROPN
easat-8115	206	7	t	t	NOUN
easat-8115	206	8	cells	cell	NOUN
easat-8115	206	9	,	,	PUNCT
easat-8115	206	10	cd8	cd8	PROPN
easat-8115	206	11	+	+	PROPN
easat-8115	206	12	t	t	NOUN
easat-8115	206	13	cells	cell	NOUN
easat-8115	206	14	will	will	AUX
easat-8115	206	15	eliminates	eliminate	VERB
easat-8115	206	16	pneumocystis	pneumocystis	NOUN
easat-8115	206	17	and	and	CCONJ
easat-8115	206	18	formed	form	VERB
easat-8115	206	19	secondary	secondary	ADJ
easat-8115	206	20	defense	defense	NOUN
easat-8115	206	21	against	against	ADP
easat-8115	206	22	fungi	fungi	PROPN
easat-8115	206	23	.	.	PUNCT
easat-8115	207	1	in	in	ADP
easat-8115	207	2	pcp	pcp	PROPN
easat-8115	207	3	,	,	PUNCT
easat-8115	207	4	a	a	DET
easat-8115	207	5	large	large	ADJ
easat-8115	207	6	number	number	NOUN
easat-8115	207	7	of	of	ADP
easat-8115	207	8	cd8	cd8	PROPN
easat-8115	207	9	+	+	PROPN
easat-8115	207	10	t	t	NOUN
easat-8115	207	11	cells	cell	NOUN
easat-8115	207	12	are	be	AUX
easat-8115	207	13	recruited	recruit	VERB
easat-8115	207	14	to	to	ADP
easat-8115	207	15	the	the	DET
easat-8115	207	16	lungs	lung	NOUN
easat-8115	207	17	.	.	PUNCT
easat-8115	208	1	elimination	elimination	NOUN
easat-8115	208	2	of	of	ADP
easat-8115	208	3	pcp	pcp	PROPN
easat-8115	208	4	agents	agent	NOUN
easat-8115	208	5	by	by	ADP
easat-8115	208	6	cd8	cd8	PROPN
easat-8115	208	7	+	+	PROPN
easat-8115	208	8	t	t	PROPN
easat-8115	208	9	cells	cell	NOUN
easat-8115	208	10	facilitated	facilitate	VERB
easat-8115	208	11	by	by	ADP
easat-8115	208	12	cytokines	cytokine	NOUN
easat-8115	208	13	such	such	ADJ
easat-8115	208	14	as	as	ADP
easat-8115	208	15	tnfα	tnfα	NOUN
easat-8115	208	16	,	,	PUNCT
easat-8115	208	17	tnf	tnf	PROPN
easat-8115	208	18	-	-	PUNCT
easat-8115	208	19	β	β	PROPN
easat-8115	208	20	or	or	CCONJ
easat-8115	208	21	ifn	ifn	PROPN
easat-8115	208	22	-	-	PUNCT
easat-8115	208	23	γ	γ	NOUN
easat-8115	208	24	.	.	PUNCT
easat-8115	208	25	low	low	ADJ
easat-8115	208	26	numbers	number	NOUN
easat-8115	208	27	of	of	ADP
easat-8115	208	28	cd8	cd8	PROPN
easat-8115	208	29	+	+	PROPN
easat-8115	208	30	t	t	PROPN
easat-8115	208	31	cells	cell	NOUN
easat-8115	208	32	in	in	ADP
easat-8115	208	33	peripheral	peripheral	ADJ
easat-8115	208	34	blood	blood	NOUN
easat-8115	208	35	are	be	AUX
easat-8115	208	36	associated	associate	VERB
easat-8115	208	37	with	with	ADP
easat-8115	208	38	poor	poor	ADJ
easat-8115	208	39	prognosis	prognosis	NOUN
easat-8115	208	40	in	in	ADP
easat-8115	208	41	non	non	ADJ
easat-8115	208	42	-	-	ADJ
easat-8115	208	43	hiv	hiv	ADJ
easat-8115	208	44	pcp	pcp	PROPN
easat-8115	208	45	patients	patient	NOUN
easat-8115	208	46	with	with	ADP
easat-8115	208	47	respiratory	respiratory	ADJ
easat-8115	208	48	failure	failure	NOUN
easat-8115	208	49	[	[	X
easat-8115	208	50	30	30	NUM
easat-8115	208	51	,	,	PUNCT
easat-8115	208	52	31	31	NUM
easat-8115	208	53	]	]	PUNCT
easat-8115	208	54	.	.	PUNCT
easat-8115	209	1	in	in	ADP
easat-8115	209	2	this	this	DET
easat-8115	209	3	study	study	NOUN
easat-8115	209	4	,	,	PUNCT
easat-8115	209	5	there	there	PRON
easat-8115	209	6	was	be	VERB
easat-8115	209	7	no	no	DET
easat-8115	209	8	significant	significant	ADJ
easat-8115	209	9	difference	difference	NOUN
easat-8115	209	10	in	in	ADP
easat-8115	209	11	cd8	cd8	PROPN
easat-8115	209	12	values	value	NOUN
easat-8115	209	13	between	between	ADP
easat-8115	209	14	groups	group	NOUN
easat-8115	209	15	with	with	ADP
easat-8115	209	16	positive	positive	ADJ
easat-8115	209	17	and	and	CCONJ
easat-8115	209	18	negative	negative	ADJ
easat-8115	209	19	pcp	pcp	PROPN
easat-8115	209	20	sputum	sputum	PROPN
easat-8115	209	21	pcr	pcr	PROPN
easat-8115	209	22	results	result	NOUN
easat-8115	209	23	.	.	PUNCT
easat-8115	210	1	however	however	ADV
easat-8115	210	2	,	,	PUNCT
easat-8115	210	3	patients	patient	NOUN
easat-8115	210	4	with	with	ADP
easat-8115	210	5	positive	positive	ADJ
easat-8115	210	6	pcp	pcp	PROPN
easat-8115	210	7	sputum	sputum	PROPN
easat-8115	210	8	pcr	pcr	PROPN
easat-8115	210	9	had	have	VERB
easat-8115	210	10	lower	low	ADJ
easat-8115	210	11	cd8	cd8	PROPN
easat-8115	210	12	values	value	NOUN
easat-8115	210	13	(	(	PUNCT
easat-8115	210	14	327.5	327.5	NUM
easat-8115	210	15	vs.	vs.	CCONJ
easat-8115	210	16	400	400	NUM
easat-8115	210	17	cells/µl	cells/µl	NOUN
easat-8115	210	18	)	)	PUNCT
easat-8115	210	19	.	.	PUNCT
easat-8115	211	1	hypoxemia	hypoxemia	PROPN
easat-8115	211	2	is	be	AUX
easat-8115	211	3	one	one	NUM
easat-8115	211	4	of	of	ADP
easat-8115	211	5	the	the	DET
easat-8115	211	6	criteria	criterion	NOUN
easat-8115	211	7	for	for	ADP
easat-8115	211	8	pcp	pcp	NOUN
easat-8115	211	9	diagnosis	diagnosis	NOUN
easat-8115	211	10	and	and	CCONJ
easat-8115	211	11	its	its	PRON
easat-8115	211	12	mortality	mortality	NOUN
easat-8115	211	13	.	.	PUNCT
easat-8115	212	1	in	in	ADP
easat-8115	212	2	severe	severe	ADJ
easat-8115	212	3	pulmonary	pulmonary	ADJ
easat-8115	212	4	inflammation	inflammation	NOUN
easat-8115	212	5	,	,	PUNCT
easat-8115	212	6	impaired	impaired	ADJ
easat-8115	212	7	gas	gas	NOUN
easat-8115	212	8	exchange	exchange	NOUN
easat-8115	212	9	will	will	AUX
easat-8115	212	10	cause	cause	VERB
easat-8115	212	11	hypoxia	hypoxia	NOUN
easat-8115	212	12	and	and	CCONJ
easat-8115	212	13	decreased	decrease	VERB
easat-8115	212	14	lung	lung	NOUN
easat-8115	212	15	compliance	compliance	NOUN
easat-8115	212	16	[	[	X
easat-8115	212	17	7	7	NUM
easat-8115	212	18	]	]	PUNCT
easat-8115	212	19	.	.	PUNCT
easat-8115	213	1	in	in	ADP
easat-8115	213	2	this	this	DET
easat-8115	213	3	study	study	NOUN
easat-8115	213	4	,	,	PUNCT
easat-8115	213	5	there	there	PRON
easat-8115	213	6	was	be	VERB
easat-8115	213	7	no	no	DET
easat-8115	213	8	significant	significant	ADJ
easat-8115	213	9	difference	difference	NOUN
easat-8115	213	10	of	of	ADP
easat-8115	213	11	aado2	aado2	ADJ
easat-8115	213	12	values	value	NOUN
easat-8115	213	13	between	between	ADP
easat-8115	213	14	groups	group	NOUN
easat-8115	213	15	.	.	PUNCT
easat-8115	214	1	however	however	ADV
easat-8115	214	2	,	,	PUNCT
easat-8115	214	3	the	the	DET
easat-8115	214	4	hiv	hiv	PROPN
easat-8115	214	5	group	group	NOUN
easat-8115	214	6	with	with	ADP
easat-8115	214	7	positive	positive	ADJ
easat-8115	214	8	sputum	sputum	NOUN
easat-8115	214	9	pcr	pcr	PROPN
easat-8115	214	10	had	have	VERB
easat-8115	214	11	a	a	DET
easat-8115	214	12	higher	high	ADJ
easat-8115	214	13	median	median	ADJ
easat-8115	214	14	aado2	aado2	NOUN
easat-8115	214	15	value	value	NOUN
easat-8115	214	16	(	(	PUNCT
easat-8115	214	17	37.6	37.6	NUM
easat-8115	214	18	vs.	vs.	ADP
easat-8115	214	19	31.6	31.6	NUM
easat-8115	214	20	)	)	PUNCT
easat-8115	214	21	.	.	PUNCT
easat-8115	215	1	this	this	PRON
easat-8115	215	2	was	be	AUX
easat-8115	215	3	also	also	ADV
easat-8115	215	4	found	find	VERB
easat-8115	215	5	in	in	ADP
easat-8115	215	6	a	a	DET
easat-8115	215	7	study	study	NOUN
easat-8115	215	8	by	by	ADP
easat-8115	215	9	li	li	PROPN
easat-8115	215	10	,	,	PUNCT
easat-8115	215	11	et	et	PROPN
easat-8115	215	12	al	al	PROPN
easat-8115	215	13	.	.	PUNCT
easat-8115	216	1	[	[	X
easat-8115	216	2	31	31	NUM
easat-8115	216	3	]	]	PUNCT
easat-8115	216	4	where	where	SCONJ
easat-8115	216	5	pcp	pcp	PROPN
easat-8115	216	6	patients	patient	NOUN
easat-8115	216	7	had	have	VERB
easat-8115	216	8	higher	high	ADJ
easat-8115	216	9	aado2	aado2	ADJ
easat-8115	216	10	values	value	NOUN
easat-8115	216	11	(	(	PUNCT
easat-8115	216	12	264.8	264.8	NUM
easat-8115	216	13	mmhg	mmhg	NOUN
easat-8115	216	14	vs.	vs.	ADP
easat-8115	216	15	67.7	67.7	NUM
easat-8115	216	16	mmhg	mmhg	NOUN
easat-8115	216	17	)	)	PUNCT
easat-8115	216	18	.	.	PUNCT
easat-8115	217	1	furthermore	furthermore	ADV
easat-8115	217	2	,	,	PUNCT
easat-8115	217	3	pcp	pcp	NOUN
easat-8115	217	4	-	-	PUNCT
easat-8115	217	5	related	relate	VERB
easat-8115	217	6	mortality	mortality	NOUN
easat-8115	217	7	was	be	AUX
easat-8115	217	8	also	also	ADV
easat-8115	217	9	associated	associate	VERB
easat-8115	217	10	with	with	ADP
easat-8115	217	11	pao2	pao2	PROPN
easat-8115	217	12	/	/	SYM
easat-8115	217	13	fio2	fio2	PROPN
easat-8115	217	14	ratio	ratio	NOUN
easat-8115	217	15	<	<	PROPN
easat-8115	217	16	160	160	NUM
easat-8115	217	17	mmhg	mmhg	NOUN
easat-8115	218	1	[	[	X
easat-8115	218	2	31	31	NUM
easat-8115	218	3	]	]	PUNCT
easat-8115	218	4	.	.	PUNCT
easat-8115	219	1	possible	possible	ADJ
easat-8115	219	2	reason	reason	NOUN
easat-8115	219	3	for	for	ADP
easat-8115	219	4	our	our	PRON
easat-8115	219	5	finding	finding	NOUN
easat-8115	219	6	may	may	AUX
easat-8115	219	7	be	be	AUX
easat-8115	219	8	due	due	ADJ
easat-8115	219	9	to	to	ADP
easat-8115	219	10	the	the	DET
easat-8115	219	11	increase	increase	NOUN
easat-8115	219	12	in	in	ADP
easat-8115	219	13	aado2	aado2	PROPN
easat-8115	219	14	not	not	PART
easat-8115	219	15	only	only	ADV
easat-8115	219	16	happens	happen	VERB
easat-8115	219	17	in	in	ADP
easat-8115	219	18	pcp	pcp	NOUN
easat-8115	219	19	patients	patient	NOUN
easat-8115	219	20	but	but	CCONJ
easat-8115	219	21	also	also	ADV
easat-8115	219	22	in	in	ADP
easat-8115	219	23	other	other	ADJ
easat-8115	219	24	conditions	condition	NOUN
easat-8115	219	25	.	.	PUNCT
easat-8115	220	1	an	an	DET
easat-8115	220	2	increase	increase	NOUN
easat-8115	220	3	in	in	ADP
easat-8115	220	4	the	the	DET
easat-8115	220	5	aado2	aado2	PROPN
easat-8115	220	6	gradient	gradient	NOUN
easat-8115	220	7	can	can	AUX
easat-8115	220	8	be	be	AUX
easat-8115	220	9	caused	cause	VERB
easat-8115	220	10	by	by	ADP
easat-8115	220	11	diseased	diseased	ADJ
easat-8115	220	12	that	that	PRON
easat-8115	220	13	caused	cause	VERB
easat-8115	220	14	increased	increase	VERB
easat-8115	220	15	dead	dead	ADJ
easat-8115	220	16	space	space	NOUN
easat-8115	220	17	ventilation	ventilation	NOUN
easat-8115	220	18	,	,	PUNCT
easat-8115	220	19	left	leave	VERB
easat-8115	220	20	to	to	ADP
easat-8115	220	21	right	right	ADJ
easat-8115	220	22	shunt	shunt	NOUN
easat-8115	220	23	,	,	PUNCT
easat-8115	220	24	and	and	CCONJ
easat-8115	220	25	perfusion	perfusion	NOUN
easat-8115	220	26	without	without	ADP
easat-8115	220	27	alveolar	alveolar	ADJ
easat-8115	220	28	ventilation	ventilation	NOUN
easat-8115	220	29	[	[	X
easat-8115	220	30	32	32	NUM
easat-8115	220	31	]	]	PUNCT
easat-8115	220	32	.	.	PUNCT
easat-8115	221	1	chest	chest	NOUN
easat-8115	221	2	x	x	NOUN
easat-8115	221	3	-	-	NOUN
easat-8115	221	4	ray	ray	NOUN
easat-8115	221	5	of	of	ADP
easat-8115	221	6	pcp	pcp	PROPN
easat-8115	221	7	patients	patient	NOUN
easat-8115	221	8	can	can	AUX
easat-8115	221	9	be	be	AUX
easat-8115	221	10	characterized	characterize	VERB
easat-8115	221	11	as	as	ADP
easat-8115	221	12	diffuse	diffuse	NOUN
easat-8115	221	13	,	,	PUNCT
easat-8115	221	14	bilateral	bilateral	ADJ
easat-8115	221	15	peri	peri	NOUN
easat-8115	221	16	-	-	PUNCT
easat-8115	221	17	hilar	hilar	ADJ
easat-8115	221	18	interstitial	interstitial	ADJ
easat-8115	221	19	infiltrates	infiltrate	NOUN
easat-8115	221	20	and	and	CCONJ
easat-8115	221	21	become	become	VERB
easat-8115	221	22	more	more	ADV
easat-8115	221	23	homogeneous	homogeneous	ADJ
easat-8115	221	24	as	as	ADP
easat-8115	221	25	disease	disease	NOUN
easat-8115	221	26	progression	progression	NOUN
easat-8115	221	27	.	.	PUNCT
easat-8115	222	1	other	other	ADJ
easat-8115	222	2	finding	find	VERB
easat-8115	222	3	such	such	ADJ
easat-8115	222	4	as	as	ADP
easat-8115	222	5	ggo	ggo	PROPN
easat-8115	222	6	with	with	ADP
easat-8115	222	7	perihilar	perihilar	ADJ
easat-8115	222	8	predominance	predominance	NOUN
easat-8115	222	9	,	,	PUNCT
easat-8115	222	10	is	be	AUX
easat-8115	222	11	an	an	DET
easat-8115	222	12	atypical	atypical	ADJ
easat-8115	222	13	image	image	NOUN
easat-8115	222	14	[	[	X
easat-8115	222	15	33	33	NUM
easat-8115	222	16	]	]	PUNCT
easat-8115	222	17	.	.	PUNCT
easat-8115	223	1	this	this	DET
easat-8115	223	2	study	study	NOUN
easat-8115	223	3	found	find	VERB
easat-8115	223	4	a	a	DET
easat-8115	223	5	significant	significant	ADJ
easat-8115	223	6	relationship	relationship	NOUN
easat-8115	223	7	between	between	ADP
easat-8115	223	8	chest	chest	NOUN
easat-8115	223	9	xray	xray	PROPN
easat-8115	223	10	results	result	NOUN
easat-8115	223	11	with	with	ADP
easat-8115	223	12	sputum	sputum	PROPN
easat-8115	223	13	pcr	pcr	PROPN
easat-8115	223	14	positivity	positivity	NOUN
easat-8115	223	15	in	in	ADP
easat-8115	223	16	hiv	hiv	PROPN
easat-8115	223	17	subjects	subject	NOUN
easat-8115	223	18	with	with	ADP
easat-8115	223	19	suspicion	suspicion	NOUN
easat-8115	223	20	of	of	ADP
easat-8115	223	21	pcp	pcp	PROPN
easat-8115	223	22	(	(	PUNCT
easat-8115	223	23	p=	p=	NOUN
easat-8115	223	24	0.003	0.003	NUM
easat-8115	223	25	)	)	PUNCT
easat-8115	223	26	.	.	PUNCT
easat-8115	224	1	subjects	subject	NOUN
easat-8115	224	2	with	with	ADP
easat-8115	224	3	typical	typical	ADJ
easat-8115	224	4	radiological	radiological	ADJ
easat-8115	224	5	results	result	NOUN
easat-8115	224	6	were	be	AUX
easat-8115	224	7	at	at	ADP
easat-8115	224	8	risk	risk	NOUN
easat-8115	224	9	of	of	ADP
easat-8115	224	10	having	have	VERB
easat-8115	224	11	positive	positive	ADJ
easat-8115	224	12	sputum	sputum	NOUN
easat-8115	224	13	pcr	pcr	NOUN
easat-8115	224	14	results	result	VERB
easat-8115	224	15	19.7	19.7	NUM
easat-8115	224	16	times	time	NOUN
easat-8115	224	17	greater	great	ADJ
easat-8115	224	18	than	than	ADP
easat-8115	224	19	those	those	PRON
easat-8115	224	20	with	with	ADP
easat-8115	224	21	normal	normal	ADJ
easat-8115	224	22	radiology	radiology	NOUN
easat-8115	224	23	,	,	PUNCT
easat-8115	224	24	while	while	SCONJ
easat-8115	224	25	subjects	subject	NOUN
easat-8115	224	26	with	with	ADP
easat-8115	224	27	atypical	atypical	ADJ
easat-8115	224	28	radiological	radiological	ADJ
easat-8115	224	29	results	result	NOUN
easat-8115	224	30	were	be	AUX
easat-8115	224	31	at	at	ADP
easat-8115	224	32	risk	risk	NOUN
easat-8115	224	33	of	of	ADP
easat-8115	224	34	having	have	VERB
easat-8115	224	35	positive	positive	ADJ
easat-8115	224	36	sputum	sputum	NOUN
easat-8115	224	37	pcr	pcr	NOUN
easat-8115	224	38	results	result	VERB
easat-8115	224	39	4.87	4.87	NUM
easat-8115	224	40	times	time	NOUN
easat-8115	224	41	greater	great	ADJ
easat-8115	224	42	than	than	ADP
easat-8115	224	43	those	those	PRON
easat-8115	224	44	with	with	ADP
easat-8115	224	45	normal	normal	ADJ
easat-8115	224	46	radiology	radiology	NOUN
easat-8115	224	47	.	.	PUNCT
easat-8115	225	1	these	these	DET
easat-8115	225	2	results	result	NOUN
easat-8115	225	3	are	be	AUX
easat-8115	225	4	supported	support	VERB
easat-8115	225	5	by	by	ADP
easat-8115	225	6	various	various	ADJ
easat-8115	225	7	studies	study	NOUN
easat-8115	225	8	that	that	PRON
easat-8115	225	9	found	find	VERB
easat-8115	225	10	atypical	atypical	ADJ
easat-8115	225	11	images	image	NOUN
easat-8115	225	12	on	on	ADP
easat-8115	225	13	chest	chest	NOUN
easat-8115	225	14	x	x	NOUN
easat-8115	225	15	-	-	NOUN
easat-8115	225	16	rays	ray	NOUN
easat-8115	225	17	of	of	ADP
easat-8115	225	18	hiv	hiv	PROPN
easat-8115	225	19	patients	patient	NOUN
easat-8115	225	20	with	with	ADP
easat-8115	225	21	pcp	pcp	PROPN
easat-8115	226	1	[	[	X
easat-8115	226	2	8	8	NUM
easat-8115	226	3	,	,	PUNCT
easat-8115	226	4	34	34	NUM
easat-8115	226	5	]	]	PUNCT
easat-8115	226	6	.	.	PUNCT
easat-8115	227	1	to	to	ADP
easat-8115	227	2	the	the	DET
easat-8115	227	3	best	good	ADJ
easat-8115	227	4	of	of	ADP
easat-8115	227	5	our	our	PRON
easat-8115	227	6	knowledge	knowledge	NOUN
easat-8115	227	7	,	,	PUNCT
easat-8115	227	8	this	this	DET
easat-8115	227	9	study	study	NOUN
easat-8115	227	10	,	,	PUNCT
easat-8115	227	11	it	it	PRON
easat-8115	227	12	is	be	AUX
easat-8115	227	13	the	the	DET
easat-8115	227	14	first	first	ADJ
easat-8115	227	15	study	study	NOUN
easat-8115	227	16	in	in	ADP
easat-8115	227	17	indonesia	indonesia	PROPN
easat-8115	227	18	that	that	PRON
easat-8115	227	19	evaluates	evaluate	VERB
easat-8115	227	20	the	the	DET
easat-8115	227	21	relationship	relationship	NOUN
easat-8115	227	22	between	between	ADP
easat-8115	227	23	clinical	clinical	ADJ
easat-8115	227	24	,	,	PUNCT
easat-8115	227	25	laboratory	laboratory	NOUN
easat-8115	227	26	and	and	CCONJ
easat-8115	227	27	radiological	radiological	ADJ
easat-8115	227	28	symptoms	symptom	NOUN
easat-8115	227	29	with	with	ADP
easat-8115	227	30	pcp	pcp	PROPN
easat-8115	227	31	sputum	sputum	PROPN
easat-8115	227	32	pcr	pcr	PROPN
easat-8115	227	33	positivity	positivity	NOUN
easat-8115	227	34	in	in	ADP
easat-8115	227	35	hiv	hiv	PROPN
easat-8115	227	36	patients	patient	NOUN
easat-8115	227	37	with	with	ADP
easat-8115	227	38	suspicion	suspicion	NOUN
easat-8115	227	39	of	of	ADP
easat-8115	227	40	pcp	pcp	PROPN
easat-8115	227	41	.	.	PUNCT
easat-8115	228	1	4.1	4.1	NUM
easat-8115	228	2	.	.	PUNCT
easat-8115	228	3	limitations	limitation	NOUN
easat-8115	228	4	this	this	DET
easat-8115	228	5	study	study	NOUN
easat-8115	228	6	has	have	VERB
easat-8115	228	7	several	several	ADJ
easat-8115	228	8	limitations	limitation	NOUN
easat-8115	228	9	.	.	PUNCT
easat-8115	229	1	first	first	ADV
easat-8115	229	2	,	,	PUNCT
easat-8115	229	3	majority	majority	NOUN
easat-8115	229	4	of	of	ADP
easat-8115	229	5	the	the	DET
easat-8115	229	6	subjects	subject	NOUN
easat-8115	229	7	were	be	AUX
easat-8115	229	8	newly	newly	ADV
easat-8115	229	9	diagnosed	diagnose	VERB
easat-8115	229	10	as	as	ADP
easat-8115	229	11	hiv	hiv	PROPN
easat-8115	229	12	;	;	PUNCT
easat-8115	229	13	second	second	ADJ
easat-8115	229	14	,	,	PUNCT
easat-8115	229	15	laboratory	laboratory	NOUN
easat-8115	229	16	parameters	parameter	NOUN
easat-8115	229	17	,	,	PUNCT
easat-8115	229	18	which	which	PRON
easat-8115	229	19	is	be	AUX
easat-8115	229	20	significant	significant	ADJ
easat-8115	229	21	for	for	ADP
easat-8115	229	22	pcp	pcp	PROPN
easat-8115	229	23	such	such	ADJ
easat-8115	229	24	as	as	ADP
easat-8115	229	25	ldh	ldh	PROPN
easat-8115	229	26	,	,	PUNCT
easat-8115	229	27	not	not	PART
easat-8115	229	28	included	include	VERB
easat-8115	229	29	in	in	ADP
easat-8115	229	30	this	this	DET
easat-8115	229	31	study	study	NOUN
easat-8115	229	32	;	;	PUNCT
easat-8115	229	33	and	and	CCONJ
easat-8115	229	34	lastly	lastly	ADV
easat-8115	229	35	,	,	PUNCT
easat-8115	229	36	this	this	DET
easat-8115	229	37	study	study	NOUN
easat-8115	229	38	did	do	AUX
easat-8115	229	39	not	not	PART
easat-8115	229	40	take	take	VERB
easat-8115	229	41	into	into	ADP
easat-8115	229	42	account	account	NOUN
easat-8115	229	43	the	the	DET
easat-8115	229	44	onset	onset	NOUN
easat-8115	229	45	of	of	ADP
easat-8115	229	46	symptoms	symptom	NOUN
easat-8115	229	47	the	the	DET
easat-8115	229	48	subject	subject	NOUN
easat-8115	229	49	had	have	AUX
easat-8115	229	50	experienced	experience	VERB
easat-8115	229	51	until	until	ADP
easat-8115	229	52	seeking	seek	VERB
easat-8115	229	53	medical	medical	ADJ
easat-8115	229	54	attention	attention	NOUN
easat-8115	229	55	.	.	PUNCT
easat-8115	230	1	5	5	X
easat-8115	230	2	.	.	X
easat-8115	230	3	conclusion	conclusion	NOUN
easat-8115	230	4	in	in	ADP
easat-8115	230	5	this	this	DET
easat-8115	230	6	study	study	NOUN
easat-8115	230	7	,	,	PUNCT
easat-8115	230	8	clinical	clinical	ADJ
easat-8115	230	9	parameters	parameter	NOUN
easat-8115	230	10	(	(	PUNCT
easat-8115	230	11	low	low	ADJ
easat-8115	230	12	grade	grade	NOUN
easat-8115	230	13	fever	fever	NOUN
easat-8115	230	14	,	,	PUNCT
easat-8115	230	15	non	non	ADJ
easat-8115	230	16	-	-	ADJ
easat-8115	230	17	productive	productive	ADJ
easat-8115	230	18	cough	cough	NOUN
easat-8115	230	19	,	,	PUNCT
easat-8115	230	20	and	and	CCONJ
easat-8115	230	21	oral	oral	ADJ
easat-8115	230	22	candidiasis	candidiasis	NOUN
easat-8115	230	23	)	)	PUNCT
easat-8115	230	24	,	,	PUNCT
easat-8115	230	25	laboratory	laboratory	NOUN
easat-8115	230	26	parameters	parameter	NOUN
easat-8115	230	27	(	(	PUNCT
easat-8115	230	28	lymphocytes	lymphocytes	PROPN
easat-8115	230	29	≤1.2x103	≤1.2x103	PROPN
easat-8115	230	30	µ/l	µ/l	PROPN
easat-8115	230	31	,	,	PUNCT
easat-8115	230	32	albumin	albumin	NOUN
easat-8115	230	33	≤3.1	≤3.1	PROPN
easat-8115	230	34	g	g	PROPN
easat-8115	230	35	/	/	SYM
easat-8115	230	36	dl	dl	PROPN
easat-8115	230	37	,	,	PUNCT
easat-8115	230	38	cd4	cd4	PROPN
easat-8115	230	39	≤200	≤200	PROPN
easat-8115	230	40	cell/µl	cell/µl	PROPN
easat-8115	230	41	)	)	PUNCT
easat-8115	230	42	,	,	PUNCT
easat-8115	230	43	and	and	CCONJ
easat-8115	230	44	radiological	radiological	ADJ
easat-8115	230	45	parameters	parameter	NOUN
easat-8115	230	46	(	(	PUNCT
easat-8115	230	47	typical	typical	ADJ
easat-8115	230	48	and	and	CCONJ
easat-8115	230	49	atypical	atypical	ADJ
easat-8115	230	50	chest	chest	NOUN
easat-8115	230	51	x	x	NOUN
easat-8115	230	52	-	-	NOUN
easat-8115	230	53	ray	ray	NOUN
easat-8115	230	54	images	image	NOUN
easat-8115	230	55	)	)	PUNCT
easat-8115	230	56	are	be	AUX
easat-8115	230	57	related	relate	VERB
easat-8115	230	58	to	to	ADP
easat-8115	230	59	sputum	sputum	PROPN
easat-8115	230	60	pcr	pcr	PROPN
easat-8115	230	61	positivity	positivity	NOUN
easat-8115	230	62	in	in	ADP
easat-8115	230	63	hiv	hiv	PROPN
easat-8115	230	64	patients	patient	NOUN
easat-8115	230	65	with	with	ADP
easat-8115	230	66	suspicion	suspicion	NOUN
easat-8115	230	67	of	of	ADP
easat-8115	230	68	pcp	pcp	PROPN
easat-8115	230	69	.	.	PUNCT
easat-8115	231	1	this	this	DET
easat-8115	231	2	finding	finding	NOUN
easat-8115	231	3	could	could	AUX
easat-8115	231	4	be	be	AUX
easat-8115	231	5	used	use	VERB
easat-8115	231	6	for	for	ADP
easat-8115	231	7	physician	physician	NOUN
easat-8115	231	8	for	for	ADP
easat-8115	231	9	establishing	establish	VERB
easat-8115	231	10	a	a	DET
easat-8115	231	11	more	more	ADV
easat-8115	231	12	systematic	systematic	ADJ
easat-8115	231	13	pcp	pcp	NOUN
easat-8115	231	14	diagnosis	diagnosis	NOUN
easat-8115	231	15	in	in	ADP
easat-8115	231	16	hiv	hiv	PROPN
easat-8115	231	17	patient	patient	NOUN
easat-8115	231	18	with	with	ADP
easat-8115	231	19	suspicion	suspicion	NOUN
easat-8115	231	20	of	of	ADP
easat-8115	231	21	pcp	pcp	PROPN
easat-8115	231	22	.	.	PUNCT
easat-8115	232	1	1339	1339	NUM
easat-8115	232	2	edelweiss	edelweiss	PROPN
easat-8115	232	3	applied	apply	VERB
easat-8115	232	4	science	science	NOUN
easat-8115	232	5	and	and	CCONJ
easat-8115	232	6	technology	technology	NOUN
easat-8115	232	7	issn	issn	PROPN
easat-8115	232	8	:	:	PUNCT
easat-8115	232	9	2576	2576	NUM
easat-8115	232	10	-	-	SYM
easat-8115	232	11	8484	8484	NUM
easat-8115	232	12	vol	vol	NOUN
easat-8115	232	13	.	.	PROPN
easat-8115	233	1	9	9	NUM
easat-8115	233	2	,	,	PUNCT
easat-8115	233	3	no	no	INTJ
easat-8115	233	4	.	.	NOUN
easat-8115	234	1	6	6	NUM
easat-8115	234	2	:	:	SYM
easat-8115	234	3	1331	1331	NUM
easat-8115	234	4	-	-	SYM
easat-8115	234	5	1341	1341	NUM
easat-8115	234	6	,	,	PUNCT
easat-8115	234	7	2025	2025	NUM
easat-8115	234	8	doi	doi	NOUN
easat-8115	234	9	:	:	PUNCT
easat-8115	234	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	234	11	©	©	PROPN
easat-8115	234	12	2025	2025	NUM
easat-8115	234	13	by	by	ADP
easat-8115	234	14	the	the	DET
easat-8115	234	15	authors	author	NOUN
easat-8115	234	16	;	;	PUNCT
easat-8115	234	17	licensee	licensee	PROPN
easat-8115	234	18	learning	learn	VERB
easat-8115	234	19	gate	gate	NOUN
easat-8115	234	20	transparency	transparency	NOUN
easat-8115	234	21	:	:	PUNCT
easat-8115	234	22	the	the	DET
easat-8115	234	23	authors	author	NOUN
easat-8115	234	24	confirm	confirm	VERB
easat-8115	234	25	that	that	SCONJ
easat-8115	234	26	the	the	DET
easat-8115	234	27	manuscript	manuscript	NOUN
easat-8115	234	28	is	be	AUX
easat-8115	234	29	an	an	DET
easat-8115	234	30	honest	honest	ADJ
easat-8115	234	31	,	,	PUNCT
easat-8115	234	32	accurate	accurate	ADJ
easat-8115	234	33	,	,	PUNCT
easat-8115	234	34	and	and	CCONJ
easat-8115	234	35	transparent	transparent	ADJ
easat-8115	234	36	account	account	NOUN
easat-8115	234	37	of	of	ADP
easat-8115	234	38	the	the	DET
easat-8115	234	39	study	study	NOUN
easat-8115	234	40	;	;	PUNCT
easat-8115	234	41	that	that	SCONJ
easat-8115	234	42	no	no	DET
easat-8115	234	43	vital	vital	ADJ
easat-8115	234	44	features	feature	NOUN
easat-8115	234	45	of	of	ADP
easat-8115	234	46	the	the	DET
easat-8115	234	47	study	study	NOUN
easat-8115	234	48	have	have	AUX
easat-8115	234	49	been	be	AUX
easat-8115	234	50	omitted	omit	VERB
easat-8115	234	51	;	;	PUNCT
easat-8115	234	52	and	and	CCONJ
easat-8115	234	53	that	that	SCONJ
easat-8115	234	54	any	any	DET
easat-8115	234	55	discrepancies	discrepancy	NOUN
easat-8115	234	56	from	from	ADP
easat-8115	234	57	the	the	DET
easat-8115	234	58	study	study	NOUN
easat-8115	234	59	as	as	SCONJ
easat-8115	234	60	planned	plan	VERB
easat-8115	234	61	have	have	AUX
easat-8115	234	62	been	be	AUX
easat-8115	234	63	explained	explain	VERB
easat-8115	234	64	.	.	PUNCT
easat-8115	235	1	this	this	DET
easat-8115	235	2	study	study	NOUN
easat-8115	235	3	followed	follow	VERB
easat-8115	235	4	all	all	DET
easat-8115	235	5	ethical	ethical	ADJ
easat-8115	235	6	practices	practice	NOUN
easat-8115	235	7	during	during	ADP
easat-8115	235	8	writing	writing	NOUN
easat-8115	235	9	.	.	PUNCT
easat-8115	236	1	copyright	copyright	NOUN
easat-8115	236	2	:	:	PUNCT
easat-8115	236	3	©	©	PROPN
easat-8115	236	4	2025	2025	NUM
easat-8115	236	5	by	by	ADP
easat-8115	236	6	the	the	DET
easat-8115	236	7	authors	author	NOUN
easat-8115	236	8	.	.	PUNCT
easat-8115	237	1	this	this	DET
easat-8115	237	2	open	open	ADJ
easat-8115	237	3	-	-	PUNCT
easat-8115	237	4	access	access	NOUN
easat-8115	237	5	article	article	NOUN
easat-8115	237	6	is	be	AUX
easat-8115	237	7	distributed	distribute	VERB
easat-8115	237	8	under	under	ADP
easat-8115	237	9	the	the	DET
easat-8115	237	10	terms	term	NOUN
easat-8115	237	11	and	and	CCONJ
easat-8115	237	12	conditions	condition	NOUN
easat-8115	237	13	of	of	ADP
easat-8115	237	14	the	the	DET
easat-8115	237	15	creative	creative	ADJ
easat-8115	237	16	commons	common	NOUN
easat-8115	237	17	attribution	attribution	NOUN
easat-8115	237	18	(	(	PUNCT
easat-8115	237	19	cc	cc	NOUN
easat-8115	237	20	by	by	ADP
easat-8115	237	21	)	)	PUNCT
easat-8115	237	22	license	license	NOUN
easat-8115	237	23	(	(	PUNCT
easat-8115	237	24	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-8115	237	25	)	)	PUNCT
easat-8115	237	26	.	.	PUNCT
easat-8115	238	1	references	reference	NOUN
easat-8115	238	2	[	[	X
easat-8115	238	3	1	1	NUM
easat-8115	238	4	]	]	PUNCT
easat-8115	238	5	k.	k.	PROPN
easat-8115	238	6	elango	elango	PROPN
easat-8115	238	7	,	,	PUNCT
easat-8115	238	8	"	"	PUNCT
easat-8115	238	9	trends	trend	NOUN
easat-8115	238	10	in	in	ADP
easat-8115	238	11	the	the	DET
easat-8115	238	12	epidemiology	epidemiology	NOUN
easat-8115	238	13	and	and	CCONJ
easat-8115	238	14	outcomes	outcome	NOUN
easat-8115	238	15	of	of	ADP
easat-8115	238	16	pneumocystis	pneumocystis	ADJ
easat-8115	238	17	pneumonia	pneumonia	NOUN
easat-8115	238	18	among	among	ADP
easat-8115	238	19	human	human	ADJ
easat-8115	238	20	immunodeficiency	immunodeficiency	NOUN
easat-8115	238	21	virus	virus	NOUN
easat-8115	238	22	(	(	PUNCT
easat-8115	238	23	hiv	hiv	PROPN
easat-8115	238	24	)	)	PUNCT
easat-8115	238	25	hospitalizations	hospitalization	NOUN
easat-8115	238	26	,	,	PUNCT
easat-8115	238	27	"	"	PUNCT
easat-8115	238	28	international	international	ADJ
easat-8115	238	29	journal	journal	NOUN
easat-8115	238	30	of	of	ADP
easat-8115	238	31	environmental	environmental	ADJ
easat-8115	238	32	research	research	NOUN
easat-8115	238	33	and	and	CCONJ
easat-8115	238	34	public	public	ADJ
easat-8115	238	35	health	health	NOUN
easat-8115	238	36	,	,	PUNCT
easat-8115	238	37	vol	vol	NOUN
easat-8115	238	38	.	.	PROPN
easat-8115	238	39	19	19	NUM
easat-8115	238	40	,	,	PUNCT
easat-8115	238	41	no	no	INTJ
easat-8115	238	42	.	.	NOUN
easat-8115	238	43	5	5	NUM
easat-8115	238	44	,	,	PUNCT
easat-8115	238	45	p.	p.	NOUN
easat-8115	238	46	2768	2768	NUM
easat-8115	238	47	,	,	PUNCT
easat-8115	238	48	2022	2022	NUM
easat-8115	238	49	.	.	PUNCT
easat-8115	239	1	https://doi.org/10.3390/ijerph19052768	https://doi.org/10.3390/ijerph19052768	PROPN
easat-8115	240	1	[	[	X
easat-8115	240	2	2	2	NUM
easat-8115	240	3	]	]	X
easat-8115	240	4	g.	g.	PROPN
easat-8115	240	5	tang	tang	PROPN
easat-8115	240	6	,	,	PUNCT
easat-8115	240	7	"	"	PUNCT
easat-8115	240	8	using	use	VERB
easat-8115	240	9	routine	routine	ADJ
easat-8115	240	10	laboratory	laboratory	NOUN
easat-8115	240	11	markers	marker	NOUN
easat-8115	240	12	and	and	CCONJ
easat-8115	240	13	immunological	immunological	ADJ
easat-8115	240	14	indicators	indicator	NOUN
easat-8115	240	15	for	for	ADP
easat-8115	240	16	predicting	predict	VERB
easat-8115	240	17	pneumocystis	pneumocystis	PROPN
easat-8115	240	18	jiroveci	jiroveci	PROPN
easat-8115	240	19	pneumonia	pneumonia	NOUN
easat-8115	240	20	in	in	ADP
easat-8115	240	21	immunocompromised	immunocompromise	VERB
easat-8115	240	22	patients	patient	NOUN
easat-8115	240	23	,	,	PUNCT
easat-8115	240	24	"	"	PUNCT
easat-8115	240	25	frontiers	frontier	NOUN
easat-8115	240	26	in	in	ADP
easat-8115	240	27	immunology	immunology	NOUN
easat-8115	240	28	,	,	PUNCT
easat-8115	240	29	vol	vol	NOUN
easat-8115	240	30	.	.	PROPN
easat-8115	240	31	12	12	NUM
easat-8115	240	32	,	,	PUNCT
easat-8115	240	33	p.	p.	NOUN
easat-8115	240	34	652383	652383	NUM
easat-8115	240	35	,	,	PUNCT
easat-8115	240	36	2021	2021	NUM
easat-8115	240	37	.	.	PUNCT
easat-8115	241	1	https://doi.org/10.3389/fimmu.2021.652383	https://doi.org/10.3389/fimmu.2021.652383	PROPN
easat-8115	242	1	[	[	X
easat-8115	242	2	3	3	X
easat-8115	242	3	]	]	PUNCT
easat-8115	242	4	w.	w.	PROPN
easat-8115	242	5	e.	e.	PROPN
easat-8115	242	6	f.	f.	PROPN
easat-8115	242	7	yustin	yustin	PROPN
easat-8115	242	8	,	,	PUNCT
easat-8115	242	9	i.	i.	PROPN
easat-8115	242	10	k.	k.	PROPN
easat-8115	242	11	a.	a.	PROPN
easat-8115	242	12	somia	somia	PROPN
easat-8115	242	13	,	,	PUNCT
easat-8115	242	14	n.	n.	PROPN
easat-8115	242	15	l.	l.	PROPN
easat-8115	242	16	p.	p.	PROPN
easat-8115	242	17	e.	e.	PROPN
easat-8115	242	18	arisanti	arisanti	PROPN
easat-8115	242	19	,	,	PUNCT
easat-8115	242	20	and	and	CCONJ
easat-8115	242	21	i.	i.	PROPN
easat-8115	242	22	g.	g.	PROPN
easat-8115	242	23	n.	n.	PROPN
easat-8115	242	24	b.	b.	PROPN
easat-8115	242	25	n.	n.	PROPN
easat-8115	242	26	artana	artana	PROPN
easat-8115	242	27	,	,	PUNCT
easat-8115	242	28	"	"	PUNCT
easat-8115	242	29	association	association	NOUN
easat-8115	242	30	between	between	ADP
easat-8115	242	31	clinical	clinical	ADJ
easat-8115	242	32	parameters	parameter	NOUN
easat-8115	242	33	,	,	PUNCT
easat-8115	242	34	laboratory	laboratory	NOUN
easat-8115	242	35	and	and	CCONJ
easat-8115	242	36	radiology	radiology	NOUN
easat-8115	242	37	along	along	ADP
easat-8115	242	38	with	with	ADP
easat-8115	242	39	validation	validation	NOUN
easat-8115	242	40	of	of	ADP
easat-8115	242	41	scoring	scoring	NOUN
easat-8115	242	42	system	system	NOUN
easat-8115	242	43	with	with	ADP
easat-8115	242	44	lung	lung	NOUN
easat-8115	242	45	tuberculosis	tuberculosis	NOUN
easat-8115	242	46	status	status	NOUN
easat-8115	242	47	in	in	ADP
easat-8115	242	48	adult	adult	NOUN
easat-8115	242	49	hiv	hiv	PROPN
easat-8115	242	50	patients	patient	NOUN
easat-8115	242	51	,	,	PUNCT
easat-8115	242	52	"	"	PUNCT
easat-8115	242	53	bali	bali	PROPN
easat-8115	242	54	medical	medical	PROPN
easat-8115	242	55	journal	journal	PROPN
easat-8115	242	56	,	,	PUNCT
easat-8115	242	57	vol	vol	NOUN
easat-8115	242	58	.	.	PROPN
easat-8115	242	59	10	10	NUM
easat-8115	242	60	,	,	PUNCT
easat-8115	242	61	no	no	INTJ
easat-8115	242	62	.	.	NOUN
easat-8115	242	63	3	3	NUM
easat-8115	242	64	,	,	PUNCT
easat-8115	242	65	pp	pp	ADJ
easat-8115	242	66	.	.	PUNCT
easat-8115	243	1	1085–1092	1085–1092	NUM
easat-8115	243	2	,	,	PUNCT
easat-8115	243	3	2021	2021	NUM
easat-8115	243	4	.	.	PUNCT
easat-8115	244	1	https://doi.org/10.15562/bmj.v10i3.2787	https://doi.org/10.15562/bmj.v10i3.2787	PROPN
easat-8115	244	2	[	[	X
easat-8115	244	3	4	4	X
easat-8115	244	4	]	]	PUNCT
easat-8115	244	5	t.	t.	PROPN
easat-8115	244	6	xue	xue	PROPN
easat-8115	244	7	,	,	PUNCT
easat-8115	244	8	x.	x.	PROPN
easat-8115	244	9	kong	kong	PROPN
easat-8115	244	10	,	,	PUNCT
easat-8115	244	11	and	and	CCONJ
easat-8115	244	12	l.	l.	PROPN
easat-8115	244	13	ma	ma	PROPN
easat-8115	244	14	,	,	PUNCT
easat-8115	244	15	"	"	PUNCT
easat-8115	244	16	trends	trend	NOUN
easat-8115	244	17	in	in	ADP
easat-8115	244	18	the	the	DET
easat-8115	244	19	epidemiology	epidemiology	NOUN
easat-8115	244	20	of	of	ADP
easat-8115	244	21	pneumocystis	pneumocystis	ADJ
easat-8115	244	22	pneumonia	pneumonia	NOUN
easat-8115	244	23	in	in	ADP
easat-8115	244	24	immunocompromised	immunocompromise	VERB
easat-8115	244	25	patients	patient	NOUN
easat-8115	244	26	without	without	ADP
easat-8115	244	27	hiv	hiv	PROPN
easat-8115	244	28	infection	infection	NOUN
easat-8115	244	29	,	,	PUNCT
easat-8115	244	30	"	"	PUNCT
easat-8115	244	31	journal	journal	NOUN
easat-8115	244	32	of	of	ADP
easat-8115	244	33	fungi	fungi	PROPN
easat-8115	244	34	,	,	PUNCT
easat-8115	244	35	vol	vol	NOUN
easat-8115	244	36	.	.	PROPN
easat-8115	244	37	9	9	NUM
easat-8115	244	38	,	,	PUNCT
easat-8115	244	39	no	no	INTJ
easat-8115	244	40	.	.	NOUN
easat-8115	244	41	8	8	NUM
easat-8115	244	42	,	,	PUNCT
easat-8115	244	43	p.	p.	NOUN
easat-8115	244	44	812	812	NUM
easat-8115	244	45	,	,	PUNCT
easat-8115	244	46	2023	2023	NUM
easat-8115	244	47	.	.	PUNCT
easat-8115	245	1	https://doi.org/10.3390/jof9080812	https://doi.org/10.3390/jof9080812	ADJ
easat-8115	245	2	[	[	PUNCT
easat-8115	245	3	5	5	NUM
easat-8115	245	4	]	]	PUNCT
easat-8115	245	5	i.	i.	PROPN
easat-8115	245	6	d.	d.	PROPN
easat-8115	245	7	p.	p.	PROPN
easat-8115	245	8	a.	a.	PROPN
easat-8115	245	9	krisdanti	krisdanti	PROPN
easat-8115	245	10	,	,	PUNCT
easat-8115	245	11	"	"	PUNCT
easat-8115	245	12	pneumocystis	pneumocystis	ADJ
easat-8115	245	13	pneumonia	pneumonia	NOUN
easat-8115	245	14	(	(	PUNCT
easat-8115	245	15	pcp	pcp	PROPN
easat-8115	245	16	)	)	PUNCT
easat-8115	245	17	and	and	CCONJ
easat-8115	245	18	covid‑19	covid‑19	VERB
easat-8115	245	19	coinfection	coinfection	NOUN
easat-8115	245	20	in	in	ADP
easat-8115	245	21	patients	patient	NOUN
easat-8115	245	22	with	with	ADP
easat-8115	245	23	human	human	ADJ
easat-8115	245	24	immunodeficiency	immunodeficiency	NOUN
easat-8115	245	25	virus	virus	NOUN
easat-8115	245	26	(	(	PUNCT
easat-8115	245	27	hiv	hiv	NOUN
easat-8115	245	28	)	)	PUNCT
easat-8115	245	29	infection	infection	NOUN
easat-8115	245	30	:	:	PUNCT
easat-8115	245	31	a	a	DET
easat-8115	245	32	literature	literature	NOUN
easat-8115	245	33	review	review	NOUN
easat-8115	245	34	,	,	PUNCT
easat-8115	245	35	"	"	PUNCT
easat-8115	245	36	intisari	intisari	PROPN
easat-8115	245	37	sains	sain	NOUN
easat-8115	245	38	medis	medis	PROPN
easat-8115	245	39	,	,	PUNCT
easat-8115	245	40	vol	vol	NOUN
easat-8115	245	41	.	.	PROPN
easat-8115	246	1	16	16	NUM
easat-8115	246	2	,	,	PUNCT
easat-8115	246	3	no	no	INTJ
easat-8115	246	4	.	.	NOUN
easat-8115	246	5	1	1	NUM
easat-8115	246	6	,	,	PUNCT
easat-8115	246	7	pp	pp	ADJ
easat-8115	246	8	.	.	PUNCT
easat-8115	247	1	243–254	243–254	NUM
easat-8115	247	2	,	,	PUNCT
easat-8115	247	3	2025	2025	NUM
easat-8115	247	4	.	.	PUNCT
easat-8115	248	1	[	[	X
easat-8115	248	2	6	6	NUM
easat-8115	248	3	]	]	PUNCT
easat-8115	248	4	e.	e.	PROPN
easat-8115	248	5	g.	g.	PROPN
easat-8115	248	6	mcdonald	mcdonald	PROPN
easat-8115	248	7	,	,	PUNCT
easat-8115	248	8	a.	a.	PROPN
easat-8115	248	9	afshar	afshar	PROPN
easat-8115	248	10	,	,	PUNCT
easat-8115	248	11	b.	b.	PROPN
easat-8115	248	12	assiri	assiri	PROPN
easat-8115	248	13	,	,	PUNCT
easat-8115	248	14	t.	t.	PROPN
easat-8115	248	15	boyles	boyles	PROPN
easat-8115	248	16	,	,	PUNCT
easat-8115	248	17	j.	j.	PROPN
easat-8115	248	18	m.	m.	PROPN
easat-8115	248	19	hsu	hsu	PROPN
easat-8115	248	20	,	,	PUNCT
easat-8115	248	21	and	and	CCONJ
easat-8115	248	22	n.	n.	PROPN
easat-8115	248	23	khuong	khuong	PROPN
easat-8115	248	24	,	,	PUNCT
easat-8115	248	25	"	"	PUNCT
easat-8115	248	26	pneumocystis	pneumocystis	ADJ
easat-8115	248	27	jirovecii	jirovecii	ADJ
easat-8115	248	28	pneumonia	pneumonia	NOUN
easat-8115	248	29	in	in	ADP
easat-8115	248	30	people	people	NOUN
easat-8115	248	31	living	live	VERB
easat-8115	248	32	with	with	ADP
easat-8115	248	33	hiv	hiv	PROPN
easat-8115	248	34	:	:	PUNCT
easat-8115	248	35	a	a	DET
easat-8115	248	36	review	review	NOUN
easat-8115	248	37	,	,	PUNCT
easat-8115	248	38	"	"	PUNCT
easat-8115	248	39	clinical	clinical	ADJ
easat-8115	248	40	microbiology	microbiology	NOUN
easat-8115	248	41	reviews	review	NOUN
easat-8115	248	42	,	,	PUNCT
easat-8115	248	43	vol	vol	NOUN
easat-8115	248	44	.	.	PROPN
easat-8115	248	45	37	37	NUM
easat-8115	248	46	,	,	PUNCT
easat-8115	248	47	no	no	INTJ
easat-8115	248	48	.	.	NOUN
easat-8115	248	49	1	1	NUM
easat-8115	248	50	,	,	PUNCT
easat-8115	248	51	p.	p.	NOUN
easat-8115	248	52	e0010122	e0010122	PROPN
easat-8115	248	53	,	,	PUNCT
easat-8115	248	54	2024	2024	NUM
easat-8115	248	55	.	.	PUNCT
easat-8115	249	1	[	[	X
easat-8115	249	2	7	7	X
easat-8115	249	3	]	]	PUNCT
easat-8115	249	4	a.	a.	NOUN
easat-8115	249	5	rozaliyani	rozaliyani	PROPN
easat-8115	249	6	et	et	PROPN
easat-8115	249	7	al	al	PROPN
easat-8115	249	8	.	.	PROPN
easat-8115	249	9	,	,	PUNCT
easat-8115	249	10	"	"	PUNCT
easat-8115	249	11	laboratory	laboratory	NOUN
easat-8115	249	12	findings	finding	NOUN
easat-8115	249	13	and	and	CCONJ
easat-8115	249	14	clinical	clinical	ADJ
easat-8115	249	15	characteristics	characteristic	NOUN
easat-8115	249	16	of	of	ADP
easat-8115	249	17	pneumocystis	pneumocystis	ADJ
easat-8115	249	18	pneumonia	pneumonia	NOUN
easat-8115	249	19	and	and	CCONJ
easat-8115	249	20	tuberculosis	tuberculosis	PRON
easat-8115	249	21	infection	infection	NOUN
easat-8115	249	22	among	among	ADP
easat-8115	249	23	hiv	hiv	PROPN
easat-8115	249	24	-	-	PUNCT
easat-8115	249	25	infected	infect	VERB
easat-8115	249	26	patients	patient	NOUN
easat-8115	249	27	with	with	ADP
easat-8115	249	28	pulmonary	pulmonary	ADJ
easat-8115	249	29	infiltrates	infiltrate	NOUN
easat-8115	249	30	in	in	ADP
easat-8115	249	31	jakarta	jakarta	PROPN
easat-8115	249	32	,	,	PUNCT
easat-8115	249	33	indonesia	indonesia	PROPN
easat-8115	249	34	,	,	PUNCT
easat-8115	249	35	"	"	PUNCT
easat-8115	249	36	tropical	tropical	ADJ
easat-8115	249	37	biomedicine	biomedicine	NOUN
easat-8115	249	38	,	,	PUNCT
easat-8115	249	39	vol	vol	NOUN
easat-8115	249	40	.	.	PROPN
easat-8115	250	1	37	37	NUM
easat-8115	250	2	,	,	PUNCT
easat-8115	250	3	no	no	INTJ
easat-8115	250	4	.	.	NOUN
easat-8115	250	5	4	4	NUM
easat-8115	250	6	,	,	PUNCT
easat-8115	250	7	pp	pp	ADJ
easat-8115	250	8	.	.	PUNCT
easat-8115	251	1	117–1123	117–1123	NUM
easat-8115	251	2	,	,	PUNCT
easat-8115	251	3	2020	2020	NUM
easat-8115	251	4	.	.	PUNCT
easat-8115	252	1	https://doi.org/10.47665/tb.37.4.1117	https://doi.org/10.47665/tb.37.4.1117	ADP
easat-8115	252	2	[	[	X
easat-8115	252	3	8	8	NUM
easat-8115	252	4	]	]	X
easat-8115	252	5	n.	n.	PROPN
easat-8115	252	6	k.	k.	PROPN
easat-8115	252	7	wills	will	NOUN
easat-8115	252	8	,	,	PUNCT
easat-8115	252	9	m.	m.	NOUN
easat-8115	252	10	adriaanse	adriaanse	ADJ
easat-8115	252	11	,	,	PUNCT
easat-8115	252	12	and	and	CCONJ
easat-8115	252	13	s.	s.	PROPN
easat-8115	252	14	erasmus	erasmus	PROPN
easat-8115	252	15	,	,	PUNCT
easat-8115	252	16	"	"	PUNCT
easat-8115	252	17	chest	chest	NOUN
easat-8115	252	18	x	x	NOUN
easat-8115	252	19	-	-	NOUN
easat-8115	252	20	ray	ray	NOUN
easat-8115	252	21	features	feature	NOUN
easat-8115	252	22	of	of	ADP
easat-8115	252	23	hiv	hiv	PROPN
easat-8115	252	24	-	-	PUNCT
easat-8115	252	25	associated	associate	VERB
easat-8115	252	26	pneumocystis	pneumocystis	ADJ
easat-8115	252	27	pneumonia	pneumonia	NOUN
easat-8115	252	28	(	(	PUNCT
easat-8115	252	29	pcp	pcp	PROPN
easat-8115	252	30	)	)	PUNCT
easat-8115	252	31	in	in	ADP
easat-8115	252	32	adults	adult	NOUN
easat-8115	252	33	:	:	PUNCT
easat-8115	252	34	a	a	DET
easat-8115	252	35	systematic	systematic	ADJ
easat-8115	252	36	review	review	NOUN
easat-8115	252	37	and	and	CCONJ
easat-8115	252	38	meta	meta	ADJ
easat-8115	252	39	-	-	PUNCT
easat-8115	252	40	analysis	analysis	NOUN
easat-8115	252	41	,	,	PUNCT
easat-8115	252	42	"	"	PUNCT
easat-8115	252	43	open	open	ADJ
easat-8115	252	44	forum	forum	NOUN
easat-8115	252	45	infectious	infectious	ADJ
easat-8115	252	46	diseases	disease	NOUN
easat-8115	252	47	,	,	PUNCT
easat-8115	252	48	vol	vol	NOUN
easat-8115	252	49	.	.	PROPN
easat-8115	253	1	11	11	NUM
easat-8115	253	2	,	,	PUNCT
easat-8115	253	3	no	no	INTJ
easat-8115	253	4	.	.	NOUN
easat-8115	253	5	4	4	NUM
easat-8115	253	6	,	,	PUNCT
easat-8115	253	7	p.	p.	NOUN
easat-8115	253	8	ofae146	ofae146	PROPN
easat-8115	253	9	,	,	PUNCT
easat-8115	253	10	2024	2024	NUM
easat-8115	253	11	.	.	PUNCT
easat-8115	254	1	https://doi.org/10.1093/ofid/ofae146	https://doi.org/10.1093/ofid/ofae146	X
easat-8115	255	1	[	[	X
easat-8115	255	2	9	9	NUM
easat-8115	255	3	]	]	PUNCT
easat-8115	255	4	s.	s.	PROPN
easat-8115	255	5	mulyani	mulyani	PROPN
easat-8115	255	6	,	,	PUNCT
easat-8115	255	7	m.	m.	NOUN
easat-8115	255	8	d.	d.	PROPN
easat-8115	255	9	p.	p.	PROPN
easat-8115	255	10	pramudianti	pramudianti	PROPN
easat-8115	255	11	,	,	PUNCT
easat-8115	255	12	and	and	CCONJ
easat-8115	255	13	d.	d.	PROPN
easat-8115	255	14	ariningrum	ariningrum	PROPN
easat-8115	255	15	,	,	PUNCT
easat-8115	255	16	"	"	PUNCT
easat-8115	255	17	the	the	DET
easat-8115	255	18	association	association	NOUN
easat-8115	255	19	of	of	ADP
easat-8115	255	20	cd4	cd4	PROPN
easat-8115	255	21	,	,	PUNCT
easat-8115	255	22	cd8	cd8	PROPN
easat-8115	255	23	,	,	PUNCT
easat-8115	255	24	and	and	CCONJ
easat-8115	255	25	cd4	cd4	PROPN
easat-8115	255	26	/	/	SYM
easat-8115	255	27	cd8	cd8	PROPN
easat-8115	255	28	ratio	ratio	NOUN
easat-8115	255	29	with	with	ADP
easat-8115	255	30	thyroid	thyroid	NOUN
easat-8115	255	31	dysfunction	dysfunction	NOUN
easat-8115	255	32	in	in	ADP
easat-8115	255	33	hiv	hiv	PROPN
easat-8115	255	34	/	/	SYM
easat-8115	255	35	aids	aids	PROPN
easat-8115	255	36	,	,	PUNCT
easat-8115	255	37	"	"	PUNCT
easat-8115	255	38	indonesian	indonesian	ADJ
easat-8115	255	39	journal	journal	NOUN
easat-8115	255	40	of	of	ADP
easat-8115	255	41	clinical	clinical	ADJ
easat-8115	255	42	pathology	pathology	NOUN
easat-8115	255	43	and	and	CCONJ
easat-8115	255	44	medical	medical	ADJ
easat-8115	255	45	laboratory	laboratory	NOUN
easat-8115	255	46	,	,	PUNCT
easat-8115	255	47	vol	vol	NOUN
easat-8115	255	48	.	.	PROPN
easat-8115	256	1	27	27	NUM
easat-8115	256	2	,	,	PUNCT
easat-8115	256	3	no	no	INTJ
easat-8115	256	4	.	.	NOUN
easat-8115	256	5	3	3	NUM
easat-8115	256	6	,	,	PUNCT
easat-8115	256	7	pp	pp	ADJ
easat-8115	256	8	.	.	PUNCT
easat-8115	257	1	326–332	326–332	NUM
easat-8115	257	2	,	,	PUNCT
easat-8115	257	3	2021	2021	NUM
easat-8115	257	4	.	.	PUNCT
easat-8115	257	5	https://doi.org/10.24293/ijcpml.v27i3.1701	https://doi.org/10.24293/ijcpml.v27i3.1701	NUM
easat-8115	258	1	[	[	X
easat-8115	258	2	10	10	NUM
easat-8115	258	3	]	]	PUNCT
easat-8115	258	4	m.	m.	NOUN
easat-8115	258	5	catalfamo	catalfamo	PROPN
easat-8115	258	6	,	,	PUNCT
easat-8115	258	7	c.	c.	PROPN
easat-8115	258	8	wilhelm	wilhelm	PROPN
easat-8115	258	9	,	,	PUNCT
easat-8115	258	10	and	and	CCONJ
easat-8115	258	11	l.	l.	PROPN
easat-8115	258	12	tcheung	tcheung	PROPN
easat-8115	258	13	,	,	PUNCT
easat-8115	258	14	"	"	PUNCT
easat-8115	258	15	cd4	cd4	PROPN
easat-8115	258	16	and	and	CCONJ
easat-8115	258	17	cd8	cd8	PROPN
easat-8115	258	18	t	t	PROPN
easat-8115	258	19	cell	cell	NOUN
easat-8115	258	20	immune	immune	ADJ
easat-8115	258	21	activation	activation	NOUN
easat-8115	258	22	during	during	ADP
easat-8115	258	23	chronic	chronic	ADJ
easat-8115	258	24	hiv	hiv	PROPN
easat-8115	258	25	infection	infection	NOUN
easat-8115	258	26	:	:	PUNCT
easat-8115	258	27	roles	role	NOUN
easat-8115	258	28	of	of	ADP
easat-8115	258	29	homeostasis	homeostasis	NOUN
easat-8115	258	30	,	,	PUNCT
easat-8115	258	31	hiv	hiv	PROPN
easat-8115	258	32	,	,	PUNCT
easat-8115	258	33	type	type	NOUN
easat-8115	258	34	i	i	PRON
easat-8115	258	35	ifn	ifn	VERB
easat-8115	258	36	,	,	PUNCT
easat-8115	258	37	and	and	CCONJ
easat-8115	258	38	il-7	il-7	X
easat-8115	258	39	,	,	PUNCT
easat-8115	258	40	"	"	PUNCT
easat-8115	258	41	journal	journal	NOUN
easat-8115	258	42	of	of	ADP
easat-8115	258	43	immunology	immunology	NOUN
easat-8115	258	44	,	,	PUNCT
easat-8115	258	45	vol	vol	NOUN
easat-8115	258	46	.	.	PROPN
easat-8115	259	1	186	186	NUM
easat-8115	259	2	,	,	PUNCT
easat-8115	259	3	no	no	INTJ
easat-8115	259	4	.	.	NOUN
easat-8115	259	5	4	4	NUM
easat-8115	259	6	,	,	PUNCT
easat-8115	259	7	pp	pp	ADJ
easat-8115	259	8	.	.	PUNCT
easat-8115	260	1	2106–2116	2106–2116	NUM
easat-8115	260	2	,	,	PUNCT
easat-8115	260	3	2011	2011	NUM
easat-8115	260	4	.	.	PUNCT
easat-8115	261	1	[	[	X
easat-8115	261	2	11	11	NUM
easat-8115	261	3	]	]	PUNCT
easat-8115	261	4	m.	m.	NOUN
easat-8115	261	5	siegel	siegel	PROPN
easat-8115	261	6	,	,	PUNCT
easat-8115	261	7	h.	h.	PROPN
easat-8115	261	8	masur	masur	PROPN
easat-8115	261	9	,	,	PUNCT
easat-8115	261	10	and	and	CCONJ
easat-8115	261	11	j.	j.	PROPN
easat-8115	261	12	kovacs	kovacs	PROPN
easat-8115	261	13	,	,	PUNCT
easat-8115	261	14	"	"	PUNCT
easat-8115	261	15	pneumocystis	pneumocystis	ADJ
easat-8115	261	16	jirovecii	jirovecii	ADJ
easat-8115	261	17	pneumonia	pneumonia	NOUN
easat-8115	261	18	in	in	ADP
easat-8115	261	19	human	human	ADJ
easat-8115	261	20	immunodeficiency	immunodeficiency	NOUN
easat-8115	261	21	virus	virus	NOUN
easat-8115	261	22	infection	infection	NOUN
easat-8115	261	23	,	,	PUNCT
easat-8115	261	24	"	"	PUNCT
easat-8115	261	25	seminars	seminar	NOUN
easat-8115	261	26	in	in	ADP
easat-8115	261	27	respiratory	respiratory	ADJ
easat-8115	261	28	and	and	CCONJ
easat-8115	261	29	critical	critical	ADJ
easat-8115	261	30	care	care	NOUN
easat-8115	261	31	medicine	medicine	NOUN
easat-8115	261	32	,	,	PUNCT
easat-8115	261	33	vol	vol	NOUN
easat-8115	261	34	.	.	PROPN
easat-8115	261	35	37	37	NUM
easat-8115	261	36	,	,	PUNCT
easat-8115	261	37	no	no	INTJ
easat-8115	261	38	.	.	NOUN
easat-8115	261	39	2	2	NUM
easat-8115	261	40	,	,	PUNCT
easat-8115	261	41	pp	pp	ADJ
easat-8115	261	42	.	.	PUNCT
easat-8115	262	1	243–256	243–256	NUM
easat-8115	262	2	,	,	PUNCT
easat-8115	262	3	2016	2016	NUM
easat-8115	262	4	.	.	PUNCT
easat-8115	263	1	https://doi.org/10.1055/s-0036-1579556	https://doi.org/10.1055/s-0036-1579556	ADJ
easat-8115	263	2	[	[	X
easat-8115	263	3	12	12	NUM
easat-8115	263	4	]	]	PUNCT
easat-8115	263	5	j.	j.	PROPN
easat-8115	263	6	truong	truong	PROPN
easat-8115	263	7	and	and	CCONJ
easat-8115	263	8	j.	j.	PROPN
easat-8115	263	9	ashurst	ashurst	PROPN
easat-8115	263	10	,	,	PUNCT
easat-8115	263	11	pneumocystis	pneumocystis	NOUN
easat-8115	263	12	jirovecii	jirovecii	NOUN
easat-8115	263	13	pneumonia	pneumonia	NOUN
easat-8115	263	14	.	.	PUNCT
easat-8115	264	1	treasure	treasure	NOUN
easat-8115	264	2	island	island	NOUN
easat-8115	264	3	(	(	PUNCT
easat-8115	264	4	fl	fl	PROPN
easat-8115	264	5	):	):	PUNCT
easat-8115	264	6	statpearls	statpearls	PROPN
easat-8115	264	7	publishing	publishing	NOUN
easat-8115	264	8	,	,	PUNCT
easat-8115	264	9	2023	2023	NUM
easat-8115	264	10	.	.	PUNCT
easat-8115	265	1	[	[	X
easat-8115	265	2	13	13	NUM
easat-8115	265	3	]	]	PUNCT
easat-8115	265	4	s.	s.	PROPN
easat-8115	265	5	k.	k.	PROPN
easat-8115	265	6	jain	jain	PROPN
easat-8115	265	7	,	,	PUNCT
easat-8115	265	8	a.	a.	NOUN
easat-8115	265	9	nyati	nyati	PROPN
easat-8115	265	10	,	,	PUNCT
easat-8115	265	11	and	and	CCONJ
easat-8115	265	12	r.	r.	PROPN
easat-8115	265	13	kumar	kumar	PROPN
easat-8115	265	14	,	,	PUNCT
easat-8115	265	15	"	"	PUNCT
easat-8115	265	16	cutaneous	cutaneous	ADJ
easat-8115	265	17	manifestations	manifestation	NOUN
easat-8115	265	18	of	of	ADP
easat-8115	265	19	hiv	hiv	PROPN
easat-8115	265	20	-	-	PUNCT
easat-8115	265	21	infection	infection	NOUN
easat-8115	265	22	in	in	ADP
easat-8115	265	23	relation	relation	NOUN
easat-8115	265	24	with	with	ADP
easat-8115	265	25	cd4	cd4	PROPN
easat-8115	265	26	cell	cell	NOUN
easat-8115	265	27	counts	count	NOUN
easat-8115	265	28	in	in	ADP
easat-8115	265	29	hadoti	hadoti	PROPN
easat-8115	265	30	region	region	PROPN
easat-8115	265	31	,	,	PUNCT
easat-8115	265	32	"	"	PUNCT
easat-8115	265	33	journal	journal	NOUN
easat-8115	265	34	of	of	ADP
easat-8115	265	35	evolution	evolution	NOUN
easat-8115	265	36	of	of	ADP
easat-8115	265	37	medical	medical	ADJ
easat-8115	265	38	and	and	CCONJ
easat-8115	265	39	dental	dental	ADJ
easat-8115	265	40	sciences	science	NOUN
easat-8115	265	41	,	,	PUNCT
easat-8115	265	42	vol	vol	NOUN
easat-8115	265	43	.	.	PROPN
easat-8115	265	44	2	2	NUM
easat-8115	265	45	,	,	PUNCT
easat-8115	265	46	no	no	INTJ
easat-8115	265	47	.	.	NOUN
easat-8115	265	48	36	36	NUM
easat-8115	265	49	,	,	PUNCT
easat-8115	265	50	pp	pp	ADJ
easat-8115	265	51	.	.	PUNCT
easat-8115	266	1	7003–7014	7003–7014	NUM
easat-8115	266	2	,	,	PUNCT
easat-8115	266	3	2013	2013	NUM
easat-8115	266	4	.	.	PUNCT
easat-8115	267	1	https://doi.org/10.14260/jemds/1246	https://doi.org/10.14260/jemds/1246	PROPN
easat-8115	268	1	[	[	X
easat-8115	268	2	14	14	NUM
easat-8115	268	3	]	]	PUNCT
easat-8115	268	4	a.	a.	NOUN
easat-8115	268	5	n.	n.	PROPN
easat-8115	268	6	charisma	charisma	PROPN
easat-8115	268	7	,	,	PUNCT
easat-8115	268	8	k.	k.	PROPN
easat-8115	269	1	p.	p.	PROPN
easat-8115	269	2	dewi	dewi	PROPN
easat-8115	269	3	,	,	PUNCT
easat-8115	269	4	and	and	CCONJ
easat-8115	269	5	e.	e.	PROPN
easat-8115	269	6	marfiani	marfiani	PROPN
easat-8115	269	7	,	,	PUNCT
easat-8115	269	8	"	"	PUNCT
easat-8115	269	9	supporting	support	VERB
easat-8115	269	10	examination	examination	NOUN
easat-8115	269	11	modalities	modality	NOUN
easat-8115	269	12	in	in	ADP
easat-8115	269	13	establishing	establish	VERB
easat-8115	269	14	the	the	DET
easat-8115	269	15	diagnosis	diagnosis	NOUN
easat-8115	269	16	of	of	ADP
easat-8115	269	17	pneumocystis	pneumocystis	ADJ
easat-8115	269	18	pneumonia	pneumonia	NOUN
easat-8115	269	19	(	(	PUNCT
easat-8115	269	20	pcp	pcp	PROPN
easat-8115	269	21	)	)	PUNCT
easat-8115	269	22	in	in	ADP
easat-8115	269	23	hiv	hiv	PROPN
easat-8115	269	24	/	/	SYM
easat-8115	269	25	aids	aids	PROPN
easat-8115	269	26	,	,	PUNCT
easat-8115	269	27	"	"	PUNCT
easat-8115	269	28	journal	journal	NOUN
easat-8115	269	29	of	of	ADP
easat-8115	269	30	biomedicine	biomedicine	NOUN
easat-8115	269	31	and	and	CCONJ
easat-8115	269	32	health	health	NOUN
easat-8115	269	33	,	,	PUNCT
easat-8115	269	34	vol	vol	NOUN
easat-8115	269	35	.	.	PROPN
easat-8115	269	36	8	8	NUM
easat-8115	269	37	,	,	PUNCT
easat-8115	269	38	no	no	INTJ
easat-8115	269	39	.	.	NOUN
easat-8115	269	40	1	1	NUM
easat-8115	269	41	,	,	PUNCT
easat-8115	269	42	pp	pp	ADJ
easat-8115	269	43	.	.	PUNCT
easat-8115	270	1	69–76	69–76	NUM
easat-8115	270	2	,	,	PUNCT
easat-8115	270	3	2021	2021	NUM
easat-8115	270	4	.	.	PUNCT
easat-8115	271	1	[	[	X
easat-8115	271	2	15	15	NUM
easat-8115	271	3	]	]	X
easat-8115	271	4	p.	p.	PROPN
easat-8115	271	5	l.	l.	PROPN
easat-8115	271	6	white	white	PROPN
easat-8115	271	7	,	,	PUNCT
easat-8115	271	8	j.	j.	PROPN
easat-8115	271	9	s.	s.	PROPN
easat-8115	271	10	price	price	PROPN
easat-8115	271	11	,	,	PUNCT
easat-8115	271	12	and	and	CCONJ
easat-8115	271	13	m.	m.	PROPN
easat-8115	271	14	backx	backx	PROPN
easat-8115	271	15	,	,	PUNCT
easat-8115	271	16	"	"	PUNCT
easat-8115	271	17	pneumocystis	pneumocystis	ADJ
easat-8115	271	18	jirovecii	jirovecii	NOUN
easat-8115	271	19	pneumonia	pneumonia	NOUN
easat-8115	271	20	:	:	PUNCT
easat-8115	271	21	epidemiology	epidemiology	NOUN
easat-8115	271	22	,	,	PUNCT
easat-8115	271	23	clinical	clinical	ADJ
easat-8115	271	24	manifestation	manifestation	NOUN
easat-8115	271	25	and	and	CCONJ
easat-8115	271	26	diagnosis	diagnosis	NOUN
easat-8115	271	27	,	,	PUNCT
easat-8115	271	28	"	"	PUNCT
easat-8115	271	29	current	current	ADJ
easat-8115	271	30	fungal	fungal	ADJ
easat-8115	271	31	infection	infection	NOUN
easat-8115	271	32	reports	report	NOUN
easat-8115	271	33	,	,	PUNCT
easat-8115	271	34	vol	vol	NOUN
easat-8115	271	35	.	.	PROPN
easat-8115	271	36	13	13	NUM
easat-8115	271	37	,	,	PUNCT
easat-8115	271	38	no	no	INTJ
easat-8115	271	39	.	.	NOUN
easat-8115	271	40	4	4	NUM
easat-8115	271	41	,	,	PUNCT
easat-8115	271	42	pp	pp	ADJ
easat-8115	271	43	.	.	PUNCT
easat-8115	272	1	260–273	260–273	NUM
easat-8115	272	2	,	,	PUNCT
easat-8115	272	3	2019	2019	NUM
easat-8115	272	4	.	.	PUNCT
easat-8115	273	1	https://doi.org/10.1007/s12281-01900349-3	https://doi.org/10.1007/s12281-01900349-3	NOUN
easat-8115	274	1	[	[	X
easat-8115	274	2	16	16	NUM
easat-8115	274	3	]	]	PUNCT
easat-8115	274	4	x.	x.	PROPN
easat-8115	274	5	d.	d.	PROPN
easat-8115	274	6	mu	mu	PROPN
easat-8115	274	7	,	,	PUNCT
easat-8115	274	8	p.	p.	PROPN
easat-8115	274	9	jia	jia	PROPN
easat-8115	274	10	,	,	PUNCT
easat-8115	274	11	l.	l.	PROPN
easat-8115	274	12	gao	gao	PROPN
easat-8115	274	13	,	,	PUNCT
easat-8115	274	14	y.	y.	PROPN
easat-8115	274	15	zhang	zhang	PROPN
easat-8115	274	16	,	,	PUNCT
easat-8115	274	17	y.	y.	PROPN
easat-8115	274	18	wang	wang	PROPN
easat-8115	274	19	,	,	PUNCT
easat-8115	274	20	and	and	CCONJ
easat-8115	274	21	y.	y.	PROPN
easat-8115	274	22	liu	liu	PROPN
easat-8115	274	23	,	,	PUNCT
easat-8115	274	24	"	"	PUNCT
easat-8115	274	25	relationship	relationship	NOUN
easat-8115	274	26	between	between	ADP
easat-8115	274	27	radiological	radiological	ADJ
easat-8115	274	28	stages	stage	NOUN
easat-8115	274	29	and	and	CCONJ
easat-8115	274	30	prognoses	prognosis	NOUN
easat-8115	274	31	of	of	ADP
easat-8115	274	32	pneumocystis	pneumocystis	ADJ
easat-8115	274	33	pneumonia	pneumonia	NOUN
easat-8115	274	34	in	in	ADP
easat-8115	274	35	non	non	ADJ
easat-8115	274	36	-	-	ADJ
easat-8115	274	37	aids	aids	ADJ
easat-8115	274	38	immunocompromised	immunocompromise	VERB
easat-8115	274	39	patients	patient	NOUN
easat-8115	274	40	,	,	PUNCT
easat-8115	274	41	"	"	PUNCT
easat-8115	274	42	chinese	chinese	ADJ
easat-8115	274	43	medical	medical	ADJ
easat-8115	274	44	journal	journal	PROPN
easat-8115	274	45	,	,	PUNCT
easat-8115	274	46	vol	vol	NOUN
easat-8115	274	47	.	.	PROPN
easat-8115	274	48	129	129	NUM
easat-8115	274	49	,	,	PUNCT
easat-8115	274	50	no	no	INTJ
easat-8115	274	51	.	.	NOUN
easat-8115	274	52	17	17	NUM
easat-8115	274	53	,	,	PUNCT
easat-8115	274	54	pp	pp	ADJ
easat-8115	274	55	.	.	PUNCT
easat-8115	274	56	2020–2025	2020–2025	NUM
easat-8115	274	57	,	,	PUNCT
easat-8115	274	58	2016	2016	NUM
easat-8115	274	59	.	.	PUNCT
easat-8115	275	1	https://doi.org/10.4103/0366-6999.189068	https://doi.org/10.4103/0366-6999.189068	VERB
easat-8115	275	2	[	[	X
easat-8115	275	3	17	17	NUM
easat-8115	275	4	]	]	PUNCT
easat-8115	275	5	a.	a.	NOUN
easat-8115	275	6	apostolopoulou	apostolopoulou	PROPN
easat-8115	275	7	and	and	CCONJ
easat-8115	275	8	j.	j.	PROPN
easat-8115	275	9	a.	a.	PROPN
easat-8115	275	10	fishman	fishman	PROPN
easat-8115	275	11	,	,	PUNCT
easat-8115	275	12	"	"	PUNCT
easat-8115	275	13	the	the	DET
easat-8115	275	14	pathogenesis	pathogenesis	NOUN
easat-8115	275	15	and	and	CCONJ
easat-8115	275	16	diagnosis	diagnosis	NOUN
easat-8115	275	17	of	of	ADP
easat-8115	275	18	pneumocystis	pneumocystis	ADJ
easat-8115	275	19	jiroveci	jiroveci	PROPN
easat-8115	275	20	pneumonia	pneumonia	NOUN
easat-8115	275	21	,	,	PUNCT
easat-8115	275	22	"	"	PUNCT
easat-8115	275	23	journal	journal	NOUN
easat-8115	275	24	of	of	ADP
easat-8115	275	25	fungi	fungi	PROPN
easat-8115	275	26	,	,	PUNCT
easat-8115	275	27	vol	vol	NOUN
easat-8115	275	28	.	.	PROPN
easat-8115	275	29	8	8	NUM
easat-8115	275	30	,	,	PUNCT
easat-8115	275	31	no	no	INTJ
easat-8115	275	32	.	.	NOUN
easat-8115	275	33	11	11	NUM
easat-8115	275	34	,	,	PUNCT
easat-8115	275	35	p.	p.	NOUN
easat-8115	275	36	1167	1167	NUM
easat-8115	275	37	,	,	PUNCT
easat-8115	275	38	2022	2022	NUM
easat-8115	275	39	.	.	PUNCT
easat-8115	276	1	https://doi.org/10.3390/jof8111167	https://doi.org/10.3390/jof8111167	PROPN
easat-8115	276	2	[	[	X
easat-8115	276	3	18	18	NUM
easat-8115	276	4	]	]	X
easat-8115	276	5	d.	d.	PROPN
easat-8115	276	6	a.	a.	NOUN
easat-8115	276	7	lindra	lindra	NOUN
easat-8115	276	8	and	and	CCONJ
easat-8115	276	9	o.	o.	NOUN
easat-8115	276	10	a.	a.	NOUN
easat-8115	276	11	sari	sari	PROPN
easat-8115	276	12	,	,	PUNCT
easat-8115	276	13	"	"	PUNCT
easat-8115	276	14	the	the	DET
easat-8115	276	15	relationship	relationship	NOUN
easat-8115	276	16	between	between	ADP
easat-8115	276	17	spo₂/fio₂	spo₂/fio₂	PROPN
easat-8115	276	18	ratio	ratio	NOUN
easat-8115	276	19	and	and	CCONJ
easat-8115	276	20	community	community	NOUN
easat-8115	276	21	-	-	PUNCT
easat-8115	276	22	acquired	acquire	VERB
easat-8115	276	23	pneumonia	pneumonia	NOUN
easat-8115	276	24	patient	patient	NOUN
easat-8115	276	25	outcomes	outcome	NOUN
easat-8115	276	26	at	at	ADP
easat-8115	276	27	kolonel	kolonel	PROPN
easat-8115	276	28	abunjani	abunjani	PROPN
easat-8115	276	29	bangko	bangko	PROPN
easat-8115	276	30	general	general	ADJ
easat-8115	276	31	hospital	hospital	NOUN
easat-8115	276	32	,	,	PUNCT
easat-8115	276	33	"	"	PUNCT
easat-8115	276	34	respiratory	respiratory	ADJ
easat-8115	276	35	science	science	NOUN
easat-8115	276	36	,	,	PUNCT
easat-8115	276	37	vol	vol	NOUN
easat-8115	276	38	.	.	PROPN
easat-8115	276	39	4	4	NUM
easat-8115	276	40	,	,	PUNCT
easat-8115	276	41	no	no	INTJ
easat-8115	276	42	.	.	NOUN
easat-8115	276	43	2	2	NUM
easat-8115	276	44	,	,	PUNCT
easat-8115	276	45	pp	pp	ADJ
easat-8115	276	46	.	.	PUNCT
easat-8115	277	1	100–106	100–106	NUM
easat-8115	277	2	,	,	PUNCT
easat-8115	277	3	2024	2024	NUM
easat-8115	277	4	.	.	PUNCT
easat-8115	278	1	[	[	X
easat-8115	278	2	19	19	NUM
easat-8115	278	3	]	]	X
easat-8115	278	4	y.	y.	PROPN
easat-8115	278	5	fukuda	fukuda	PROPN
easat-8115	278	6	,	,	PUNCT
easat-8115	278	7	a.	a.	PROPN
easat-8115	278	8	tanaka	tanaka	PROPN
easat-8115	278	9	,	,	PUNCT
easat-8115	278	10	t.	t.	PROPN
easat-8115	278	11	homma	homma	PROPN
easat-8115	278	12	,	,	PUNCT
easat-8115	278	13	y.	y.	PROPN
easat-8115	278	14	sasaki	sasaki	PROPN
easat-8115	278	15	,	,	PUNCT
easat-8115	278	16	and	and	CCONJ
easat-8115	278	17	t.	t.	PROPN
easat-8115	278	18	nishida	nishida	PROPN
easat-8115	278	19	,	,	PUNCT
easat-8115	278	20	"	"	PUNCT
easat-8115	278	21	utility	utility	NOUN
easat-8115	278	22	of	of	ADP
easat-8115	278	23	spo₂/fio₂	spo₂/fio₂	PROPN
easat-8115	278	24	ratio	ratio	NOUN
easat-8115	278	25	for	for	ADP
easat-8115	278	26	acute	acute	ADJ
easat-8115	278	27	hypoxemic	hypoxemic	ADJ
easat-8115	278	28	respiratory	respiratory	ADJ
easat-8115	278	29	failure	failure	NOUN
easat-8115	278	30	with	with	ADP
easat-8115	278	31	bilateral	bilateral	ADJ
easat-8115	278	32	opacities	opacity	NOUN
easat-8115	278	33	in	in	ADP
easat-8115	278	34	the	the	DET
easat-8115	278	35	icu	icu	NOUN
easat-8115	278	36	,	,	PUNCT
easat-8115	278	37	"	"	PUNCT
easat-8115	278	38	plos	plos	PROPN
easat-8115	278	39	one	one	NUM
easat-8115	278	40	,	,	PUNCT
easat-8115	278	41	vol	vol	NOUN
easat-8115	278	42	.	.	PROPN
easat-8115	278	43	16	16	NUM
easat-8115	278	44	,	,	PUNCT
easat-8115	278	45	no	no	INTJ
easat-8115	278	46	.	.	NOUN
easat-8115	278	47	1	1	NUM
easat-8115	278	48	,	,	PUNCT
easat-8115	278	49	p.	p.	NOUN
easat-8115	278	50	e0245927	e0245927	NUM
easat-8115	278	51	,	,	PUNCT
easat-8115	278	52	2021	2021	NUM
easat-8115	278	53	.	.	PUNCT
easat-8115	279	1	https://doi.org/10.1371/journal.pone.0245927	https://doi.org/10.1371/journal.pone.0245927	PROPN
easat-8115	279	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-8115	279	3	https://doi.org/10.3390/ijerph19052768	https://doi.org/10.3390/ijerph19052768	PROPN
easat-8115	279	4	https://doi.org/10.3389/fimmu.2021.652383	https://doi.org/10.3389/fimmu.2021.652383	PROPN
easat-8115	279	5	https://doi.org/10.15562/bmj.v10i3.2787	https://doi.org/10.15562/bmj.v10i3.2787	PROPN
easat-8115	279	6	https://doi.org/10.3390/jof9080812	https://doi.org/10.3390/jof9080812	NOUN
easat-8115	279	7	https://doi.org/10.47665/tb.37.4.1117	https://doi.org/10.47665/tb.37.4.1117	ADP
easat-8115	279	8	https://doi.org/10.1093/ofid/ofae146	https://doi.org/10.1093/ofid/ofae146	NOUN
easat-8115	279	9	https://doi.org/10.24293/ijcpml.v27i3.1701	https://doi.org/10.24293/ijcpml.v27i3.1701	X
easat-8115	279	10	https://doi.org/10.1055/s-0036-1579556	https://doi.org/10.1055/s-0036-1579556	PROPN
easat-8115	279	11	https://doi.org/10.14260/jemds/1246	https://doi.org/10.14260/jemds/1246	PROPN
easat-8115	279	12	https://doi.org/10.1007/s12281-019-00349-3	https://doi.org/10.1007/s12281-019-00349-3	NUM
easat-8115	279	13	https://doi.org/10.1007/s12281-019-00349-3	https://doi.org/10.1007/s12281-019-00349-3	NUM
easat-8115	279	14	https://doi.org/10.4103/0366-6999.189068	https://doi.org/10.4103/0366-6999.189068	VERB
easat-8115	279	15	https://doi.org/10.3390/jof8111167	https://doi.org/10.3390/jof8111167	ADJ
easat-8115	279	16	https://doi.org/10.1371/journal.pone.0245927	https://doi.org/10.1371/journal.pone.0245927	PROPN
easat-8115	279	17	1340	1340	NUM
easat-8115	279	18	edelweiss	edelweiss	PROPN
easat-8115	279	19	applied	apply	VERB
easat-8115	279	20	science	science	NOUN
easat-8115	279	21	and	and	CCONJ
easat-8115	279	22	technology	technology	NOUN
easat-8115	279	23	issn	issn	PROPN
easat-8115	279	24	:	:	PUNCT
easat-8115	279	25	2576	2576	NUM
easat-8115	279	26	-	-	SYM
easat-8115	279	27	8484	8484	NUM
easat-8115	279	28	vol	vol	NOUN
easat-8115	279	29	.	.	PROPN
easat-8115	280	1	9	9	NUM
easat-8115	280	2	,	,	PUNCT
easat-8115	280	3	no	no	INTJ
easat-8115	280	4	.	.	NOUN
easat-8115	281	1	6	6	NUM
easat-8115	281	2	:	:	SYM
easat-8115	281	3	1331	1331	NUM
easat-8115	281	4	-	-	SYM
easat-8115	281	5	1341	1341	NUM
easat-8115	281	6	,	,	PUNCT
easat-8115	281	7	2025	2025	NUM
easat-8115	281	8	doi	doi	NOUN
easat-8115	281	9	:	:	PUNCT
easat-8115	281	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	281	11	©	©	PROPN
easat-8115	281	12	2025	2025	NUM
easat-8115	281	13	by	by	ADP
easat-8115	281	14	the	the	DET
easat-8115	281	15	authors	author	NOUN
easat-8115	281	16	;	;	PUNCT
easat-8115	281	17	licensee	licensee	PROPN
easat-8115	281	18	learning	learning	NOUN
easat-8115	281	19	gate	gate	NOUN
easat-8115	282	1	[	[	X
easat-8115	282	2	20	20	NUM
easat-8115	282	3	]	]	PUNCT
easat-8115	282	4	e.	e.	PROPN
easat-8115	282	5	pretorius	pretorius	PROPN
easat-8115	282	6	,	,	PUNCT
easat-8115	282	7	"	"	PUNCT
easat-8115	282	8	platelets	platelet	VERB
easat-8115	282	9	in	in	ADP
easat-8115	282	10	hiv	hiv	PROPN
easat-8115	282	11	:	:	PUNCT
easat-8115	282	12	a	a	DET
easat-8115	282	13	guardian	guardian	NOUN
easat-8115	282	14	of	of	ADP
easat-8115	282	15	host	host	NOUN
easat-8115	282	16	defence	defence	NOUN
easat-8115	282	17	or	or	CCONJ
easat-8115	282	18	transient	transient	ADJ
easat-8115	282	19	reservoir	reservoir	NOUN
easat-8115	282	20	of	of	ADP
easat-8115	282	21	the	the	DET
easat-8115	282	22	virus	virus	NOUN
easat-8115	282	23	?	?	PUNCT
easat-8115	282	24	,	,	PUNCT
easat-8115	282	25	"	"	PUNCT
easat-8115	282	26	frontiers	frontier	NOUN
easat-8115	282	27	in	in	ADP
easat-8115	282	28	immunology	immunology	NOUN
easat-8115	282	29	,	,	PUNCT
easat-8115	282	30	vol	vol	NOUN
easat-8115	282	31	.	.	PROPN
easat-8115	282	32	12	12	NUM
easat-8115	282	33	,	,	PUNCT
easat-8115	282	34	p.	p.	NOUN
easat-8115	282	35	649465	649465	NUM
easat-8115	282	36	,	,	PUNCT
easat-8115	282	37	2021	2021	NUM
easat-8115	282	38	.	.	PUNCT
easat-8115	283	1	https://doi.org/10.3389/fimmu.2021.649465	https://doi.org/10.3389/fimmu.2021.649465	PROPN
easat-8115	283	2	[	[	X
easat-8115	283	3	21	21	NUM
easat-8115	283	4	]	]	PUNCT
easat-8115	283	5	m.	m.	NOUN
easat-8115	283	6	a.	a.	PROPN
easat-8115	283	7	v.	v.	ADP
easat-8115	283	8	prianggandanni	prianggandanni	PROPN
easat-8115	283	9	,	,	PUNCT
easat-8115	283	10	a.	a.	PROPN
easat-8115	283	11	a.	a.	PROPN
easat-8115	283	12	w.	w.	PROPN
easat-8115	283	13	lestari	lestari	PROPN
easat-8115	283	14	,	,	PUNCT
easat-8115	283	15	i.	i.	PROPN
easat-8115	283	16	n.	n.	PROPN
easat-8115	283	17	wande	wande	PROPN
easat-8115	283	18	,	,	PUNCT
easat-8115	283	19	i.	i.	PROPN
easat-8115	283	20	g.	g.	PROPN
easat-8115	283	21	n.	n.	PROPN
easat-8115	283	22	a.	a.	PROPN
easat-8115	283	23	putra	putra	PROPN
easat-8115	283	24	,	,	PUNCT
easat-8115	283	25	and	and	CCONJ
easat-8115	283	26	i.	i.	PROPN
easat-8115	283	27	m.	m.	PROPN
easat-8115	283	28	a.	a.	PROPN
easat-8115	283	29	adnyana	adnyana	PROPN
easat-8115	283	30	,	,	PUNCT
easat-8115	283	31	"	"	PUNCT
easat-8115	283	32	correlation	correlation	NOUN
easat-8115	283	33	between	between	ADP
easat-8115	283	34	t	t	PROPN
easat-8115	283	35	-	-	PUNCT
easat-8115	283	36	lymphocyte	lymphocyte	NOUN
easat-8115	283	37	cd4	cd4	PROPN
easat-8115	283	38	+	+	PROPN
easat-8115	283	39	and	and	CCONJ
easat-8115	283	40	total	total	ADJ
easat-8115	283	41	lymphocyte	lymphocyte	ADJ
easat-8115	283	42	count	count	NOUN
easat-8115	283	43	(	(	PUNCT
easat-8115	283	44	tlc	tlc	NOUN
easat-8115	283	45	)	)	PUNCT
easat-8115	283	46	,	,	PUNCT
easat-8115	283	47	hemoglobin	hemoglobin	NOUN
easat-8115	283	48	,	,	PUNCT
easat-8115	283	49	neutrophil	neutrophil	ADJ
easat-8115	283	50	to	to	ADP
easat-8115	283	51	lymphocyte	lymphocyte	ADJ
easat-8115	283	52	ratio	ratio	NOUN
easat-8115	283	53	(	(	PUNCT
easat-8115	283	54	nlr	nlr	PROPN
easat-8115	283	55	)	)	PUNCT
easat-8115	283	56	and	and	CCONJ
easat-8115	283	57	t	t	PROPN
easat-8115	283	58	-	-	PUNCT
easat-8115	283	59	lymphocyte	lymphocyte	ADJ
easat-8115	283	60	cd4+/cd8	cd4+/cd8	NOUN
easat-8115	283	61	+	+	CCONJ
easat-8115	283	62	ratio	ratio	NOUN
easat-8115	283	63	in	in	ADP
easat-8115	283	64	hiv	hiv	PROPN
easat-8115	283	65	patients	patient	NOUN
easat-8115	283	66	at	at	ADP
easat-8115	283	67	prof	prof	PROPN
easat-8115	283	68	.	.	PUNCT
easat-8115	284	1	dr	dr	PROPN
easat-8115	284	2	.	.	PROPN
easat-8115	285	1	i.g.n.g	i.g.n.g	PROPN
easat-8115	285	2	ngoerah	ngoerah	NOUN
easat-8115	285	3	hospital	hospital	NOUN
easat-8115	285	4	,	,	PUNCT
easat-8115	285	5	denpasar	denpasar	PROPN
easat-8115	285	6	,	,	PUNCT
easat-8115	285	7	bali	bali	PROPN
easat-8115	285	8	,	,	PUNCT
easat-8115	285	9	indonesia	indonesia	PROPN
easat-8115	285	10	,	,	PUNCT
easat-8115	285	11	"	"	PUNCT
easat-8115	285	12	bali	bali	PROPN
easat-8115	285	13	medical	medical	PROPN
easat-8115	285	14	journal	journal	PROPN
easat-8115	285	15	,	,	PUNCT
easat-8115	285	16	vol	vol	NOUN
easat-8115	285	17	.	.	PROPN
easat-8115	285	18	12	12	NUM
easat-8115	285	19	,	,	PUNCT
easat-8115	285	20	no	no	INTJ
easat-8115	285	21	.	.	NOUN
easat-8115	285	22	2	2	NUM
easat-8115	285	23	,	,	PUNCT
easat-8115	285	24	pp	pp	ADJ
easat-8115	285	25	.	.	PUNCT
easat-8115	286	1	2017–2021	2017–2021	NUM
easat-8115	286	2	,	,	PUNCT
easat-8115	286	3	2023	2023	NUM
easat-8115	286	4	.	.	PUNCT
easat-8115	287	1	[	[	X
easat-8115	287	2	22	22	NUM
easat-8115	287	3	]	]	X
easat-8115	287	4	e.	e.	PROPN
easat-8115	287	5	charpentier	charpentier	PROPN
easat-8115	287	6	,	,	PUNCT
easat-8115	287	7	s.	s.	PROPN
easat-8115	287	8	ménard	ménard	PROPN
easat-8115	287	9	,	,	PUNCT
easat-8115	287	10	c.	c.	PROPN
easat-8115	287	11	marques	marques	PROPN
easat-8115	287	12	,	,	PUNCT
easat-8115	287	13	a.	a.	NOUN
easat-8115	287	14	berry	berry	NOUN
easat-8115	287	15	,	,	PUNCT
easat-8115	287	16	and	and	CCONJ
easat-8115	287	17	x.	x.	NOUN
easat-8115	287	18	iriart	iriart	NOUN
easat-8115	287	19	,	,	PUNCT
easat-8115	287	20	"	"	PUNCT
easat-8115	287	21	immune	immune	ADJ
easat-8115	287	22	response	response	NOUN
easat-8115	287	23	in	in	ADP
easat-8115	287	24	pneumocystis	pneumocystis	ADJ
easat-8115	287	25	infections	infection	NOUN
easat-8115	287	26	according	accord	VERB
easat-8115	287	27	to	to	ADP
easat-8115	287	28	the	the	DET
easat-8115	287	29	host	host	NOUN
easat-8115	287	30	immune	immune	ADJ
easat-8115	287	31	system	system	NOUN
easat-8115	287	32	status	status	NOUN
easat-8115	287	33	,	,	PUNCT
easat-8115	287	34	"	"	PUNCT
easat-8115	287	35	journal	journal	NOUN
easat-8115	287	36	of	of	ADP
easat-8115	287	37	fungi	fungi	PROPN
easat-8115	287	38	,	,	PUNCT
easat-8115	287	39	vol	vol	NOUN
easat-8115	287	40	.	.	PROPN
easat-8115	287	41	7	7	NUM
easat-8115	287	42	,	,	PUNCT
easat-8115	287	43	no	no	INTJ
easat-8115	287	44	.	.	NOUN
easat-8115	287	45	8	8	NUM
easat-8115	287	46	,	,	PUNCT
easat-8115	287	47	p.	p.	NOUN
easat-8115	287	48	625	625	NUM
easat-8115	287	49	,	,	PUNCT
easat-8115	287	50	2021	2021	NUM
easat-8115	287	51	.	.	PUNCT
easat-8115	288	1	https://doi.org/10.3390/jof7080625	https://doi.org/10.3390/jof7080625	NOUN
easat-8115	288	2	[	[	X
easat-8115	288	3	23	23	NUM
easat-8115	288	4	]	]	X
easat-8115	288	5	c.	c.	PROPN
easat-8115	288	6	j.	j.	PROPN
easat-8115	288	7	wiedermann	wiedermann	PROPN
easat-8115	288	8	,	,	PUNCT
easat-8115	288	9	"	"	PUNCT
easat-8115	288	10	hypoalbuminemia	hypoalbuminemia	ADV
easat-8115	288	11	as	as	ADP
easat-8115	288	12	surrogate	surrogate	ADJ
easat-8115	288	13	and	and	CCONJ
easat-8115	288	14	culprit	culprit	NOUN
easat-8115	288	15	of	of	ADP
easat-8115	288	16	infections	infection	NOUN
easat-8115	288	17	,	,	PUNCT
easat-8115	288	18	"	"	PUNCT
easat-8115	288	19	international	international	ADJ
easat-8115	288	20	journal	journal	NOUN
easat-8115	288	21	of	of	ADP
easat-8115	288	22	molecular	molecular	ADJ
easat-8115	288	23	sciences	science	NOUN
easat-8115	288	24	,	,	PUNCT
easat-8115	288	25	vol	vol	NOUN
easat-8115	288	26	.	.	PROPN
easat-8115	289	1	22	22	NUM
easat-8115	289	2	,	,	PUNCT
easat-8115	289	3	no	no	INTJ
easat-8115	289	4	.	.	NOUN
easat-8115	289	5	9	9	NUM
easat-8115	289	6	,	,	PUNCT
easat-8115	289	7	p.	p.	NOUN
easat-8115	289	8	4496	4496	NUM
easat-8115	289	9	,	,	PUNCT
easat-8115	289	10	2021	2021	NUM
easat-8115	289	11	.	.	PUNCT
easat-8115	290	1	https://doi.org/10.3390/ijms22094496	https://doi.org/10.3390/ijms22094496	NOUN
easat-8115	291	1	[	[	X
easat-8115	291	2	24	24	NUM
easat-8115	291	3	]	]	X
easat-8115	291	4	y.	y.	PROPN
easat-8115	291	5	chen	chen	PROPN
easat-8115	291	6	,	,	PUNCT
easat-8115	291	7	l.	l.	PROPN
easat-8115	291	8	zhang	zhang	PROPN
easat-8115	291	9	,	,	PUNCT
easat-8115	291	10	x.	x.	PROPN
easat-8115	291	11	wang	wang	PROPN
easat-8115	291	12	,	,	PUNCT
easat-8115	291	13	q.	q.	PROPN
easat-8115	291	14	liu	liu	PROPN
easat-8115	291	15	,	,	PUNCT
easat-8115	291	16	and	and	CCONJ
easat-8115	291	17	h.	h.	PROPN
easat-8115	291	18	li	li	PROPN
easat-8115	291	19	,	,	PUNCT
easat-8115	291	20	"	"	PUNCT
easat-8115	291	21	role	role	NOUN
easat-8115	291	22	of	of	ADP
easat-8115	291	23	gm	gm	PROPN
easat-8115	291	24	-	-	PUNCT
easat-8115	291	25	csf	csf	NOUN
easat-8115	291	26	in	in	ADP
easat-8115	291	27	lung	lung	NOUN
easat-8115	291	28	balance	balance	NOUN
easat-8115	291	29	and	and	CCONJ
easat-8115	291	30	disease	disease	NOUN
easat-8115	291	31	,	,	PUNCT
easat-8115	291	32	"	"	PUNCT
easat-8115	291	33	frontiers	frontier	NOUN
easat-8115	291	34	in	in	ADP
easat-8115	291	35	immunology	immunology	NOUN
easat-8115	291	36	,	,	PUNCT
easat-8115	291	37	vol	vol	NOUN
easat-8115	291	38	.	.	PROPN
easat-8115	291	39	14	14	NUM
easat-8115	291	40	,	,	PUNCT
easat-8115	291	41	p.	p.	NOUN
easat-8115	291	42	1158859	1158859	NUM
easat-8115	291	43	,	,	PUNCT
easat-8115	291	44	2023	2023	NUM
easat-8115	291	45	.	.	PUNCT
easat-8115	292	1	https://doi.org/10.3389/fimmu.2023.1158859	https://doi.org/10.3389/fimmu.2023.1158859	PROPN
easat-8115	293	1	[	[	X
easat-8115	293	2	25	25	NUM
easat-8115	293	3	]	]	PUNCT
easat-8115	293	4	e.	e.	PROPN
easat-8115	293	5	i.	i.	PROPN
easat-8115	293	6	obeagu	obeagu	PROPN
easat-8115	293	7	and	and	CCONJ
easat-8115	293	8	g.	g.	PROPN
easat-8115	293	9	u.	u.	PROPN
easat-8115	293	10	obeagu	obeagu	PROPN
easat-8115	293	11	,	,	PUNCT
easat-8115	293	12	"	"	PUNCT
easat-8115	293	13	utilization	utilization	NOUN
easat-8115	293	14	of	of	ADP
easat-8115	293	15	immunological	immunological	ADJ
easat-8115	293	16	ratios	ratio	NOUN
easat-8115	293	17	in	in	ADP
easat-8115	293	18	hiv	hiv	PROPN
easat-8115	293	19	:	:	PUNCT
easat-8115	293	20	implications	implication	NOUN
easat-8115	293	21	for	for	ADP
easat-8115	293	22	monitoring	monitoring	NOUN
easat-8115	293	23	and	and	CCONJ
easat-8115	293	24	therapeutic	therapeutic	ADJ
easat-8115	293	25	strategies	strategy	NOUN
easat-8115	293	26	,	,	PUNCT
easat-8115	293	27	"	"	PUNCT
easat-8115	293	28	medicine	medicine	NOUN
easat-8115	293	29	,	,	PUNCT
easat-8115	293	30	vol	vol	NOUN
easat-8115	293	31	.	.	PROPN
easat-8115	293	32	103	103	NUM
easat-8115	293	33	,	,	PUNCT
easat-8115	293	34	no	no	INTJ
easat-8115	293	35	.	.	NOUN
easat-8115	293	36	9	9	NUM
easat-8115	293	37	,	,	PUNCT
easat-8115	293	38	p.	p.	NOUN
easat-8115	293	39	e37354	e37354	PROPN
easat-8115	293	40	,	,	PUNCT
easat-8115	293	41	2024	2024	NUM
easat-8115	293	42	.	.	PUNCT
easat-8115	294	1	[	[	X
easat-8115	294	2	26	26	NUM
easat-8115	294	3	]	]	X
easat-8115	294	4	y.	y.	PROPN
easat-8115	294	5	yabuuchi	yabuuchi	PROPN
easat-8115	294	6	,	,	PUNCT
easat-8115	294	7	m.	m.	NOUN
easat-8115	294	8	matsuyama	matsuyama	PROPN
easat-8115	294	9	,	,	PUNCT
easat-8115	294	10	s.	s.	PROPN
easat-8115	294	11	matsumura	matsumura	PROPN
easat-8115	294	12	,	,	PUNCT
easat-8115	294	13	t.	t.	NOUN
easat-8115	294	14	morimoto	morimoto	NOUN
easat-8115	294	15	,	,	PUNCT
easat-8115	294	16	and	and	CCONJ
easat-8115	294	17	s.	s.	PROPN
easat-8115	294	18	nakao	nakao	PROPN
easat-8115	294	19	,	,	PUNCT
easat-8115	294	20	"	"	PUNCT
easat-8115	294	21	a	a	DET
easat-8115	294	22	case	case	NOUN
easat-8115	294	23	of	of	ADP
easat-8115	294	24	pneumocystis	pneumocystis	ADJ
easat-8115	294	25	jirovecii	jirovecii	ADJ
easat-8115	294	26	pneumonia	pneumonia	NOUN
easat-8115	294	27	in	in	ADP
easat-8115	294	28	a	a	DET
easat-8115	294	29	patient	patient	NOUN
easat-8115	294	30	with	with	ADP
easat-8115	294	31	acquired	acquire	VERB
easat-8115	294	32	immune	immune	ADJ
easat-8115	294	33	deficiency	deficiency	NOUN
easat-8115	294	34	syndrome	syndrome	NOUN
easat-8115	294	35	who	who	PRON
easat-8115	294	36	showed	show	VERB
easat-8115	294	37	eosinophilia	eosinophilia	PROPN
easat-8115	294	38	and	and	CCONJ
easat-8115	294	39	an	an	DET
easat-8115	294	40	increased	increase	VERB
easat-8115	294	41	serum	serum	NOUN
easat-8115	294	42	tarc	tarc	PROPN
easat-8115	294	43	/	/	SYM
easat-8115	294	44	ccl17	ccl17	ADJ
easat-8115	294	45	level	level	NOUN
easat-8115	294	46	,	,	PUNCT
easat-8115	294	47	"	"	PUNCT
easat-8115	294	48	multidisciplinary	multidisciplinary	ADJ
easat-8115	294	49	respiratory	respiratory	ADJ
easat-8115	294	50	medicine	medicine	NOUN
easat-8115	294	51	,	,	PUNCT
easat-8115	294	52	vol	vol	NOUN
easat-8115	294	53	.	.	PROPN
easat-8115	294	54	17	17	NUM
easat-8115	294	55	,	,	PUNCT
easat-8115	294	56	no	no	INTJ
easat-8115	294	57	.	.	NOUN
easat-8115	294	58	2	2	NUM
easat-8115	294	59	,	,	PUNCT
easat-8115	294	60	p.	p.	NOUN
easat-8115	294	61	802	802	NUM
easat-8115	294	62	,	,	PUNCT
easat-8115	294	63	2022	2022	NUM
easat-8115	294	64	.	.	PUNCT
easat-8115	295	1	https://doi.org/10.4081/mrm.2022.802	https://doi.org/10.4081/mrm.2022.802	PROPN
easat-8115	295	2	[	[	X
easat-8115	295	3	27	27	NUM
easat-8115	295	4	]	]	X
easat-8115	295	5	n.	n.	PROPN
easat-8115	295	6	m.	m.	NOUN
easat-8115	295	7	graham	graham	PROPN
easat-8115	295	8	et	et	PROPN
easat-8115	295	9	al	al	PROPN
easat-8115	295	10	.	.	PROPN
easat-8115	295	11	,	,	PUNCT
easat-8115	295	12	"	"	PUNCT
easat-8115	295	13	prognostic	prognostic	ADJ
easat-8115	295	14	value	value	NOUN
easat-8115	295	15	of	of	ADP
easat-8115	295	16	combined	combine	VERB
easat-8115	295	17	response	response	NOUN
easat-8115	295	18	markers	marker	NOUN
easat-8115	295	19	among	among	ADP
easat-8115	295	20	human	human	ADJ
easat-8115	295	21	immunodeficiency	immunodeficiency	NOUN
easat-8115	295	22	virus	virus	NOUN
easat-8115	295	23	-	-	PUNCT
easat-8115	295	24	infected	infect	VERB
easat-8115	295	25	persons	person	NOUN
easat-8115	295	26	:	:	PUNCT
easat-8115	295	27	possible	possible	ADJ
easat-8115	295	28	aid	aid	NOUN
easat-8115	295	29	in	in	ADP
easat-8115	295	30	the	the	DET
easat-8115	295	31	decision	decision	NOUN
easat-8115	295	32	to	to	PART
easat-8115	295	33	change	change	VERB
easat-8115	295	34	zidovudine	zidovudine	PROPN
easat-8115	295	35	monotherapy	monotherapy	NOUN
easat-8115	295	36	,	,	PUNCT
easat-8115	295	37	"	"	PUNCT
easat-8115	295	38	clinical	clinical	ADJ
easat-8115	295	39	infectious	infectious	ADJ
easat-8115	295	40	diseases	disease	NOUN
easat-8115	295	41	,	,	PUNCT
easat-8115	295	42	vol	vol	NOUN
easat-8115	295	43	.	.	PROPN
easat-8115	295	44	20	20	NUM
easat-8115	295	45	,	,	PUNCT
easat-8115	295	46	no	no	INTJ
easat-8115	295	47	.	.	NOUN
easat-8115	295	48	2	2	NUM
easat-8115	295	49	,	,	PUNCT
easat-8115	295	50	pp	pp	ADJ
easat-8115	295	51	.	.	PUNCT
easat-8115	296	1	352–362	352–362	NUM
easat-8115	296	2	,	,	PUNCT
easat-8115	296	3	1995	1995	NUM
easat-8115	296	4	.	.	PUNCT
easat-8115	297	1	https://doi.org/10.1093/clinids/20.2.352	https://doi.org/10.1093/clinids/20.2.352	NUM
easat-8115	297	2	[	[	X
easat-8115	297	3	28	28	NUM
easat-8115	297	4	]	]	X
easat-8115	297	5	c.	c.	PROPN
easat-8115	297	6	obirikorang	obirikorang	PROPN
easat-8115	297	7	,	,	PUNCT
easat-8115	297	8	l.	l.	PROPN
easat-8115	297	9	quaye	quaye	PROPN
easat-8115	297	10	,	,	PUNCT
easat-8115	297	11	and	and	CCONJ
easat-8115	297	12	i.	i.	PROPN
easat-8115	297	13	acheampong	acheampong	PROPN
easat-8115	297	14	,	,	PUNCT
easat-8115	297	15	"	"	PUNCT
easat-8115	297	16	total	total	ADJ
easat-8115	297	17	lymphocyte	lymphocyte	ADJ
easat-8115	297	18	count	count	NOUN
easat-8115	297	19	as	as	ADP
easat-8115	297	20	a	a	DET
easat-8115	297	21	surrogate	surrogate	ADJ
easat-8115	297	22	marker	marker	NOUN
easat-8115	297	23	for	for	ADP
easat-8115	297	24	cd4	cd4	PROPN
easat-8115	297	25	count	count	NOUN
easat-8115	297	26	in	in	ADP
easat-8115	297	27	resource	resource	NOUN
easat-8115	297	28	-	-	PUNCT
easat-8115	297	29	limited	limit	VERB
easat-8115	297	30	settings	setting	NOUN
easat-8115	297	31	,	,	PUNCT
easat-8115	297	32	"	"	PUNCT
easat-8115	297	33	bmc	bmc	VERB
easat-8115	297	34	infectious	infectious	ADJ
easat-8115	297	35	diseases	disease	NOUN
easat-8115	297	36	,	,	PUNCT
easat-8115	297	37	vol	vol	NOUN
easat-8115	297	38	.	.	PROPN
easat-8115	297	39	12	12	NUM
easat-8115	297	40	,	,	PUNCT
easat-8115	297	41	no	no	INTJ
easat-8115	297	42	.	.	NOUN
easat-8115	297	43	1	1	NUM
easat-8115	297	44	,	,	PUNCT
easat-8115	297	45	p.	p.	NOUN
easat-8115	297	46	128	128	NUM
easat-8115	297	47	,	,	PUNCT
easat-8115	297	48	2012	2012	NUM
easat-8115	297	49	.	.	PUNCT
easat-8115	298	1	https://doi.org/10.1186/1471-233412-128	https://doi.org/10.1186/1471-233412-128	PROPN
easat-8115	299	1	[	[	X
easat-8115	299	2	29	29	NUM
easat-8115	299	3	]	]	PUNCT
easat-8115	299	4	b.	b.	PROPN
easat-8115	299	5	p.	p.	PROPN
easat-8115	299	6	epling	epling	PROPN
easat-8115	299	7	,	,	PUNCT
easat-8115	299	8	m.	m.	NOUN
easat-8115	299	9	manion	manion	NOUN
easat-8115	299	10	,	,	PUNCT
easat-8115	299	11	a.	a.	NOUN
easat-8115	299	12	sirajuddin	sirajuddin	PROPN
easat-8115	299	13	,	,	PUNCT
easat-8115	299	14	m.	m.	PROPN
easat-8115	299	15	c.	c.	PROPN
easat-8115	299	16	rodriguez	rodriguez	PROPN
easat-8115	299	17	-	-	PUNCT
easat-8115	299	18	barradas	barradas	PROPN
easat-8115	299	19	,	,	PUNCT
easat-8115	299	20	j.	j.	PROPN
easat-8115	299	21	a.	a.	PROPN
easat-8115	299	22	aberg	aberg	PROPN
easat-8115	299	23	,	,	PUNCT
easat-8115	299	24	and	and	CCONJ
easat-8115	299	25	m.	m.	NOUN
easat-8115	299	26	j.	j.	PROPN
easat-8115	299	27	gill	gill	PROPN
easat-8115	299	28	,	,	PUNCT
easat-8115	299	29	"	"	PUNCT
easat-8115	299	30	long	long	ADJ
easat-8115	299	31	-	-	PUNCT
easat-8115	299	32	term	term	NOUN
easat-8115	299	33	outcomes	outcome	NOUN
easat-8115	299	34	of	of	ADP
easat-8115	299	35	patients	patient	NOUN
easat-8115	299	36	with	with	ADP
easat-8115	299	37	hiv	hiv	PROPN
easat-8115	299	38	and	and	CCONJ
easat-8115	299	39	pneumocystis	pneumocystis	ADJ
easat-8115	299	40	jirovecii	jirovecii	ADJ
easat-8115	299	41	pneumonia	pneumonia	NOUN
easat-8115	299	42	in	in	ADP
easat-8115	299	43	the	the	DET
easat-8115	299	44	antiretroviral	antiretroviral	ADJ
easat-8115	299	45	therapy	therapy	NOUN
easat-8115	299	46	era	era	NOUN
easat-8115	299	47	,	,	PUNCT
easat-8115	299	48	"	"	PUNCT
easat-8115	299	49	open	open	ADJ
easat-8115	299	50	forum	forum	VERB
easat-8115	299	51	infectious	infectious	ADJ
easat-8115	299	52	diseases	disease	NOUN
easat-8115	299	53	,	,	PUNCT
easat-8115	299	54	vol	vol	NOUN
easat-8115	299	55	.	.	PROPN
easat-8115	299	56	10	10	NUM
easat-8115	299	57	,	,	PUNCT
easat-8115	299	58	no	no	INTJ
easat-8115	299	59	.	.	NOUN
easat-8115	299	60	8	8	NUM
easat-8115	299	61	,	,	PUNCT
easat-8115	299	62	p.	p.	NOUN
easat-8115	299	63	ofad408	ofad408	PROPN
easat-8115	299	64	,	,	PUNCT
easat-8115	299	65	2023	2023	NUM
easat-8115	299	66	.	.	PUNCT
easat-8115	300	1	https://doi.org/10.1093/ofid/ofad408	https://doi.org/10.1093/ofid/ofad408	X
easat-8115	301	1	[	[	X
easat-8115	301	2	30	30	NUM
easat-8115	301	3	]	]	X
easat-8115	301	4	j.	j.	PROPN
easat-8115	301	5	li	li	PROPN
easat-8115	301	6	,	,	PUNCT
easat-8115	301	7	x.	x.	PROPN
easat-8115	301	8	mu	mu	PROPN
easat-8115	301	9	,	,	PUNCT
easat-8115	301	10	h.	h.	PROPN
easat-8115	301	11	li	li	PROPN
easat-8115	301	12	,	,	PUNCT
easat-8115	301	13	y.	y.	PROPN
easat-8115	301	14	zhang	zhang	PROPN
easat-8115	301	15	,	,	PUNCT
easat-8115	301	16	and	and	CCONJ
easat-8115	301	17	l.	l.	PROPN
easat-8115	301	18	wang	wang	PROPN
easat-8115	301	19	,	,	PUNCT
easat-8115	301	20	"	"	PUNCT
easat-8115	301	21	clinical	clinical	ADJ
easat-8115	301	22	course	course	NOUN
easat-8115	301	23	and	and	CCONJ
easat-8115	301	24	prognostic	prognostic	ADJ
easat-8115	301	25	factors	factor	NOUN
easat-8115	301	26	of	of	ADP
easat-8115	301	27	pneumocystis	pneumocystis	ADJ
easat-8115	301	28	pneumonia	pneumonia	NOUN
easat-8115	301	29	with	with	ADP
easat-8115	301	30	respiratory	respiratory	ADJ
easat-8115	301	31	failure	failure	NOUN
easat-8115	301	32	in	in	ADP
easat-8115	301	33	non	non	ADJ
easat-8115	301	34	-	-	ADJ
easat-8115	301	35	hiv	hiv	ADJ
easat-8115	301	36	patients	patient	NOUN
easat-8115	301	37	,	,	PUNCT
easat-8115	301	38	"	"	PUNCT
easat-8115	301	39	frontiers	frontier	NOUN
easat-8115	301	40	in	in	ADP
easat-8115	301	41	cellular	cellular	ADJ
easat-8115	301	42	and	and	CCONJ
easat-8115	301	43	infection	infection	NOUN
easat-8115	301	44	microbiology	microbiology	NOUN
easat-8115	301	45	,	,	PUNCT
easat-8115	301	46	vol	vol	NOUN
easat-8115	301	47	.	.	PROPN
easat-8115	301	48	14	14	NUM
easat-8115	301	49	,	,	PUNCT
easat-8115	301	50	p.	p.	NOUN
easat-8115	301	51	1380494	1380494	NUM
easat-8115	301	52	,	,	PUNCT
easat-8115	301	53	2024	2024	NUM
easat-8115	301	54	.	.	PUNCT
easat-8115	302	1	https://doi.org/10.3389/fcimb.2024.1380494	https://doi.org/10.3389/fcimb.2024.1380494	NOUN
easat-8115	303	1	[	[	X
easat-8115	303	2	31	31	NUM
easat-8115	303	3	]	]	X
easat-8115	303	4	y.	y.	PROPN
easat-8115	303	5	li	li	PROPN
easat-8115	303	6	,	,	PUNCT
easat-8115	303	7	m.	m.	NOUN
easat-8115	303	8	ghannoum	ghannoum	PROPN
easat-8115	303	9	,	,	PUNCT
easat-8115	303	10	c.	c.	PROPN
easat-8115	303	11	deng	deng	PROPN
easat-8115	303	12	,	,	PUNCT
easat-8115	303	13	h.	h.	PROPN
easat-8115	303	14	masur	masur	PROPN
easat-8115	303	15	,	,	PUNCT
easat-8115	303	16	and	and	CCONJ
easat-8115	303	17	l.	l.	PROPN
easat-8115	303	18	huang	huang	PROPN
easat-8115	303	19	,	,	PUNCT
easat-8115	303	20	"	"	PUNCT
easat-8115	303	21	pneumocystis	pneumocystis	ADJ
easat-8115	303	22	pneumonia	pneumonia	NOUN
easat-8115	303	23	in	in	ADP
easat-8115	303	24	patients	patient	NOUN
easat-8115	303	25	with	with	ADP
easat-8115	303	26	inflammatory	inflammatory	ADJ
easat-8115	303	27	or	or	CCONJ
easat-8115	303	28	autoimmune	autoimmune	ADJ
easat-8115	303	29	diseases	disease	NOUN
easat-8115	303	30	:	:	PUNCT
easat-8115	303	31	usefulness	usefulness	NOUN
easat-8115	303	32	of	of	ADP
easat-8115	303	33	lymphocyte	lymphocyte	ADJ
easat-8115	303	34	subtyping	subtyping	NOUN
easat-8115	303	35	,	,	PUNCT
easat-8115	303	36	"	"	PUNCT
easat-8115	303	37	international	international	ADJ
easat-8115	303	38	journal	journal	NOUN
easat-8115	303	39	of	of	ADP
easat-8115	303	40	infectious	infectious	ADJ
easat-8115	303	41	diseases	disease	NOUN
easat-8115	303	42	,	,	PUNCT
easat-8115	303	43	vol	vol	NOUN
easat-8115	303	44	.	.	PROPN
easat-8115	303	45	57	57	NUM
easat-8115	303	46	,	,	PUNCT
easat-8115	303	47	pp	pp	ADJ
easat-8115	303	48	.	.	PUNCT
easat-8115	304	1	108–115	108–115	NUM
easat-8115	304	2	,	,	PUNCT
easat-8115	304	3	2017	2017	NUM
easat-8115	304	4	.	.	PUNCT
easat-8115	305	1	[	[	X
easat-8115	305	2	32	32	NUM
easat-8115	305	3	]	]	PUNCT
easat-8115	305	4	d.	d.	PROPN
easat-8115	305	5	o.	o.	PROPN
easat-8115	305	6	c.	c.	PROPN
easat-8115	305	7	nwonu	nwonu	PROPN
easat-8115	305	8	,	,	PUNCT
easat-8115	305	9	m.	m.	NOUN
easat-8115	305	10	d.	d.	PROPN
easat-8115	305	11	m.	m.	PROPN
easat-8115	305	12	dong	dong	PROPN
easat-8115	305	13	,	,	PUNCT
easat-8115	305	14	and	and	CCONJ
easat-8115	305	15	m.	m.	PROPN
easat-8115	305	16	d.	d.	PROPN
easat-8115	305	17	d.	d.	PROPN
easat-8115	305	18	kramer	kramer	PROPN
easat-8115	305	19	,	,	PUNCT
easat-8115	305	20	"	"	PUNCT
easat-8115	305	21	an	an	DET
easat-8115	305	22	educational	educational	ADJ
easat-8115	305	23	case	case	NOUN
easat-8115	305	24	for	for	ADP
easat-8115	305	25	applying	apply	VERB
easat-8115	305	26	the	the	DET
easat-8115	305	27	alveolar	alveolar	ADJ
easat-8115	305	28	-	-	PUNCT
easat-8115	305	29	arterial	arterial	NOUN
easat-8115	305	30	gradient	gradient	NOUN
easat-8115	305	31	in	in	ADP
easat-8115	305	32	hypoxemia	hypoxemia	PROPN
easat-8115	305	33	:	:	PUNCT
easat-8115	305	34	an	an	DET
easat-8115	305	35	underutilized	underutilized	ADJ
easat-8115	305	36	and	and	CCONJ
easat-8115	305	37	underappreciated	underappreciated	ADJ
easat-8115	305	38	clinical	clinical	ADJ
easat-8115	305	39	tool	tool	NOUN
easat-8115	305	40	,	,	PUNCT
easat-8115	305	41	"	"	PUNCT
easat-8115	305	42	the	the	DET
easat-8115	305	43	medicine	medicine	PROPN
easat-8115	305	44	forum	forum	PROPN
easat-8115	305	45	,	,	PUNCT
easat-8115	305	46	vol	vol	NOUN
easat-8115	305	47	.	.	PROPN
easat-8115	306	1	24	24	NUM
easat-8115	306	2	,	,	PUNCT
easat-8115	306	3	no	no	INTJ
easat-8115	306	4	.	.	NOUN
easat-8115	306	5	1	1	NUM
easat-8115	306	6	,	,	PUNCT
easat-8115	306	7	pp	pp	ADJ
easat-8115	306	8	.	.	PUNCT
easat-8115	306	9	17	17	NUM
easat-8115	306	10	,	,	PUNCT
easat-8115	306	11	2023	2023	NUM
easat-8115	306	12	.	.	PUNCT
easat-8115	307	1	[	[	X
easat-8115	307	2	33	33	NUM
easat-8115	307	3	]	]	PUNCT
easat-8115	307	4	b.	b.	PROPN
easat-8115	307	5	langevin	langevin	PROPN
easat-8115	307	6	and	and	CCONJ
easat-8115	307	7	m.	m.	NOUN
easat-8115	307	8	saleh	saleh	NOUN
easat-8115	307	9	,	,	PUNCT
easat-8115	307	10	"	"	PUNCT
easat-8115	307	11	radiological	radiological	ADJ
easat-8115	307	12	presentation	presentation	NOUN
easat-8115	307	13	of	of	ADP
easat-8115	307	14	pneumocystis	pneumocystis	ADJ
easat-8115	307	15	jiroveci	jiroveci	PROPN
easat-8115	307	16	pneumonia	pneumonia	NOUN
easat-8115	307	17	mimicking	mimic	VERB
easat-8115	307	18	bacterial	bacterial	ADJ
easat-8115	307	19	pneumonia	pneumonia	NOUN
easat-8115	307	20	,	,	PUNCT
easat-8115	307	21	"	"	PUNCT
easat-8115	307	22	bmj	bmj	PROPN
easat-8115	307	23	case	case	NOUN
easat-8115	307	24	reports	report	VERB
easat-8115	307	25	,	,	PUNCT
easat-8115	307	26	2016	2016	NUM
easat-8115	307	27	,	,	PUNCT
easat-8115	307	28	p.	p.	NOUN
easat-8115	307	29	bcr2016215207	bcr2016215207	NOUN
easat-8115	307	30	,	,	PUNCT
easat-8115	307	31	2016	2016	NUM
easat-8115	307	32	.	.	PUNCT
easat-8115	308	1	https://doi.org/10.1136/bcr-2016-215207	https://doi.org/10.1136/bcr-2016-215207	NOUN
easat-8115	309	1	[	[	X
easat-8115	309	2	34	34	NUM
easat-8115	309	3	]	]	X
easat-8115	309	4	j.	j.	PROPN
easat-8115	309	5	m.	m.	PROPN
easat-8115	309	6	hsu	hsu	PROPN
easat-8115	309	7	,	,	PUNCT
easat-8115	309	8	a.	a.	PROPN
easat-8115	309	9	hass	hass	PROPN
easat-8115	309	10	,	,	PUNCT
easat-8115	309	11	m.	m.	NOUN
easat-8115	309	12	a.	a.	NOUN
easat-8115	309	13	gingras	gingras	PROPN
easat-8115	309	14	,	,	PUNCT
easat-8115	309	15	d.	d.	PROPN
easat-8115	309	16	yang	yang	PROPN
easat-8115	309	17	,	,	PUNCT
easat-8115	309	18	p.	p.	PROPN
easat-8115	309	19	kulkarni	kulkarni	PROPN
easat-8115	309	20	,	,	PUNCT
easat-8115	309	21	and	and	CCONJ
easat-8115	309	22	l.	l.	PROPN
easat-8115	309	23	huang	huang	PROPN
easat-8115	309	24	,	,	PUNCT
easat-8115	309	25	"	"	PUNCT
easat-8115	309	26	radiographic	radiographic	ADJ
easat-8115	309	27	features	feature	NOUN
easat-8115	309	28	in	in	ADP
easat-8115	309	29	patients	patient	NOUN
easat-8115	309	30	investigated	investigate	VERB
easat-8115	309	31	for	for	ADP
easat-8115	309	32	pneumocystis	pneumocystis	ADJ
easat-8115	309	33	jirovecii	jirovecii	NOUN
easat-8115	309	34	pneumonia	pneumonia	NOUN
easat-8115	309	35	:	:	PUNCT
easat-8115	309	36	a	a	DET
easat-8115	309	37	nested	nested	ADJ
easat-8115	309	38	case	case	NOUN
easat-8115	309	39	-	-	PUNCT
easat-8115	309	40	control	control	NOUN
easat-8115	309	41	study	study	NOUN
easat-8115	309	42	,	,	PUNCT
easat-8115	309	43	"	"	PUNCT
easat-8115	309	44	bmc	bmc	VERB
easat-8115	309	45	infectious	infectious	ADJ
easat-8115	309	46	diseases	disease	NOUN
easat-8115	309	47	,	,	PUNCT
easat-8115	309	48	vol	vol	NOUN
easat-8115	309	49	.	.	PROPN
easat-8115	309	50	20	20	NUM
easat-8115	309	51	,	,	PUNCT
easat-8115	309	52	no	no	INTJ
easat-8115	309	53	.	.	NOUN
easat-8115	309	54	1	1	NUM
easat-8115	309	55	,	,	PUNCT
easat-8115	309	56	p.	p.	NOUN
easat-8115	309	57	492	492	NUM
easat-8115	309	58	,	,	PUNCT
easat-8115	309	59	2020	2020	NUM
easat-8115	309	60	.	.	PUNCT
easat-8115	310	1	https://doi.org/10.1186/s12879-020-05217-x	https://doi.org/10.1186/s12879-020-05217-x	PROPN
easat-8115	310	2	https://doi.org/10.3389/fimmu.2021.649465	https://doi.org/10.3389/fimmu.2021.649465	PROPN
easat-8115	310	3	https://doi.org/10.3390/jof7080625	https://doi.org/10.3390/jof7080625	NOUN
easat-8115	310	4	https://doi.org/10.3390/ijms22094496	https://doi.org/10.3390/ijms22094496	NOUN
easat-8115	310	5	https://doi.org/10.3389/fimmu.2023.1158859	https://doi.org/10.3389/fimmu.2023.1158859	PROPN
easat-8115	310	6	https://doi.org/10.4081/mrm.2022.802	https://doi.org/10.4081/mrm.2022.802	ADJ
easat-8115	310	7	https://doi.org/10.1093/clinids/20.2.352	https://doi.org/10.1093/clinids/20.2.352	NUM
easat-8115	310	8	https://doi.org/10.1186/1471-2334-12-128	https://doi.org/10.1186/1471-2334-12-128	NOUN
easat-8115	310	9	https://doi.org/10.1186/1471-2334-12-128	https://doi.org/10.1186/1471-2334-12-128	NOUN
easat-8115	310	10	https://doi.org/10.1093/ofid/ofad408	https://doi.org/10.1093/ofid/ofad408	ADV
easat-8115	310	11	https://doi.org/10.3389/fcimb.2024.1380494	https://doi.org/10.3389/fcimb.2024.1380494	PROPN
easat-8115	310	12	https://doi.org/10.1136/bcr-2016-215207	https://doi.org/10.1136/bcr-2016-215207	NOUN
easat-8115	310	13	https://doi.org/10.1186/s12879-020-05217-x	https://doi.org/10.1186/s12879-020-05217-x	PROPN
easat-8115	310	14	1341	1341	NUM
easat-8115	310	15	edelweiss	edelweiss	PROPN
easat-8115	310	16	applied	apply	VERB
easat-8115	310	17	science	science	NOUN
easat-8115	310	18	and	and	CCONJ
easat-8115	310	19	technology	technology	NOUN
easat-8115	310	20	issn	issn	PROPN
easat-8115	310	21	:	:	PUNCT
easat-8115	310	22	2576	2576	NUM
easat-8115	310	23	-	-	SYM
easat-8115	310	24	8484	8484	NUM
easat-8115	310	25	vol	vol	NOUN
easat-8115	310	26	.	.	PROPN
easat-8115	311	1	9	9	NUM
easat-8115	311	2	,	,	PUNCT
easat-8115	311	3	no	no	INTJ
easat-8115	311	4	.	.	NOUN
easat-8115	312	1	6	6	NUM
easat-8115	312	2	:	:	SYM
easat-8115	312	3	1331	1331	NUM
easat-8115	312	4	-	-	SYM
easat-8115	312	5	1341	1341	NUM
easat-8115	312	6	,	,	PUNCT
easat-8115	312	7	2025	2025	NUM
easat-8115	312	8	doi	doi	NOUN
easat-8115	312	9	:	:	PUNCT
easat-8115	312	10	10.55214/25768484.v9i6.8115	10.55214/25768484.v9i6.8115	NUM
easat-8115	312	11	©	©	PROPN
easat-8115	312	12	2025	2025	NUM
easat-8115	312	13	by	by	ADP
easat-8115	312	14	the	the	DET
easat-8115	312	15	authors	author	NOUN
easat-8115	312	16	;	;	PUNCT
easat-8115	312	17	licensee	licensee	PROPN
easat-8115	312	18	learning	learn	VERB
easat-8115	312	19	gate	gate	NOUN
easat-8115	312	20	table	table	NOUN
easat-8115	312	21	2	2	NUM
easat-8115	312	22	.	.	PUNCT
easat-8115	312	23	clinical	clinical	ADJ
easat-8115	312	24	manifestation	manifestation	NOUN
easat-8115	312	25	,	,	PUNCT
easat-8115	312	26	laboratory	laboratory	NOUN
easat-8115	312	27	,	,	PUNCT
easat-8115	312	28	and	and	CCONJ
easat-8115	312	29	radiological	radiological	ADJ
easat-8115	312	30	parameters	parameter	NOUN
easat-8115	312	31	.	.	PUNCT
easat-8115	313	1	n	n	PROPN
easat-8115	313	2	(	(	PUNCT
easat-8115	313	3	%	%	INTJ
easat-8115	313	4	)	)	PUNCT
easat-8115	313	5	mean	mean	NOUN
easat-8115	313	6	±	±	NUM
easat-8115	313	7	sd	sd	ADP
easat-8115	313	8	clinical	clinical	ADJ
easat-8115	313	9	manifestation	manifestation	NOUN
easat-8115	313	10	dyspnoea	dyspnoea	PROPN
easat-8115	313	11	67	67	NUM
easat-8115	313	12	(	(	PUNCT
easat-8115	313	13	83.8	83.8	NUM
easat-8115	313	14	%	%	NOUN
easat-8115	313	15	)	)	PUNCT
easat-8115	313	16	oral	oral	ADJ
easat-8115	313	17	candidiasis	candidiasis	NOUN
easat-8115	313	18	43	43	NUM
easat-8115	313	19	(	(	PUNCT
easat-8115	313	20	53.8	53.8	NUM
easat-8115	313	21	%	%	NOUN
easat-8115	313	22	)	)	PUNCT
easat-8115	313	23	non	non	ADJ
easat-8115	313	24	-	-	ADJ
easat-8115	313	25	productive	productive	ADJ
easat-8115	313	26	cough	cough	NOUN
easat-8115	313	27	40	40	NUM
easat-8115	313	28	(	(	PUNCT
easat-8115	313	29	50	50	NUM
easat-8115	313	30	%	%	NOUN
easat-8115	313	31	)	)	PUNCT
easat-8115	313	32	low	low	ADJ
easat-8115	313	33	grade	grade	NOUN
easat-8115	313	34	fever	fever	NOUN
easat-8115	313	35	47	47	NUM
easat-8115	313	36	(	(	PUNCT
easat-8115	313	37	40	40	NUM
easat-8115	313	38	%	%	NOUN
easat-8115	313	39	)	)	PUNCT
easat-8115	313	40	spo2	spo2	PROPN
easat-8115	313	41	/	/	SYM
easat-8115	313	42	fio2	fio2	PROPN
easat-8115	313	43	354.8	354.8	NUM
easat-8115	313	44	±	±	NOUN
easat-8115	313	45	14.248	14.248	NUM
easat-8115	313	46	laboratory	laboratory	NOUN
easat-8115	313	47	haemoglobin	haemoglobin	NOUN
easat-8115	313	48	(	(	PUNCT
easat-8115	313	49	g	g	PROPN
easat-8115	313	50	/	/	SYM
easat-8115	313	51	dl	dl	NOUN
easat-8115	313	52	)	)	PUNCT
easat-8115	313	53	11,49	11,49	NUM
easat-8115	313	54	±	±	NOUN
easat-8115	313	55	0,28	0,28	NUM
easat-8115	314	1	platelet	platelet	NOUN
easat-8115	314	2	(	(	PUNCT
easat-8115	314	3	103/µl	103/µl	X
easat-8115	314	4	)	)	PUNCT
easat-8115	314	5	290,2	290,2	NUM
easat-8115	314	6	±	±	NUM
easat-8115	314	7	14,86	14,86	NUM
easat-8115	314	8	wbc	wbc	PROPN
easat-8115	314	9	(	(	PUNCT
easat-8115	314	10	103/µl	103/µl	NUM
easat-8115	314	11	)	)	PUNCT
easat-8115	314	12	8.6	8.6	NUM
easat-8115	314	13	±	±	NUM
easat-8115	314	14	4.5	4.5	NUM
easat-8115	314	15	lymphocyte(103/µl	lymphocyte(103/µl	NOUN
easat-8115	314	16	)	)	PUNCT
easat-8115	314	17	1.2	1.2	NUM
easat-8115	314	18	±	±	NUM
easat-8115	314	19	0.89	0.89	NUM
easat-8115	314	20	nlr	nlr	PROPN
easat-8115	314	21	12,7	12,7	NUM
easat-8115	314	22	±	±	PROPN
easat-8115	314	23	1,95	1,95	NUM
easat-8115	314	24	mlr	mlr	NOUN
easat-8115	314	25	0.79	0.79	NUM
easat-8115	314	26	±	±	NUM
easat-8115	314	27	0.07	0.07	NUM
easat-8115	314	28	albumin	albumin	NOUN
easat-8115	314	29	(	(	PUNCT
easat-8115	314	30	g	g	PROPN
easat-8115	314	31	/	/	SYM
easat-8115	314	32	dl	dl	NOUN
easat-8115	314	33	)	)	PUNCT
easat-8115	314	34	3.41	3.41	NUM
easat-8115	314	35	±	±	NUM
easat-8115	314	36	0.31	0.31	NUM
easat-8115	314	37	eosinophil	eosinophil	ADJ
easat-8115	314	38	(	(	PUNCT
easat-8115	314	39	103/µl	103/µl	NUM
easat-8115	314	40	)	)	PUNCT
easat-8115	314	41	0.083	0.083	NUM
easat-8115	314	42	±	±	PROPN
easat-8115	314	43	0.012	0.012	NUM
easat-8115	314	44	cd4	cd4	PROPN
easat-8115	314	45	(	(	PUNCT
easat-8115	314	46	cells/µl	cells/µl	NOUN
easat-8115	314	47	)	)	PUNCT
easat-8115	314	48	149.36	149.36	NUM
easat-8115	314	49	±	±	NUM
easat-8115	314	50	21.3	21.3	NUM
easat-8115	314	51	cd8	cd8	PROPN
easat-8115	314	52	(	(	PUNCT
easat-8115	314	53	cells/µl	cells/µl	NOUN
easat-8115	314	54	)	)	PUNCT
easat-8115	314	55	565.11	565.11	NUM
easat-8115	314	56	±	±	NOUN
easat-8115	314	57	57.54	57.54	NUM
easat-8115	314	58	aado2	aado2	NOUN
easat-8115	314	59	48.43	48.43	NUM
easat-8115	314	60	±	±	NUM
easat-8115	314	61	4.34	4.34	NUM
easat-8115	314	62	radiological	radiological	ADJ
easat-8115	314	63	typical(ground	typical(ground	ADJ
easat-8115	314	64	glass	glass	NOUN
easat-8115	314	65	opacity	opacity	NOUN
easat-8115	314	66	,	,	PUNCT
easat-8115	314	67	interstitial	interstitial	ADJ
easat-8115	314	68	infiltrates	infiltrate	NOUN
easat-8115	314	69	,	,	PUNCT
easat-8115	314	70	reticulogranular	reticulogranular	NOUN
easat-8115	314	71	)	)	PUNCT
easat-8115	314	72	13	13	NUM
easat-8115	314	73	(	(	PUNCT
easat-8115	314	74	16.3	16.3	NUM
easat-8115	314	75	%	%	NOUN
easat-8115	314	76	)	)	PUNCT
easat-8115	314	77	atypical	atypical	ADJ
easat-8115	314	78	(	(	PUNCT
easat-8115	314	79	infiltrates	infiltrate	NOUN
easat-8115	314	80	,	,	PUNCT
easat-8115	314	81	consolidation	consolidation	NOUN
easat-8115	314	82	)	)	PUNCT
easat-8115	314	83	53	53	NUM
easat-8115	314	84	(	(	PUNCT
easat-8115	314	85	66.3	66.3	NUM
easat-8115	314	86	%	%	NOUN
easat-8115	314	87	)	)	PUNCT
easat-8115	314	88	normal	normal	ADJ
easat-8115	314	89	14	14	NUM
easat-8115	314	90	(	(	PUNCT
easat-8115	314	91	17.5	17.5	NUM
easat-8115	314	92	%	%	NOUN
easat-8115	314	93	)	)	PUNCT
easat-8115	314	94	note	note	NOUN
easat-8115	314	95	:	:	PUNCT
easat-8115	314	96	nlr	nlr	PROPN
easat-8115	314	97	=	=	NOUN
easat-8115	314	98	neutrophil	neutrophil	ADJ
easat-8115	314	99	lymphocyte	lymphocyte	ADJ
easat-8115	314	100	ratio	ratio	NOUN
easat-8115	314	101	)	)	PUNCT
easat-8115	314	102	;	;	PUNCT
easat-8115	315	1	mlr	mlr	PROPN
easat-8115	315	2	=	=	NOUN
easat-8115	315	3	monocytes	monocyte	VERB
easat-8115	315	4	lymphocyte	lymphocyte	ADJ
easat-8115	315	5	ratio	ratio	NOUN
easat-8115	315	6	)	)	PUNCT
easat-8115	315	7	.	.	PUNCT
easat-8115	316	1	table	table	NOUN
easat-8115	316	2	6	6	NUM
easat-8115	316	3	.	.	PUNCT
easat-8115	316	4	relationship	relationship	NOUN
easat-8115	316	5	of	of	ADP
easat-8115	316	6	chest	chest	NOUN
easat-8115	316	7	x	x	NOUN
easat-8115	316	8	-	-	NOUN
easat-8115	316	9	ray	ray	NOUN
easat-8115	316	10	results	result	NOUN
easat-8115	316	11	with	with	ADP
easat-8115	316	12	sputum	sputum	PROPN
easat-8115	316	13	pcr	pcr	PROPN
easat-8115	316	14	positivity	positivity	NOUN
easat-8115	316	15	in	in	ADP
easat-8115	316	16	study	study	NOUN
easat-8115	316	17	subjects	subject	NOUN
easat-8115	316	18	.	.	PUNCT
easat-8115	317	1	radiological	radiological	ADJ
easat-8115	317	2	sputum	sputum	PROPN
easat-8115	317	3	pcr	pcr	PROPN
easat-8115	317	4	bivariate	bivariate	ADJ
easat-8115	317	5	analysis	analysis	NOUN
easat-8115	317	6	multivariate	multivariate	NOUN
easat-8115	317	7	analysis	analysis	NOUN
easat-8115	317	8	p	p	NOUN
easat-8115	317	9	-	-	PUNCT
easat-8115	317	10	value	value	NOUN
easat-8115	317	11	pr	pr	NOUN
easat-8115	317	12	(	(	PUNCT
easat-8115	317	13	95%ci	95%ci	NUM
easat-8115	317	14	)	)	PUNCT
easat-8115	317	15	p	p	NOUN
easat-8115	317	16	-	-	PUNCT
easat-8115	317	17	value	value	NOUN
easat-8115	317	18	pr	pr	NOUN
easat-8115	317	19	(	(	PUNCT
easat-8115	317	20	95%ci	95%ci	NUM
easat-8115	317	21	)	)	PUNCT
easat-8115	317	22	positive	positive	ADJ
easat-8115	317	23	(	(	PUNCT
easat-8115	317	24	n	n	NOUN
easat-8115	317	25	=	=	SYM
easat-8115	317	26	50	50	NUM
easat-8115	317	27	)	)	PUNCT
easat-8115	317	28	negative	negative	ADJ
easat-8115	317	29	(	(	PUNCT
easat-8115	317	30	n	n	NOUN
easat-8115	317	31	=	=	SYM
easat-8115	317	32	30	30	NUM
easat-8115	317	33	)	)	PUNCT
easat-8115	317	34	atypical	atypical	ADJ
easat-8115	317	35	36	36	NUM
easat-8115	317	36	(	(	PUNCT
easat-8115	317	37	72	72	NUM
easat-8115	317	38	%	%	NOUN
easat-8115	317	39	)	)	PUNCT
easat-8115	317	40	17	17	NUM
easat-8115	317	41	(	(	PUNCT
easat-8115	317	42	56.7	56.7	NUM
easat-8115	317	43	%	%	NOUN
easat-8115	317	44	)	)	PUNCT
easat-8115	317	45	0.02	0.02	NUM
easat-8115	317	46	5.21	5.21	NUM
easat-8115	317	47	(	(	PUNCT
easat-8115	317	48	1.29	1.29	NUM
easat-8115	317	49	-	-	SYM
easat-8115	317	50	21	21	NUM
easat-8115	317	51	)	)	PUNCT
easat-8115	317	52	0.02	0.02	NUM
easat-8115	317	53	5.43	5.43	NUM
easat-8115	317	54	(	(	PUNCT
easat-8115	317	55	1.47	1.47	NUM
easat-8115	317	56	20.05	20.05	NUM
easat-8115	317	57	)	)	PUNCT
easat-8115	317	58	typical	typical	ADJ
easat-8115	317	59	10	10	NUM
easat-8115	317	60	(	(	PUNCT
easat-8115	317	61	20	20	NUM
easat-8115	317	62	%	%	NOUN
easat-8115	317	63	)	)	PUNCT
easat-8115	317	64	3	3	NUM
easat-8115	317	65	(	(	PUNCT
easat-8115	317	66	10	10	NUM
easat-8115	317	67	%	%	NOUN
easat-8115	317	68	)	)	PUNCT
easat-8115	317	69	0.05	0.05	NUM
easat-8115	317	70	15	15	NUM
easat-8115	317	71	.	.	PUNCT
easat-8115	318	1	(	(	PUNCT
easat-8115	318	2	2.28	2.28	NUM
easat-8115	318	3	-	-	SYM
easat-8115	318	4	109.2	109.2	NUM
easat-8115	318	5	)	)	PUNCT
easat-8115	318	6	0.01	0.01	NUM
easat-8115	318	7	20.6(2.9	20.6(2.9	NUM
easat-8115	318	8	–	–	PUNCT
easat-8115	318	9	144.2	144.2	NUM
easat-8115	318	10	)	)	PUNCT